B-REF	Advisory Council for the Concerted Action in Health Care (ACCAHC) (2003). Health Care Finance, User
I-REF	Orientation and Quality. Report 2003, Summary. Bonn (http://www.svr-
I-REF	gesundheit.de/gutacht/sogu03/03eng/engl03.pdf).
B-REF	Afonso, Nelia; Nassif, George; Aranha, Anil; DeLor, Bonnie; Cardozo, Lavoisier (2006). Low-density Lipo-
I-REF	protein Cholesterol Goal Attainment Among High-risk Patients: Does a Combined Intervention Targeting
I-REF	Patients and Providers Work? Am J Manag Care 12 (10), S. 589- 594
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_06octAfonso589to594.pdf).
B-REF	Ahlamaa-Tuompo, Jaana; Linna, Miika; Kekomäki, Martti (1998). Impact of user charges and socio-
I-REF	economic environment on visits to paediatric trauma unit in Finland. Scand J Pub Health 26 (4), S. 265-269
I-REF	(http://sjp.sagepub.com/cgi/reprint/26/4/265).
B-REF	Ahlamaa-Tuompo, Jaana; Linna, Miika; Kekomäki, Martti (1998). User charges and the demand for acute
I-REF	paediatric traumatology services. Pub Health 112 (5), S. 327-329.
B-REF	Ahlamaa-Tuompo, Jaana (1999). The Effect of User Charges and Socio-Demographic Environment on Pae-
I-REF	diatric Trauma Hospitalisation in Helsinki in 1989-1994. Eur J Epidem 15 (2), S. 133-139
I-REF	(http://www.springerlink.com/content/r88752270210180g/fulltext.pdf).
B-REF	Alan, Sule; Crossley, Thomas; Grootendorst, Paul; Veall, Michael (2002a). Out-of-Pocket Prescription Drug
I-REF	Expenditures and Public Prescription Drug Programs. Research Institute for Quantitative Studies in Eco-
I-REF	nomics and Population, Research Report No. 379, McMaster University Hamilton, L8S 4M4
I-REF	(http://socserv2.mcmaster.ca/qsep/p/qsep379.pdf).
B-REF	Alan, Sule; Crossley, Thomas; Grootendorst, Paul; Veall, Michael (2002b). The effects of drug subsidies on
I-REF	out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada. J H Econ 21 (5), S.
I-REF	805–826.
B-REF	Alan, Sule; Crossley, Thomas; Grootendorst, Paul; Veall, Michael (2003). Out-of-Pocket Prescription Drug
I-REF	Expenditures and Public Prescription Drug Programs. Forschungsinstitut zur Zukunft der Arbeit/Institute for
I-REF	the Study of Labor, IZA Discussion Paper No. 695, Bonn (http://opus.zbw-
I-REF	kiel.de/volltexte/2003/290/pdf/dp695.pdf; http://socserv.mcmaster.ca/rdc/RDCwp1.pdf).
B-REF	Alber, Jens (2002). Besser als sein Ruf. Der Sozialstaat als erfolgreiches Modell. WZB-Mitteilungen 98.
I-REF	Wissenschaftszentrum Berlin für Sozialforschung. Berlin (http://www.wz-
I-REF	berlin.de/publikation/pdf/wm98/WM98_24-28.pdf).
B-REF	Alevizos, Alevizos; Mihas, Constantinos; Mariolis, Anargiros (2007). The Effects of Cost Sharing on Statin
I-REF	Adherence. Am J Man Care 13 (8), S. e2-e3
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_07AUG_WebLtrToEd.pdf).
B-REF	Alexander, Caleb; Tseng, Chien-Weng (2004). Six strategies to identify and assist patients burdened by out-
I-REF	of-pocket prescription costs. Clevel Clin J Med 71 (5), S. 433-437
I-REF	(http://home.uchicago.edu/~galexand/Alexander504.pdf).
B-REF	Alexander, Caleb; Casalino, Laurence; Meltzer, David (2003). Patient-physician communication about out-
I-REF	of-pocket costs. JAMA 290 (7), S. 953-958 (http://jama.ama-assn.org/cgi/reprint/290/7/953.pdf).
B-REF	Alexander, Caleb; Casalino, Laurence; Meltzer, David (2005). Physician Strategies to Reduce Patients’ Out-
I-REF	of-pocket Prescription Costs. Arch Intern Med 165 (6), S. 633-636 (http://archinte.ama-
I-REF	assn.org/cgi/content/reprint/165/6/633).
B-REF	Altman, Drew (2004). The New Medicare Prescription-Drug Legislation. N Engl J Med 350 (1), S. 9-10
I-REF	(http://content.nejm.org/cgi/reprint/350/1/9.pdf).
B-REF	Anderson, Ronald; Bozzette, Samuel; Shapiro, Martin; St. Clair, Patricia; Morton, Sally; Crystal, Stephen;
I-REF	Goldman, Dana; Wenter, Neil; Gifford, Allen; Leibowitz, Arleen; Asch, Steven; Berry, Sandra; Nakazono,
I-REF	Terry; Heslin, Kevin; Cunningham, Willam; and the HCSUSConsortium (2000). Access of Vulnerable
I-REF	Groups to Antiretroviral Therapy Among Persons in Care for HIV in the United States. H Serv Res 35 (2),
I-REF	S. 389-416 (http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1089126&blobtype=pdf).
B-REF	Andersson, Karolina; Petzold, Max-Gustav; Sonesson, Christian; Lonnroth, Knut; Carlsten, Anders (2006).
I-REF	Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?: Interrupted
I-REF	time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002. H Pol 79 (2-3), S.
I-REF	231-243.
B-REF	Anell, Anders; Svensson, Marianne (1999). User charges in health care: the Swedish case. World Health
I-REF	Organization, Geneva, Eurohealth 5 (3), S. 25-26
I-REF	(http://www.euro.who.int/document/obs/EuroHealth5_3.pdf).
B-REF	Anis, Aslam; Guh, Daphne; Wang, Xiao-hua (2001). A dog’s breakfast: prescription drug coverage varies
I-REF	widely across Canada. Med Care 39 (4), S. 315-326.
B-REF	Anis, Alsam; Guh, Daphne; Lacaille, Diane; Marra, Carlo; Rashidi, Amir; Li, Xin; Esdaile, John
I-REF	(2005).When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital
I-REF	admissions and filling of prescriptions. CMAJ 173(11), S. 1335–1340
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1283500&blobtype=pdf).
B-REF	AOK Mediendienst – Presseservice Gesundheit (2002). Gesundheitspolitiker streiten sich um einen Selbst-
I-REF	behalt für Versicherte – Was ist das eigentlich, Herr Dr. Jacobs? psg thema Ausgabe 5, S. 15-16. Bonn,
I-REF	13.9.2002.
B-REF	AOK-Mediendienst (2005). Von A(rztbesuch) bis Z(uzahlung): Das gilt 2006. Pressestelle des AOK-
I-REF	Bundesverbandes, Bonn.
B-REF	Applegate, William (2002). Elderly Patients' Adherence to Statin Therapy. JAMA 288 (4), S. 495-497
I-REF	(http://jama.ama-assn.org/cgi/reprint/288/4/495).
B-REF	Arhin-Tenkorang, Dyna (2000). Mobilizing Resources for Health: The Case of User Fees Revisited. CMH
I-REF	Working Paper Series, Paper No WG3:6. Washington D.C.
I-REF	(http://www.cmhealth.org/docs/wg3_paper6.pdf).
B-REF	Arrow, Kenneth (1963). Uncertainty and the Welfare Economics of Medical Care. Am Econ Rev 53 (5), S.
I-REF	941-973 (http://links.jstor.org/sici?sici=0002-
I-REF	8282%28196312%2953%3A5%3C941%3AUATWEO%3E2.0.CO%3B2-C).
B-REF	Arzneimittelbrief (2007). Ein Vorbericht des IQWiG zur Hypertoniebehandlung: Vergleichende Nutzenbe-
I-REF	wertung verschiedener Antihypertensiva als Therapie der ersten Wahl. Der Arzneimittelbrief 41 (4), S. 27-
I-REF	29 (http://www.arzneimittelbrief.de/_anfang/Artikel.aspx?J=2007&S=27;
I-REF	http://www.arzneimittelbrief.de/_anfang/DER_ARZNEIMITTELBRIEF.aspx?J=2007&S=27).
B-REF	Ashley, John; LeBow, Robert; Pero, Robert (2001). Health for All 101. Policy Resolution # 01-01(I),
I-REF	American College of Preventive Medicine, Washington DC (http://www.acpm.org/res_0101I.htm).
B-REF	Ashley, John; LeBow, Robert; Pero, Robert (2002). Health for All. Policy Resolution # 03-02(A), American
I-REF	College of Preventive Medicine, Washington DC (http://www.acpm.org/res_0302A.pdf).
B-REF	Asplin, Brent; Rhodes, Karin; Levy, Helen; Lurie, Nicole; Crain, Lauren; Carlin, Bradley; Kellermann, Ar-
I-REF	thur (2005). Insurance Status and Access to Urgent Ambulatory Care Follow-up Appointments. JAMA 294
I-REF	(10), S. 1248-1254 (http://jama.ama-assn.org/cgi/reprint/294/10/1248).
B-REF	Atella, Vincenzo; Peracchi, Franco; Depalo, Domenico; Rossetti, Claudio (2006). Drug compliance, co-
I-REF	payment and health outcomes: evidence from a panel of Italian patients. H Econ 15 (9), S. 875-892
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/112664983/PDFSTART;
I-REF	http://www.rand.org/labor/adp_pdfs/2006_peracchi.pdf).
B-REF	Augurzky, Boris; Bauer, Thomas; Schaffner, Sandra (2006). Copayments in the German Health System –
I-REF	Does it work? RWI Discussion paper No. 43, Rheinisch-Westfälisches Institut für Wirtschaftsforschung, Es-
I-REF	sen/IZA Discussion Paper 2292, Forschungsinstitut zur Zukunft der Arbeit (Institute for the Study of Labor),
I-REF	Bonn (http://ftp.iza.org/dp2290.pdf#search=%22Augurzky%20Bauer%20Schaffner%20Copayments%22;
I-REF	http://www.rwi-
I-REF	es-
I-REF	sen.de/pls/portal30/docs/FOLDER/PUBLIKATIONEN/RWIDP/RWI_DP043/DP_06_043.PDF#search=%2
I-REF	2Augurzky%20Bauer%20Schaffner%20Copayments%22;
I-REF	http://www.iza.org/index_html?lang=en&mainframe=http%3A//www.iza.org/en/webcontent/personnel/phot
I-REF	os/index_html%3Fkey%3D271&topSelect=personnel&subSelect=fellows).
B-REF	Avorn, Jerry; Monette, Johanne; Lacour, Anne; Bohn, Ronda; Monane, Mark; Mogun, Helen; LeLorier,
I-REF	Jacques (1998). Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279 (18),
I-REF	S.1458-1462 (http://jama.ama-assn.org/cgi/reprint/279/18/1458).
B-REF	Avorn, Jerry (2006). Part “D” for “Defective” – The Medicare Drug-Benefit Chaos. N Engl J Med 354 (13),
I-REF	S. 1339-1341 (http://content.nejm.org/cgi/reprint/354/13/1339.pdf).
B-REF	Babazono, Akira; Ogawa, Takanori; Babazono, Tsuneko; Hamada, Hirohisa; Tsuda, Toshihide; Aoyama,
I-REF	Hideyasu (1991). The Effect of a Cost Sharing Provision in Japan. Fam Pract 8 (3), S. 247-252
I-REF	(http://fampra.oxfordjournals.org/cgi/reprint/8/3/247).
B-REF	Babazono, Akira; Tsuda, Toshihide; Yamamoto, Eiji; Mino, Yoshio; Une, Hiroshi; Hillman, Alan (2003). Ef-
I-REF	fects of an Increase in Patient Copayments on Medical Service Demands of the Insured in Japan. Int J Techn
I-REF	Ass Health Care 19 (3), S. 465-475 (Abstract:
I-REF	http://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=176027).
B-REF	Babisch, Wolfgang (2000). Traffic Noise and Cardiovascular Disease: Epidemiological Review and Synthe-
I-REF	sis. Noise and Health 2 (8), S. 9-32 (Abstract:
I-REF	http://www.ingentaconnect.com/content/nrn/nh/2000/00000002/00000008/art00002;jsessionid=1q93djl06g
B-REF	w7v.alice).
B-REF	Bachmann, Lucas; Gutzwiller, Florian; Puhan, Milo; Steurer, Johann; Steurer-Stey, Claudia; Gigerenzer,
I-REF	Gerd (2007). Do citizens have minimum medical knowledge? – A survey. BMC Medicine 5 (14)
I-REF	(http://www.biomedcentral.com/1741-7015/5/14).
B-REF	Bae, Seung-in; Paltiel, David; Fuhlbrigge, Anne; Weiss, Scott; Kuntz, Karen (2007). Modeling the Potential
I-REF	Impact of a Prescription Drug Copayment Increase on the Adult Asthmatic Medicaid Population. Value in
I-REF	Health 11 (1), S. 110-118 (http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1524-4733.2007.00219.x).
B-REF	Baker, Judy; van der Gaag, Jacques (1993). Equity in health care and health care financing: evidence from
I-REF	five developing countries. In: van Doorslaer, Eddy; Wagstaff, Adam; Rutton, Frans. Equity in the Finance
I-REF	and Delivery of Health Care: An International Perspective. Oxford University Press, Oxford.
B-REF	Bakker, Frank; van Vliet, René (1995). The introduction of deductibles for prescription drugs in a national
I-REF	health insurance: compulsory or voluntary? H Pol 31 (1), S. 53–65.
B-REF	Baldwin, Arthur; Mulkey, Marian; Kagan, Matthew (2005). The Price of Illness: Cost Sharing and Health
I-REF	Plan Benefits. Issue Brief Sept. 2005, California Healthcare Foundation, Oakland
I-REF	(http://www.chcf.org/documents/insurance/ThePriceofIllnessConsumerCostSharing.pdf).
B-REF	Bankrate.com (2005). Health insurance terms and definitions.
I-REF	(http://www.bankrate.com/nscre/news/insur/20020709a.asp#b).
B-REF	Barer, Morris; Bhatia, Vandha; Stoddart, Greg; Evans, Robert (1993a). User Charges, Snares and Delusions:
I-REF	Another look at the literature. Centre for Health Services and Policy Research, University of British Colum-
I-REF	bia. HPRU, 93. 14D. Calgary (http://www.chspr.ubc.ca//hpru/pdf/hpru93-14D.pdf).
B-REF	Barer, Morris; Bhatia, Vandha; Stoddart, Greg; Evans, Robert (1993b). The Remarkable Tenacity of User
I-REF	Charges: A Concise History of the Participation, Positions and Rationales of Canadian Interest Groups over
I-REF	“Direct Patient Participation” in Health Care Financing. Centre for Health Services and Policy Research,
I-REF	University of British Columbia. HPRU, 93. 15D. Calgary. (http://www.chspr.ubc.ca//hpru/pdf/hpru93-
I-REF	15D.pdf).
B-REF	Barer, Morris; Evans, Robert; Hertzman, Clyde; Johri, Mira (1998). Lies, Damned Lies, and Health Care
I-REF	Zombies: Discredited Ideas That Will Not Die. HPI Discussion Paper No. 10, The University of Texas –
I-REF	Houston Health Science Center (HPRU 98:5D) (www.chspr.ubc.ca/hpru/pdf/hpru98-05D.pdf).
B-REF	Barnett, Barbara (1998). FHI – Do Client Fees Help or Hurt? Family Health International, Durham
I-REF	(http://www.fhi.org/en/RH/Pubs/Network/v18_2/NW182ch2.htm).
B-REF	Barry, Michael; Tilson, Lesley; Ryan, Máirín (2004). Pricing and reimbursement of drugs in Ireland. Eur J
I-REF	H Econ 5 (2), S. 190–194 (http://www.springerlink.com/content/t2fuflk8np1w55yw/fulltext.pdf).
B-REF	Batnia, Vandha; Stoddart, Greg; Barer, Morris; Evans, Robert (1993). User Charges in Health Care: A Bib-
I-REF	liography. Health Policy Research Unit, University of British Columbia, Vancouver.
B-REF	Baume, Elaine; Juárez, Mercedes; Standing, Hillary (2000). Gender and Health Equity Resource Folder. In-
I-REF	stitute of Development Studies, Universität Sussex, Brighton.
I-REF	(http://www.ids.ac.uk/bridge/Reports/geneqfolder.pdf)
B-REF	Beck, Ralf (1974). The effects of Co-Payment on the Poor. J Hum Res 9 (1), S. 129-142
I-REF	(http://links.jstor.org/sici?sici=0022-
I-REF	166X%28197424%299%3A1%3C129%3ATEOCOT%3E2.0.CO%3B2-S).
B-REF	Beck, Ralf; Horne, John (1980). Utilization of publicly insured public services in Saskatchewan before, dur-
I-REF	ing and after copayment. Med Care 18 (8), S. 787-806 (http://links.jstor.org/sici?sici=0022-
I-REF	4367%28197603%2943%3A1%3C73%3AECARAE%3E2.0.CO%3B2-0).
B-REF	Becker, Karolin; Zweifel, Peter (2005). Cost Sharing in Health Insurance: An Instrument for Risk Selection?
I-REF	Working Paper No. 0513, Sozialökonomisches Institut (Socioeconomic Institute), Universität Zürich
I-REF	(http://www.soi.unizh.ch/research/wp/wp0513.pdf).
B-REF	Beer, François-Joachim; Beer-Poitevin, Françoise (1980). Die Selbstbeteiligung in der französischen Kran-
I-REF	kenversicherung. In: Internationale Gesellschaft für Gesundheitsökonomie, S. 75-78.
B-REF	Benítez-Silva, Hugo; Buchinsky, Moshe; Chan, Hiu Man; Cheidvasser, Sofia; Rust, John (2004). How Large
I-REF	is the Bias in Self-Reported Disability? J Appl Econ 19 (6), S. 649–670
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/109799429/PDFSTART).
B-REF	Benner, Joshua; Glynn, Robert; Mogun, Helen; Neumann, Peter; Weinstein, Milton; Avorn, Jerry (2002).
I-REF	Long-term persistence in use of statin therapy in elderly patients. JAMA 288 (4), S. 455-461
I-REF	(http://jama.ama-assn.org/cgi/reprint/288/4/455).
B-REF	Bentur, Netta; Gross, Revital; Resnitzki, Shirly; Brammli-Greenberg, Shuli (2004). The Effect of Co-
I-REF	Payments on the Accessibility of Primary Health Services for Stroke Patients. Soc Sec: J Welfare and Int
I-REF	Soc Sec Studies 66, S. 63-75.
B-REF	Berié, Hermann; Braeseke, Grit; Fink, Ulf; Völker, Ingrid (2005). Strukturen und Kostensteuerungsmecha-
I-REF	nismen im deutschen Gesundheitswesen unter besonderer Berücksichtigung der GKV. Gutachten im Auftrag
I-REF	des AOK-Bundesverbandes. WISO – Institut für Wirtschaft & Soziales GmbH, Berlin (http://www.wiso-
I-REF	gruppe.de/download/wiso_gutachten_200509.pdf).
B-REF	Berk, Mark; Monheit, Alan; Hagan, Michael (1988). How the U.S. Spent Its Health Care Dollar: 1929–
I-REF	1980. H Aff Fall 1988, S. 46–60 (http://content.healthaffairs.org/cgi/reprint/7/4/46).
B-REF	Berk, Mark; Monheit, Alan (1992). The Concentration of Health Expenditures: An Update. H Aff Winter
I-REF	1992, S. 145–149 (http://content.healthaffairs.org/cgi/reprint/11/4/145).
B-REF	Berk, Mark; Monheit, Alan (2001). The Concentration Of Health Care Expenditures, Revisited. H Aff 20
I-REF	(2), S. 9-18 (http://content.healthaffairs.org/cgi/reprint/20/2/9).
B-REF	Berki, S.E. (1986). A Look At Catastrophic Medical Expenses And The Poor. H Aff 5 (4), S. 138- 145
I-REF	(http://content.healthaffairs.org/cgi/reprint/5/4/138).
B-REF	Berlemann, M., A. Karmann (1998). Moral Hazard im Gesundheitswesen – Ein Beispiel aus der Kieferor-
I-REF	thopädie. Zeitschr Wirtsch Sozialwiss (ZWS), Bd. 118, S. 573-595.
B-REF	Bhattacharya, Jayanta; Neeraj, Sood (2005). Health Insurance and the Obesity Externality. NBER Working
I-REF	Paper No. W11529, Washington DC
I-REF	(http://papers.ssrn.com/sol3/papers.cfm?abstract_id=776017#PaperDownload).
B-REF	BIG – Die Direktkrankenkasse (2004). Presseportal: forsa-Umfrage lässt keine Rückschlüsse auf Wahlab-
I-REF	sicht zu. Dortmund (http://www.presseportal.de/story.htx?nr=532722).
B-REF	Birch, Stephen (1986). Relationship between increasing prescription charges and consumption in groups not
I-REF	exempt from charges. J R Coll Gen Pract 36 (285), S. 154-156
I-REF	(http://www.pubmedcentral.nih.gov/tocrender.fcgi?iid=138912).
B-REF	Birch, Stephen (1989). Health care charges: lessons from the U.K.. H Pol 13 (2), S. 145-157.
B-REF	Birch, Steven (2004). Charging the patient to save the system? Like bailing water with a sieve.
I-REF	CMAJ/JAMC 170 (12), S. 1812-1813 (http://www.cmaj.ca/cgi/content/full/170/12/1812).
B-REF	Birkett, Donald; Mitchell, Andrew; McManus, Peter (2001). A Cost-Effectiveness Approach To Drug Sub-
I-REF	sidy And Pricing In Australia. H Aff 20 (3), S. 104-114
I-REF	(http://content.healthaffairs.org/cgi/reprint/20/3/104).
B-REF	Bitrán, Ricardo; Giedion, Ursula (2003). Waivers and Exemptions for Health Services in Developing Coun-
I-REF	tries. Social Safety Net Primer Series, Worldbank, Washington
I-REF	(http://wbln0018.worldbank.org/HDNet/hddocs.nsf/65538a343139acab85256cb70055e6ed/2327dc75151b9f
I-REF	1385256cf0005e323c/$FILE/0308.pdf).
B-REF	Blais, Lucie; Couture, Julie; Rahme, Elham; Le Lorier, Jacques (1997). Évaluation de l'impact du régime
I-REF	général d'assurance-médicaments du Québec sur la consommation de médicaments chez les ainés.
I-REF	L’Actualité Médicale, Association des Médecins de langue française du Canada, Montreal (Abstract:
I-REF	http://www.sqgeriatrie.org/pdf/BULLETIN-MARS-2000.pdf).
B-REF	Blais, Lucie; Boucher, Jean-Marc; Couture, Julie; Rahme, Elham; LeLorier, Jacques (1999). Impact of the
I-REF	Quebec cost sharing drug insurance plan on the monthly dispensed prescriptions of 4 classes of medications
I-REF	among elderly. Abstract presented at Canadian Association for Population Therapeutics Annual Conference,
I-REF	Halifax. Pharmacoepidemd Drug Safety 8 (S2), S. S79-S196 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/63001476/PDFSTART).
B-REF	Blais, Lucie; Boucher, Jean-Marc; Couture, Julie; Rahme, Elham; LeLorier, Jacques (2001). Impact of a
I-REF	cost sharing drug insurance plan on drug utlilization among elderly. J Am Ger Soc 49 (4), S. 410-414
I-REF	(http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1532-5415.2001.49084.x).
B-REF	Blais, Lucie; Couture, Julie; Rahme, Elham; LeLorier, Jacques(2003). Impact of a cost sharing drug insur-
I-REF	ance plan on drug utilization among individuals receiving social assistance. H Pol 64 (2), S. 163-172.
B-REF	Blendon, Robert; Leitman, Robert; Morrison, Ian; Donelan, Karen (1990). Satisfaction withHealth Systems
I-REF	in Ten Nations. H Aff 9 (2), S. 185–192 (http://content.healthaffairs.org/cgi/reprint/9/2/185).
B-REF	Blendon, Robert; Schoen, Cathy; DesRoches, Catherine; Osborn, Robin; Scoles, Kimberly; Zapert, Kinga
I-REF	(2002). Inequities In Health Care: A Five-Country Survey. H Aff 21 (3), S. 182-191
I-REF	(http://content.healthaffairs.org/cgi/reprint/21/3/182.pdf).
B-REF	Block, Adam (2007). Costs and Benefits of Direct-to-Consumer Advertising: The Case of Depression.
I-REF	Pharmacoecon 25 (6), S. 511-521 (Abstract:
I-REF	http://pharmacoeconomics.adisonline.com/pt/re/phe/abstract.00019053-200725060-00006.htm).
B-REF	Bloom, Gerald (1997). Primary Health Care Meets the Market: Lessons from China and Vietnam. Institute
I-REF	for Development Studies (IDS), Working Paper 53, Brighton, ISBN 1 85864 119 5
I-REF	(http://www.ids.ac.uk/ids/bookshop/wp/wp53.pdf).
B-REF	Bloom, Bernard (2001). Another Theory About Healthcare Expenditures and Inflation Refuted by the Facts.
I-REF	Am J Manag Care 7 (7), S. 740-741
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC2001julBloom740_741.pdf).
B-REF	Bluestein, Jan (1995). Medicare Coverage, Supplemental Insurance, and the Use of Mammography by Older
I-REF	Women. N Engl J Med 332 (17), S. 1138-1143 (http://content.nejm.org/cgi/reprint/332/17/1138.pdf).
B-REF	Blumenthal, David (2006a). Employer-Sponsored Health Insurance in the United States – Origins and Im-
I-REF	plications. N Engl J Med 355 (1), S. 82-88 (http://content.nejm.org/cgi/reprint/355/1/82.pdf).
B-REF	Blumenthal, David (2006b). Employer-Sponsored Insurance – Riding the Health Care Tiger. N Engl J Med
I-REF	355 (2), S. 195-202 (http://content.nejm.org/cgi/reprint/355/2/195.pdf).
B-REF	Blustein, Jan (2000). Drug coverage and drug purchases by Medicare beneficiaries with hypertension. H Aff
I-REF	19 (2), S. 219-230 (http://content.healthaffairs.org/cgi/reprint/19/2/219).
B-REF	Bodenheimer, Thomas (2001). Affordable Prescriptions for the Elderly. JAMA 286 (14), S. 1762-1763
I-REF	(http://jama.ama-assn.org/cgi/reprint/286/14/1762).
B-REF	Bodenheimer, Thomas (2005). High and Rising Health Care Costs. Part 1: Seeking an Explanation. Ann Int
I-REF	Med 142 (10), S. 847-854 (http://www.annals.org/cgi/reprint/142/10/847.pdf).
B-REF	Bodenheimer, Thomas (2005). High and Rising Health Care Costs. Part 3: The Role of Health Care Provid-
I-REF	ers. Ann Intern Med 142 (12), S. 996-1002 (http://www.annals.org/cgi/reprint/142/12_Part_1/996.pdf).
B-REF	Böcken, Jan; Butzlaff, Martin; Esche, Andreas (Hrsg.) (2000). Reformen im Gesundheitswesen. Ergebnisse
I-REF	der internationalen Recherche. Verlag Bertelsmann Stiftung, Gütersloh (http://www.bertelsmann-
I-REF	stiftung.de/cps/rde/xbcr/SID-0A000F0A-1EB3E760/stiftung/515.pdf).
B-REF	Boos-Nünning, Ursula; Lauterbach, Karl; Karsten, Rudolf; Weisskirchen, Gerd (2004). Mut zur Verände-
I-REF	rung. Innovation und Chancengleichheit durch eine integrierte Bildungs-, Gesundheits- und Familienpolitik.
I-REF	Friedrich-Ebert-Stiftung, Bonn
I-REF	(http://fesportal.fes.de/pls/portal30/docs/FOLDER/PRESSE/PRESSEARCHIV/2004/PUBLIKATIONEN20
I-REF	04/INNOVATIONUNDCHANCENGLEICHHEIT.PDF).
B-REF	Bozette, Frank; Joce, Geoffrey; McCaffrey, Daniel; Leibowitz, Arleen; Morton, Sally; Berry, Sandra;
I-REF	Rastegar, Afshin; Timberlake, David; Shapiro, Martin; Goldman, Dana (2001). Expenditures for the Care of
I-REF	HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy. N Engl J Med 344 (11), S. 817-
I-REF	823 (http://content.nejm.org/cgi/reprint/344/11/817.pdf).
B-REF	Braam, Tamara (2005). The impact of health sector financing reforms on sexual and reproductive health
I-REF	services in Africa. University of the Witwatersrand, Johannesburg: Ravindran, Sundari; de Pinho, Helen
I-REF	(Eds.). The right reform? Health Sector Reforms and Sexual and Reproductive Health. Women`s Health Pro-
I-REF	ject, School of Public Health, University of the Witwatersrand
I-REF	(http://www.wits.ac.za/whp/rightsandreforms/docs/AFRICAFINANCE.pdf).
B-REF	Braithwaite, Scott; Rosen, Allison (2007). Linking Cost Sharing to Value: An Unrivaled Yet Unrealized
I-REF	Public Health Opportunity. Ann Intern Med 146 (8), S. 602-605
I-REF	(http://www.annals.org/cgi/reprint/146/8/602.pdf).
B-REF	Brammli-Greenberg, Shuli (2003). Co-Payments for Health-Plan Services. Health Policy Division, JDC-
I-REF	Brookdale Institute, Jerusalem.
B-REF	Brauer, Michael; Hoek, Gerard; van Vliet, Patricia; Meliefste, Kees; Fischer, Paul; Wijga, Alet; Koopman,
I-REF	Laurens; Neijens, Herman; Gerritsen, Jorrit; Kerkhof, Marjan; Heinrich, Joachim; Bellander, Tom; Brunek-
I-REF	reef, Bert (2002). Air Pollution from Traffic and the Development of Respiratory Infections and Asthmatic
I-REF	and Allergic Symptoms in Children. Am J Respir Crit Care Med 166 (8). S. 1092–1098
I-REF	(http://ajrccm.atsjournals.org/cgi/reprint/166/8/1092.pdf).
B-REF	Brett, Allan (2007). Two-Tiered Health Care: A Problematic Double Standard. Arch Intern Med 167 (5), S.
I-REF	430-432 (http://archinte.ama-assn.org/cgi/content/reprint/167/5/430).
B-REF	Breyer, Friedrich (1984). Moral Hazard und der optimale Krankenversicherungsvertrag. Eine Übersicht.
I-REF	Zeitschr ges Staatswiss 140, S. 288-307
I-REF	(http://www.digizeitschriften.de/no_cache/home/jkdigitools/loader/?tx_jkDigiTools_pi1%5BIDDOC%5D=
I-REF	154908).
B-REF	Breyer, Friedrich (1991). Distribution effects of coinsurance options in social health insurance systems. In:
I-REF	López-Casasnovas, Guillem (ed). Incentives in health systems. Springer, Berlin Heidelberg New York.
B-REF	Breyer, Friedrich; Haufler, Andreas (2000). Health Care Reform: Separating Insurance from Income Redis-
I-REF	tribution. Int Tax Publ Fin 7 (4-5), S. 445–461 (http://www-cgi.uni-
I-REF	regensburg.de/Fakultaeten/WiWi/Wiegard/start/de/lehre/2002-2003/seminar/Health_care_reform.pdf).
B-REF	Breyer, Friedrich; Haufler, Andreas (2000). Health Care Reform: Separating Insurance from Income Redis-
I-REF	tribution. DIW Discussion Paper No. 205, Berlin (http://opus.zbw-
I-REF	kiel.de/volltexte/2003/222/pdf/dp205.pdf).
B-REF	Breyer, Friedrich; Zweifel, Peter; Kifmann, Matthias (2005). Gesundheitsökonomik. 5. Auflage. Springer-
I-REF	Verlag, Berlin-Heidelberg-New York.
B-REF	Briesacher, Becky; Kamal-Bahl, Sachim; Hochberg, Marc; Orwig, Denise; Kahler, Kristjan (2004). Three-
I-REF	tiered-copayment drug coverage and use of nonsteroid anti-inflammatory drugs. Arch Int Med 164 (15), S.
I-REF	1679-1684 (http://archinte.ama-assn.org/cgi/content/reprint/164/15/1679).
B-REF	Briesacher, Becky; Stuart, Bruce; Ren, Xiaoqang; Doshi, Jalpa; Wrobel, Marian (2005). Medicare benefici-
I-REF	aries and the impact of gaining prescription drug coverage on inpatient and physician spending. H Serv Res
I-REF	40 (5, Part1), P. 1279-1296 (http://www.blackwell-synergy.com/doi/full/10.1111/j.1475-6773.2005.00432.x;
I-REF	http://www.findarticles.com/p/articles/mi_m4149/is_5_40/ai_n15874887).
B-REF	Brixner, Diana; Joish, Vijay; Oderda, Gary; Avey, Steven; Hanson, Douglas; Cannon, Eric (2007). Effects
I-REF	of Benefit Design Change Across 5 Disease States. Am J Man Care 13 (6, Part 2), S. 370-376
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2_Brixner370to76.pdf).
B-REF	Brodsky, David (1987). The Correlates of Cost-Conscious Behavior Among Elderly Consumers of Health
I-REF	Care Services. J Appl Geront 6 (1), S. 25-38 (http://jag.sagepub.com/cgi/reprint/6/1/25).
B-REF	Brook, Robert; Ware, John; Rogers, William; Keeler, Emmett; Davies, Allyson; Donald, Cathy; Goldberg,
I-REF	George (1983). Does free care improve adults health? Results from a randomized controlled trial. N Engl J
I-REF	Med 309 (23), S. 1426-1434 (http://content.nejm.org/cgi/content/abstract/309/23/1426).
B-REF	Brook, Robert (1989). Practice guidelines and practicing medicine. Are they compatible? JAMA 262 (21),
I-REF	S. 3027-3030 (http://jama.ama-assn.org/cgi/content/abstract/262/21/3027).
B-REF	Brooks, Robert (1980). Der Selbstbehalt in der österreichischen Sozialversicherung. In: Internationale Ge-
I-REF	sellschaft für Gesundheitsökonomie, S. 58-60.
B-REF	Büchi, Martin; Bachmann, Lucas; Fischer, Joachim; Peltenburg, Michael; Steurer, Johann (2000). Alle
I-REF	Macht den Patienten? Vom ärztlichen Paternalismus zum Shared Decision Making. Schweizerische Ärzte-
I-REF	zeitung 81 (49), S. 2776-2780 (http://www.saez.ch/pdf/2000/2000-49/2000-49-1017.PDF).
B-REF	Bundesverband der Arzneimittelhersteller (BAH) (1999a). BAH-Bevölkerungsbefragung: 62 Prozent der
I-REF	Bundesbürger betreiben regelmäßig Selbstmedikation. Das Freie Medikament 1-3/99 (http://www.bah-
I-REF	bonn.de/forum/publikationen/dfm/dfm1-3-99.htm#BAH-Bev%f6lkerungsbefragung).
B-REF	Bundesverband der Arzneimittelhersteller (BAH) (1999b). Der Selbstmedikationsmarkt 1998. Das Freie
I-REF	Medikament 1-3/99 (http://www.bah-bonn.de/forum/publikationen/dfm/dfm1-3-99.htm#BAH-
I-REF	Bev%f6lkerungsbefragung).
B-REF	Buntin, Melinda; Damberg, Cheryl; Haviland, Amelia; Kapur, Kanika; Lurie, Nicole; McDevitt, Roland;
I-REF	Marquis, Susan (2006). Consumer-Directed Health Care: Early Evidence About Effects On Cost And Qual-
I-REF	ity. H Aff 25 (6), pp. W516-W530 (http://content.healthaffairs.org/cgi/content/full/hlthaff.25.w516).
B-REF	Burström, Bo (2002). Increasing inequalities in health care utilisation across income groups in Sweden dur-
I-REF	ing the 1990s? H Pol 62 (2), S. 117-129.
B-REF	Burström, Bo (2004). User charges in Sweden. European Observatory on Health Systems and Policies, Euro
I-REF	Observer 6 (3), S. 5-6 (http://www.euro.who.int/document/Obs/EuroObserver6_3.pdf).
B-REF	Busch, Susan; Barry, Colleen; Vegso, Sally; Sindelar, Jody; Cullen, Mark (2006). Effects Of A Cost-Sharing
I-REF	Exemption On Use Of Preventive Services At One Large Employer. H Aff 25 (6), S. 1529-1536
I-REF	(http://content.healthaffairs.org/cgi/reprint/25/6/1529).
B-REF	Busse, Reinhard; Riesberg, Annette (2004). Health Care Systems in Transition. Germany. WHO Regional
I-REF	Office for Europe on behalf of the European Observatory on Health Systems and Policies, Kopenhagen
I-REF	(http://www.healthpolicymonitor.org/Downloads/HiT_Germany_2005.pdf).
B-REF	Busse, Reinhard; Schlette, Sophia (Hrsg.) (2004). Gesundheitspolitik in Industrieländern. Ausgabe 2. Im
I-REF	Blickpunkt: Gesundheitspolitik und Alter, Arzneimittelpolitik, Fachkräfteentwicklung. Verlag Bertelsmann-
I-REF	stiftung, Gütersloh. ISBN 3-89204-767-7 (http://www.wm.tu-berlin.de/~mig/papers/index.html).
B-REF	Busse, Reinhard; Schlette, Sophia (2005). Gesundheitspolitik in Industrieländern. Ausgabe 4. Im Blick-
I-REF	punkt: Zugang, Primärversorgung, Organisationsreform. Verlag Bertelsmann Stiftung, Gütersloh
I-REF	(http://www.healthpolicymonitor.org/Downloads/Gesundheitspolitik_in_Industrielaendern_Ausgabe_4.pdf;j
I-REF	sessionid=0DD454B3CBD59FED2F2ECA72FEDB7BA0).
B-REF	Busse, Reinhard; Schreyögg, Jonas; Henke, Klaus-Dirk 2005). Regulation of pharmaceutical markets in
I-REF	Germany: improving efficiency and controlling expenditures? Int J H Plan Mgmt 20 (4), S. 329-349
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/112140375/PDFSTART).
I-REF	Butler, Robert (2001). Old and Poor in America. Issue Brief, International Longevity Center, New York
I-REF	(www.ilcusa.org/_lib/pdf/brief_001.pdf).
B-REF	Canadian Alliance Grassroots (2002). Doctors Want More Private Care. Belleville/Ontario
I-REF	(http://www.canadiangrassroots.ca/sections.php?op=printpage&artid=38).
B-REF	Canadian Health Services Research Foundation (CHSRF) (2001). Myth: User fees stop waste and ensure
I-REF	better use of the healthcare system. Myth busters. (http://www.chrsf.ca).
B-REF	Cannon, Christopher; Braunwald, Eugene; McCabe, Carolyn; Rader, Daniel; Rouleau, Jean; Belder, Rene;
I-REF	Joyal, Steven; Hill, Karen; Pfeffer, Marc; Skene, Allan (2004). Intensive versus Moderate Lipid Lowering
I-REF	with Statins after Acute Coronary Syndromes. N Engl J Med 350 (15), S. 1495–1504
I-REF	(http://content.nejm.org/cgi/reprint/350/15/1495.pdf).
B-REF	Carlsen, Frederick; Grytten, Jostein; Kjelvik, Julie; Skau, Irene (2007). Better primary physician services
I-REF	lead to fewer hospital admissions. Eur J Health Econ 8 (1), S. 17–24
I-REF	(http://www.springerlink.com/content/9030485k85884r54/fulltext.pdf).
B-REF	Carlson, Matthew; DeVoe, Jennifer; Wright, Bill (2006). Short-Term Impacts of Coverage Loss in a Medi-
I-REF	caid Population: Early Results From a Prospective Cohort Study of the Oregon Health Plan. Ann Fam 4 (5),
I-REF	S. 391-398 (http://www.annfammed.org/cgi/reprint/4/5/391).
B-REF	Carroll, Margaret; Lacher, David; Sorlie, Paul; Cleeman, James; Gordon, David; Wolz, Michael; Grundy,
I-REF	Scott; Johnson, Clifford (2005). Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002. JAMA 294
I-REF	(14), S. 1773-1781 (http://jama.ama-assn.org/cgi/reprint/294/14/1773).
B-REF	Chandra, Amitabh; Gruber, Jonathan; McKnight, Robin (2007). Patient Cost-Sharing, Hospitalization Off-
I-REF	sets, and the Design of Optimal Health Insurance for the Elderly. Working Paper 12972, National Bureau of
I-REF	Economic Research, Cambridge (http://www.nber.org/papers/w12972).
B-REF	Chauhan, Anoop; Chatterjee, Anwesh; Johnston, Sebastian (2005). Acute Respiratory Infections. In:
I-REF	Krzyzanowski, Michael, Kuna-Dibbert, Birgit, Schneider, Jürgen: S. 44-69.
B-REF	Chen, Meei-shia; Mastilica, Miroslav (1998). Health care reform in Croatia: for better or for worse? Am J
I-REF	Publ H 88 (8), S. 1156-1160 (http://www.ajph.org/cgi/reprint/88/8/1156).
B-REF	Cherkin, Daniel; Grothaus, Louis; Wagner, Edward (1989). The effect of office visit copayments on utiliza-
I-REF	tion in a health maintenance organization. Med Care 27 (11), S. 1036-1045.
B-REF	Cherkin, Daniel; Grothaus, Louis; Wagner, Edward (1992). Is magnitude of co-payment effect related to in-
I-REF	come? Using census data for health services research. Soc Sci Med 34 (1), S. 33-41.
B-REF	Chernew, Michael; Encinosa, William; Hirth, Richard (2000). Optimal health insurance: the case of observ-
I-REF	able, severe illness. J H Econ 19 (5), S. 585-609.
B-REF	Chernew, Michael; Smith, Dean; Kirking, Duane; Fendrick, Mark (2001). Decomposing Pharmaceutical
I-REF	Cost Growth in Different Types of Health Plans. Am J Manag Care 7 (7), S. 667 -673
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC2001julCHERNEW667_673.pdf).
B-REF	Chernew, Michael; Rosen, Allison; Fendrick, Mark (2006). Rising Out-of-pocket Costs in Disease Man-
I-REF	agement Programs. Am J Manag Care 12 (3), S. 150-154
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_06mar_Chernew150to54.pdf).
B-REF	Chernew, Michael; Rosen, Allison; Fendrick, Mark (2007). Value-based Insurance Design. H Aff 26 (2), S.
I-REF	w195-w203 (http://content.healthaffairs.org/cgi/reprint/26/2/w195;
I-REF	http://www.sph.umich.edu/vbidcenter/pdfs/w195Chernew.pdf).
B-REF	Chewning, Betty (2006). The healthy adherer and the placebo effect. BMJ 333 (7557), S. 18-19
I-REF	(http://bmj.bmjjournals.com/cgi/reprint_abr/333/7557/18.pdf).
B-REF	Choe, Hae Mi; Stevenson, James; Streetman, Daniel; Heisler, Michele; Standiford, Connie; Piette, John
I-REF	(2007). Impact of Patient Financial Incentives on Participation and Outcomes in a Statin Pill-splitting Pro-
I-REF	gram. Am J Man Care 13 (6, Part 1), S. 298-304
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC07_junPrt1Choe298to304.pdf).
B-REF	Choudhry, Niteesh; Avorn, Jerry; Antman, Elliott; Schneeweiss, Sebastian; Shrank, William (2007). Should
I-REF	Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An Economic
I-REF	Analysis. H Aff 26 (1), S. 186-194 (http://content.healthaffairs.org/cgi/reprint/26/1/186).
B-REF	Chubon, Sandra; Schulz, Richard; Lingle Jr., Earle; Coster-Schulz, Marcia (1994). Too Many Medications,
I-REF	Too Little Money: How Do Patients Cope? Public Health Nursing 11 (6), S. 412–415
I-REF	(http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1525-1446.1994.tb00207.x).
B-REF	Ciechanowski, Paul; Katon, Wayne; Russo, Joan (2000). Depression and Diabetes: Impact of Depressive
I-REF	Symptoms on Adherence, Function, and Costs. Arch Intern Med 160 (21), S. 3278-3285
I-REF	(http://archinte.ama-assn.org/cgi/reprint/160/21/3278).
B-REF	Clade, Harald; Merten, Martina (2004). Direktbeteiligung: Deutschland liegt auf einem Mittelplatz. Dt Ärz-
I-REF	tebl 101 (34-35), S. A-2288 / B-1920 / C-1848
I-REF	(http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=43081).
B-REF	Claxton, Gary; Gil, Isadora; Finder, Benjamin; Holve, Erin; Gabel, Jon; Pickreign, Jeremy; Whitmore,
I-REF	Heidi; Hawkins, Samantha; Fahlman, Cheryl (2004). Employer Health Benefits: 2004 Annual Survey. Henry
I-REF	Kaiser Family Foundation; Health Research and Education Trust, Menlo Park/Chicago, ISBN 0-87258-812-
I-REF	2 (http://www.kff.org/insurance/7148/upload/2004-Employer-Health-Benefits-Survey-Full-Report.pdf).
B-REF	Claxton, Gary; Gil, Isadora; Finder, Benjamin; Gabel, Jon; Pickreign, Jeremy; Whitmore, Heidi; Hawkins,
I-REF	Samantha (2005). Employer Health Benefits: 2005 Summary of Findungs: 2005 Henry Kaiser Family Foun-
I-REF	dation/Health Research and Education Trust, Menlo Park/Chicago, ISBN 1-55648-329-5
I-REF	(http://www.kff.org/insurance/7315/upload/7315.pdf).
B-REF	Cole, Alexander; Norman, Heather; Weatherby, Lisa; Walker, Alexander (2006). Drug Copayment and Ad-
I-REF	herence in Chronic Heart Failure: Effect on Cost and Outcomes. Pharmacotherapy 26 (8), S. 1157-1164
I-REF	(http://www.atypon-link.com/PPI/doi/pdf/10.1592/phco.26.8.1157).
B-REF	Coleman, Eric; Smith, Jodi; Raha, Devbani; Min, Sung-joon (2006). Posthospital Medication Discrepancies.
I-REF	Prevalence and Contributing Factors. Arch Int Med 165 (18), S. 1842-1847 (http://archinte.ama-
I-REF	assn.org/cgi/reprint/166/17/1802).
B-REF	Collins, David; Quick, Jonathan; Musau, Stephen; Kraushaar Daniel (1996). Health Financing Reform in
I-REF	Kenya: The Fall and Rise of Cost Sharing, 1989-94. Management Sciences for Health, Boston.
B-REF	Colombo, Francesca; Tapay, Nicole (2004). Private Health Insurance in OECD Countries: The Benefits and
I-REF	Costs for Individuals and Health Systems. OECD Health Working Paper 15
I-REF	(http://www.oecd.org/dataoecd/34/56/33698043.pdf).
B-REF	Contoyannis, Paul; Hurley, Jeremiah; Grootendorst, Paul; Jeon, Sung-Hee; Tamblyn, Robyn (2005). Esti-
I-REF	mating the price elasticity of expenditure for prescription drugs in the presence of non-linear price sched-
I-REF	ules: an illustration from Quebec, Canada. H Econ 14 (9), S. 909-923
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/111081767/PDFSTART).
B-REF	Coombs, John; Cornish, Laura; Hiller, Paula; Smith, Dean (2002). Compliance and Refill Pattern Behavior
I-REF	With HMG-CoA Reductase Inhibitors After Acute Myocardial Infarction. Manag Care Interface 15 (1), S.
I-REF	54-58, 60
I-REF	(http://www.medicomint.com/Search/SubjectDetails.asp?SUBJECT=Compliance+and+Refill+Pattern+Beha
I-REF	vior+With+HMG%2DCoA+Reductase+Inhibitors+After+Acute+Myocardial+Infarction).
B-REF	Cooper, Michael; Culyer, Anthony (Eds.) (1973). Health Economics. Penguin Books, Hammonds-
I-REF	worth/Baltimore/Rongwood.
B-REF	Coulson, Edward; Terza, Joseph; Neslusan, Cheryl; Stuart, Bruce (1995). Estimating the Moral-Hazard Ef-
I-REF	fect of Supplemental Medical Insurance in the Demand for Prescription Drugs by the Elderly. Am Econ Rev
I-REF	85 (2) [Papers and Proceedings of the Hundredth and Seventh Annual Meeting of the American Economic
I-REF	Association Washington, DC, January 6-8, 1995], S. 122-126 (http://links.jstor.org/sici?sici=0002-
I-REF	8282%28199505%2985%3A2%3C122%3AETMEOS%3E2.0.CO%3B2-Z).
B-REF	Council of the European Union (2007). Joint Report on Social Protection and Social Inclusion 2007. EU
I-REF	Council, Brussels (http://register.consilium.europa.eu/pdf/en/07/st06/st06694.en07.pdf).
B-REF	Cox, Emily; Jernigan, Cindy; Coons, Stephen; Draugalis, JoLaine (2001). Medicare Beneficiaries' Manage-
I-REF	ment of Capped Prescription Benefits. Med Care 39 (3), S. 296-301 (http://links.jstor.org/sici?sici=0025-
I-REF	7079%28200103%2939%3A3%3C296%3AMBMOCP%3E2.0.CO%3B2).
B-REF	Crawford, Steven; Ramsey, Christian; Splinter, Garth (2004). It’s Health Care, Not Welfare. Final Report
I-REF	Submitted to The Oklahoma Health Care Authority. Health Care Not Welfare Project Team, Primary Care
I-REF	Health Policy Division, Department of Family & Preventive Medicine, University of Oklahoma Health Sci-
I-REF	ences Center, Oklahoma City (http://www.statecoverage.net/hrsa/ok.pdf;
I-REF	http://www.statecoverage.net/statereports/ok8.pdf).
B-REF	Creese, Andrew (1997). User fees: They don't reduce costs, and they increase inequity. BMJ 315 (7102), S.
I-REF	202-203 (http://bmj.bmjjournals.com/cgi/content/full/315/7102/202).
B-REF	Cross, Margaretann (2003). Will New Benefit Design Harm Some Patients? Managed Care Dec 2003
I-REF	(http://www.managedcaremag.com/archives/0312/0312.outcomes.html).
B-REF	Crown, William; Berndt, Ernst; Baser, Onur; Finkelstein, Stan; Witt, Whitney (2003). Benefit Plan Design
I-REF	and Prescription Drug Utilization Among Asthmatics: Do Patient Copayments Matter? National Bureau of
I-REF	Economic Research, NBER Working Paper 10738, Cambridge (http://www.nber.org/papers/w10062.pdf).
B-REF	Crown, William; Berndt, Ernst; Baser, Onur; Finkelstein, Stan; Witt, Whitney; Maguire, Jonathan; Haver,
I-REF	Kenan (2004). Benefit plan design and prescription drug utilization among asthmatics: do patient copay-
I-REF	ments matter? Front H Pol Res 7 (1), S. 95-127
I-REF	(http://www.bepress.com/cgi/viewcontent.cgi?article=1053&context=fhep;
I-REF	http://web.ebscohost.com/ehost/pdf?vid=3&hid=117&sid=da9961f6-3fe4-488c-8627-
I-REF	b1f1f3f2e18e%40sessionmgr9).
B-REF	Crystal, Stephen; Johnson, Richard; Harman, Jeffrey; Sambamoorthi, Usha; Kumar, Rizie (2000). Out-of-
I-REF	pocket health care costs among older Americans. J Gerontol B Psychol 55 (1), S. 51-62
I-REF	(http://psychsoc.gerontologyjournals.org/cgi/reprint/55/1/S51).
B-REF	Currie, Gillian; Nielson, Norma (1999). Models for Funding Prescription Drug Program. Working Paper No.
I-REF	2002-16, Research Report to the Institute of Health Economics, Edmonton
I-REF	(http://www.ihe.ca/publications/papers/pdf/1999-05paper.pdf).
B-REF	Davidson, Stephen; Connelly, John; Blim, Don; Strain, James; Taylor, Doyl (1980). Consumer Cost-Sharing
I-REF	as a Means to Reduce Health Care Costs. Pediatrics 65 (1), S. 168-170
I-REF	(http://pediatrics.aappublications.org/cgi/reprint/65/1/168).
B-REF	Cutler, David (2001). Health Care and the Public Sector. Paper prepared for the Handbook of Public Eco-
I-REF	nomics, Harvard University and NBER, Boston
I-REF	(http://post.economics.harvard.edu/faculty/dcutler/papers/cutler_handbook_chapter_3-12-01.pdf).
B-REF	Davis, Karen (2004). Consumer Directed Health Care: Will It Improve Health System Performance? H Serv
I-REF	Res 39 (4 part 2), S. 1219-1233 (http://www.blackwell-synergy.com/doi/full/10.1111/j.1475-
I-REF	6773.2004.00284.x; http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1361064&blobtype=pdf).
B-REF	Davis, Karen; Schoen, Cathy; Schoenbaum, Stephen; Audet, Anne-Marie; Doty, Michelle; Holmgren,
I-REF	Alyssa; Kriss, Jennifer (2006). Mirror, Mirror on the Wall: An Update on the Quality of American Health
I-REF	Care Through the Patient's Lens. The Commonwealth Fund, New York
I-REF	(http://www.cmwf.org/usr_doc/Davis_mirrormirror_915.pdf).
B-REF	Dawson, Diane (1999). Why charge patients if there are better ways to contain costs, encourage efficiency
I-REF	and reach for equity? Eurohealth 5 (3). Geneva: World Health Organization, S. 29-31
I-REF	(http://www.euro.who.int/document/obs/EuroHealth5_3.pdf).
B-REF	Deber, Raisa; Kraetschmer, Nancy; Irvine, Jane (1996). What role do patients wish to play in treatment de-
I-REF	cision making? Arch Int Med 156 (13), S. 1414-1420 (http://archinte.ama-
I-REF	assn.org/cgi/content/reprint/156/13/1414).
B-REF	Deber, Raisa (2000). Getting what we pay for: Myths and Realities about Financing Canada’s Health Care
I-REF	System. Background Paper Prepared for the Dialogue on Health Reform. Department of Health Administra-
I-REF	tion, University of Toronto.
B-REF	Deber, Raisa; Forget, Evelyn; Roos, Leslie (2004). Medical savings accounts in a universal system: wishful
I-REF	thinking meets evidence. H Pol 70 (1), S. 49-66.
B-REF	de Lemos, James; Blazing, Michael; Wiviott, Stephen; Lewis, Eldrin; Fox, Keith; White, Harvey; Rouleau,
I-REF	Jean-Lucien; Pedersen, Terje; Gardner, Laura; Mukherjee, Robin; Ramsey, Karen; Palmisano, Joanne; Bil-
I-REF	heimer, David; Pfeffer, Marc; Califf, Robert; Braunwald, Eugene for the A to Z Investigators (2004). Early
I-REF	intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z
I-REF	of the A to Z trial. JAMA 292 (11), S. 1307-1316 (http://jama.ama-assn.org/cgi/reprint/292/11/1307).
B-REF	Delesie, Lucas (1985). Cost-sharing and the patient's choice of provider: M. Susan Marquis Rand Corpora-
I-REF	tion, Health Insurance Experiment Series, Santa Monica, California, 1984. H Pol 5 (1), S. 86.
B-REF	Delnoij, Diana; Groenewegen, Peter; Roos, C.; Hutten, Jack; Friele, Roland (2000). Die Zuzahlungsregelun-
I-REF	gen im niederländischen Krankenkassengesetz: eine Evaluation der Effekte. Gesundheitswesen 62 (1), S. 39-
I-REF	44 (http://www.thieme-connect.de/ejournals/pdf/gesu/doi/10.1055/s-2000-10311.pdf).
B-REF	Deppe, Hans-Ulrich (1987). Krankheit ist ohne Politik nicht heilbar. Edition suhrkamp, Bd. 391, 1. Auflage,
I-REF	Frankfurt.
B-REF	Deppe, Hans-Ulrich (2002). Zur sozialen Anatomie des Gesundheitssystems. Neoliberalismus und Gesund-
I-REF	heitspolitik in Deutschland. Verlag für Akademische Schriften, Frankfurt.
B-REF	Deppe, Hans-Ulrich (2003). Weil du arm bist, musst du früher sterben". Die Folgen der Agenda 2010 für die
I-REF	Gesundheitspolitik. InformationsDienst (ID), Ausgabe 152/26. Glienicke/Nordbahn
I-REF	(http://www.berlinvonunten.net/texte/ivc24-id152-deppe.htm).
B-REF	Deutsche Bank Research (o.J.). Wieviel Marktwirtschaft verträgt das Gesundheitswesen? Frankfurt
I-REF	(http://www.dbresearch.com/PROD/DBR_INTERNET_DE-PROD/PROD0000000000047007.pdf).
B-REF	Deutsche Morbus Crohn / Colitis ulcerosa Vereinigung (DCCV e.V.) (2004). Verarmung und Verzicht auf
I-REF	medizinische Versorgung. Erste Ergebnisse einer Befragung über die Gesundheitskosten von Patientinnen
I-REF	und Patienten mit chronisch entzündlichen Darmerkrankungen. Leverkusen.
B-REF	Dezhi, Yu (1992). Changes in Health Care Financing and Health Status: The Case of China in the 1980s. In-
I-REF	nocenti Occasional Papers EPS Nr. 34. Florenz.
B-REF	Dixon, Anna; Mossialos, Elias (2001). Funding Health Care in Europe: Recent Experiences. Health Care
I-REF	UK, King’s Fund.
B-REF	Dixon, Anna; Mossialos, Elias (Eds.) (2002). Health Care Systems in eight countries: trends and challenges.
I-REF	The European Observatory on Health Care Systems. London. ISBN 0 7530 1548 X (http://www.hm-
I-REF	treasury.gov.uk/media/70855/observatory_report.pdf).
B-REF	Dixon, Anna; McDaid, David; Healey, Andrew; Knapp, Martin (2002a). Financing Mental Health: Equity
I-REF	and Efficiency Concerns for Low and Middle Income Countries. LSE Health and Social Care, London
I-REF	School of Economics, London (http://www.mentalhealth-
I-REF	econ.org/Documents/dp1734%20WHO%20financing%20MH9%20ro.doc).
B-REF	Dixon, Anna; Langenbrunner, Jack; Mossialos, Elias (2002b). Facing the Challenges of Health Care Financ-
I-REF	ing. Background Paper for USAID Conference: Ten Years of Health System Transition in Central and East-
I-REF	ern Europe and Eurasia, 29.-31.7.2002, Washington.
I-REF	(http://www.eurasiahealthtransitionconference.org/Healthfinancing.pdf).
B-REF	Dockery, Douglas; Stone, Peter (2007). Cardiovascular Risks from Fine Particulate Air Pollution. N Engl J
I-REF	Med 356 (5), S. 511-513 (http://content.nejm.org/cgi/reprint/356/5/511.pdf).
B-REF	Docteur, Elizabeth; Oxley, Howard (2003). Health-Care Systems: Lessons from the Reform Experience.
I-REF	OECD Health Working Paper 9, OECD, Paris (http://www.oecd.org/dataoecd/5/53/22364122.pdf;
I-REF	http://www.olis.oecd.org/olis/2003doc.nsf/43bb6130e5e86e5fc12569fa005d004c/b64eaf1a3e9cf262c1256df
I-REF	300536279/$FILE/JT00155489.DOC).
B-REF	Donaldson, Cam, Gerard, Karen, Mitton, Craig, Jan, Stephen and Wiseman, Virginia (2004). Economics of
I-REF	health care financing: the visible hand. Zweite Ausgabe, Basingstoke, Palgrave Macmillan
I-REF	(http://www.palgrave.com/pdfs/0333984315.pdf).
B-REF	Dong, Hengjin; Bogg, Lennart; Wang, Keli; Rehnberg, Clas; Diwan, Vinod (1999). A description of outpa-
I-REF	tient drug use in rural China: evidence of differences due to insurance coverage. Int. J. H Plan Mgmt 14 (1),
I-REF	S. 41-56 (http://www3.interscience.wiley.com/cgi-bin/fulltext/45002108/PDFSTART).
B-REF	Donges, Juergen; Eekhoff, Wolfgang; Möschel, Wernhard; Neumann, Manfred; Sievert, Olaf (2002). Mehr
I-REF	Eigenverantwortung und Wettbewerb im Gesundheitswesen. Schriftenreihe der Stiftung Marktwirtschaft,
I-REF	Bd. 39. Frankfurt. ISBN 3-89015-086-1 (http://www.insm.de/Downloads/PDF_-
I-REF	_Dateien/Publikationen_Kostenlose_Downloads/Stiftung_Marktwirtschaft/kk39.pdf).
B-REF	Dor, Avi; Encinosa, William (2004). Does Cost Sharing Affect Compliance? The Case of Prescription
I-REF	Drugs. Working Paper 10738, National Bureau of Economic Research, Cambridge
I-REF	(http://www.nber.org/papers/w10738).
B-REF	Dow, William (1997). Health Care Prices, Health and Labor Outcomes: Experimental Evidence, RAND
I-REF	(unveröffentlicht). WHO 1999, S. 10.
B-REF	Dow, William; Gertler, Paul; Schoeni, Robert; Strauss, John; Thomas, Duncan (2000). Health care prices,
I-REF	health and labor outcomes: Experimental evidence. RAND, Santa Monica (http://www-
I-REF	personal.umich.edu/~bschoeni/irms2.pdf).
B-REF	Downs, John; Clearfield, Michael; Weis, Stephen; Whitney, Edwin; Shapiro, Deborah; Beere, Polly; Lan-
I-REF	gendorfer, Alexandra; Stein, Evan; Kruyer, William; Gotto, Antonio Jr for the AFCAPS/TexCAPS Research
I-REF	Group (1998). Primary prevention of acute coronary events with lovastatin in men and women with average
I-REF	cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas coronary atherosclerosis prevention
I-REF	study. JAMA 279 (20), S. 1615–22 (http://jama.ama-assn.org/cgi/reprint/279/20/1615).
B-REF	Drèze, Jacques (2001). Loss reduction and implicit deductibles in Medical Insurance. Université Catholique,
I-REF	Louvain (http://www.core.ucl.ac.be/services/psfiles/dp02/dp2002-5).
B-REF	Drummond, Michael; Jönsson, Bengt (2003). Moving Beyond the Drug Budget Silo Mentality in Europe.
I-REF	Value in Health 6 (s1), S. S74-S77 (http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1524-
I-REF	4733.6.s1.8.x).
B-REF	Dührssen, Annemarie; Jorswiek, Eberhard (1965). Eine empirisch-statistische Untersuchung zur Leistungs-
I-REF	fähigkeit psychoanalytischer Behandlung (An empirical and statistical inquiry into the therapeutic potential
I-REF	of psychoanalytic treatment) Der Nervenarzt 36 (4), S. 166–169 [Nachdruck in Zsch psychosom Med 44, S.
I-REF	311-318].
B-REF	Dunn, Jeffrey; Cannon, Eric; Mitchell, Matthew; Curtiss, Frederic (2006). Utilization and drug cost out-
I-REF	comes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system. J Manag
I-REF	Care Pharm 12 (4) S. 294-302 (http://www.amcp.org/data/jmcp/May06_Journal.pdf).
B-REF	Dustan, Harriet; Caplan, Louis; Curry, Charles; de Leon, Antonio; Douglas, Frank; Frishman, William; Hill,
I-REF	Martha; Washington, Reginald; Steigerwalt, Susan; Shulman, Neil (1992). Report of the Task Force on the
I-REF	Availability of Cardiovascular Drugs to the Medically Indigent. Circ 85 (2), S. 849–860
I-REF	(http://circ.ahajournals.org/cgi/reprint/85/2/849).
B-REF	Eichner, Matthew (1998). The Demand for Medical Care: What People Pay does Matter. Am Econ Rev 88
I-REF	(2), S. 117-121 (http://links.jstor.org/sici?sici=0002-
I-REF	8282%28199805%2988%3A2%3C117%3ATDFMCW%3E2.0.CO%3B2-0).
B-REF	Eisenberg; John; Power, Elaine (2000). Transforming Insurance Coverage Into Quality Health Care. Voltage
I-REF	Drops From Potential to Delivered Quality. JAMA 284 (16), S. 2100-2107. (http://jama.ama-
I-REF	assn.org/cgi/reprint/284/16/2100).
B-REF	Elliott, Catherine (1991). Implications of Uncollectibles for Hospitalization Coinsurance Rates. J Risk Insur
I-REF	58 (4), S. 616-641+644-645 (http://links.jstor.org/sici?sici=0022-
I-REF	4367%28199112%2958%3A4%3C616%3AIOUFHC%3E2.0.CO%3B2-7).
B-REF	Elliott, Rachel; Majumdar, Sumit; Gillick, Muriel; Soumerai, Stephen (2005). Medicare Drug Benefit:
I-REF	Benefits and Consequences for the Poor and the Disabled. N Engl J Med 353 (26), S. 2739-2741
I-REF	(http://content.nejm.org/cgi/reprint/353/26/2739.pdf).
B-REF	Elliott, Paul; Shaddick, Gavin; Wakefield, Jonathan; de Hoogh, Cornelis; Briggs, David (2007). Long-term
I-REF	associations of outdoor air pollution with mortality in Great Britain. Thorax 62 (12), S. 1088-1094
I-REF	(http://thorax.bmj.com/cgi/content/full/62/12/1088).
B-REF	Ellis, Jeffrey; Erickson, Steven; Stevenson, James; Bernstein, Steven; Stiles, Renee; Fendrick, Mark (2004).
I-REF	Suboptimal Statin Adherence and Discontinuation in Primary and Secondary Prevention Populations Should
I-REF	We Target Patients with the Most to Gain? J Gen Int Med 19 (6), S. 638-645 (http://www.blackwell-
I-REF	synergy.com/doi/pdf/10.1111/j.1525-1497.2004.30516.x).
B-REF	Ellis, Randall (1986). Rational Behavior in the Presence of Coverage Ceilings and Deductibles. RAND J
I-REF	Econ 17 (2), S. 158-175 (http://links.jstor.org/sici?sici=0741-
I-REF	6261%28198622%2917%3A2%3C158%3ARBITPO%3E2.0.CO%3B2-9).
B-REF	Ellis, Randall; McGuire, Thomas (1986). Provider behavior under prospective reimbursement: Cost sharing
I-REF	and supply. J H Econ 5 (2), S. 129-151.
B-REF	Elofsson, Stig; Unden, Anna-Lena; Krakau, Ingvar. (1998). Patient charges – A Hindrance to Financially
I-REF	and Psicosocially Disadvantaged Groups Seeking Care. Soc Sc Med 46 (10), S. 1375-1380.
B-REF	Ensor, Tim; Duran-Moreno, Antonio (2002). Corruption as a challenge to effective regulation in the health
I-REF	sector. Saltman, Busse, Mossialos 2002, S. 106-124 (http://www.who.dk/document/OBS/REBC05.pdf).
B-REF	Enthoven, Alain (2004). Perspective: Market Forces And Efficient Health Care Systems. H Aff 23 (2), S.
I-REF	25-27 (http://content.healthaffairs.org/cgi/reprint/23/2/25).
B-REF	Entwistle, Vikki (2004).Trust and shared decision-making: an emerging research agenda. H Expect 7 (4), S.
I-REF	271–273 (http://www.blackwell-synergy.com/doi/full/10.1111/j.1369-7625.2004.00304.x).
B-REF	Erlinger, Rainer (2006). Unärztliche Käuflichkeit. Heil- oder Marktkräfte? Das Gesundheitswesen ohne
I-REF	Halt. Süddeutsche Zeitung 244, 23.10.2006.
B-REF	Ernst, Michael; Kelly, Michael; Hoehns, James; Swegle, John; Buys, Lucinda; Logemann, Craig; Ford, Ju-
I-REF	lie; Kautzman, Holli; Sorofman, Bernard; Pretorius, Richard (2000). Prescription Medication Costs. A Study
I-REF	of Physician Familiarity. Fam Med 9, S. 1002-1007 (http://archfami.ama-assn.org/cgi/reprint/9/10/1002).
B-REF	Esposito, Domenico (2002). You Get What you Copay For. The Influence of Patient Copayment on the De-
I-REF	mand for Drugs within a Therpeutic Class: The Case of Statins. Universität Kalifornien, Santa Barbara
I-REF	(http://www.econ.ucsb.edu/papers/wp16-021.pdf).
B-REF	Ettelt, Stefanie; Nolte, Ellen; Mays, Nicholas; Thomson, Sarah; McKee, Martin; and the International
I-REF	Healthcare Comparisons Network (2006). Policy brief. Health care outside hospital. Accessing generalist
I-REF	and specialist care in eight countries. European Observatory on Health Systems and Policies/World Health
I-REF	Organization, Copenhagen (http://www.euro.who.int/Document/E89259.pdf).
B-REF	Evans, Robert; Barer, Morris; Stoddart, Greg (1993a). The truth about user fees. Policy Options 14 (8), S. 4-
I-REF	9.
B-REF	Evans, Robert; Barer, Morris; Stoddart, Greg; Bhatia, Vandha (1993b). Who are the Zombie Masters, and
I-REF	what do they want? Centre for Health Services and Policy Research, University of British Columbia. HPRU,
I-REF	93. 13D. Calgary (http://www.chspr.ubc.ca//hpru/pdf/hpru93-13D.pdf).
B-REF	Evans, Robert; Barer, Morris; Stoddart, Greg; Bhatia, Vandha (1993c). It’s not the Money, it’s the Principle:
I-REF	Why User Charges for some services and not Others? Centre for Health Services and Policy Research, Uni-
I-REF	versity of British Columbia. HPRU, 93. 16D. Calgary (http://www.chspr.ubc.ca//hpru/pdf/hpru93-16D.pdf).
B-REF	Evans, Robert; Barer, Morris; Stoddart, Greg (1993d). Charging Peter to Pay Paul: Accounting for the Fi-
I-REF	nancial Effects of User Charges. Centre for Health Services and Policy Research, University of British Co-
I-REF	lumbia. HPRU, 93. 17D. Calgary (http://www.chspr.ubc.ca//hpru/pdf/hpru93-17D.pdf).
B-REF	Evans, Robert; Barer, Morris; Lewis, Steven; Rachlis, Michael; Stoddart, Greg (1995). User fees for Health
I-REF	Care: Why a Bad Idea Keeps Coming Back (Or, What’s Health Got to Do With It?). Can J Aging 14 (2), S.
I-REF	360-390.
B-REF	Evans, Robert; Barer, Morris; Lewis, Steven; Rachlis, Michael; Stoddart, Greg (2000). Private Highway,
I-REF	One-Way-Street: The Deklein and Fall of Canadian Medicare? University of British Columbia, Calgary
I-REF	(http://www.chspr.ubc.ca//hpru/pdf/hpru00-3D.pdf).
B-REF	Evans, Robert (1997). Going for the Gold: The Redistributive Agenda behind Market-Based Health Care
I-REF	Reform. J H Polit Pol Law 22 (2), S. 427-465 (http://jhppl.dukejournals.org/cgi/reprint/22/2/427;
I-REF	http://web.ebscohost.com/ehost/pdf?vid=3&hid=117&sid=b703f69b-1851-4b45-892a-
I-REF	d3bc2e69e4b9%40sessionmgr9).
B-REF	Evans, Robert (2000). Canada. Reconsidering the Role of Competition in Health Care Markets. J H Polit Pol
I-REF	Law 25 (5), S. 889-897 (http://jhppl.dukejournals.org/cgi/reprint/25/5/889;
I-REF	http://muse.jhu.edu/journals/journal_of_health_politics_policy_and_law/v025/25.5evans.pdf;
I-REF	http://web.ebscohost.com/ehost/pdf?vid=3&hid=113&sid=b703f69b-1851-4b45-892a-
I-REF	d3bc2e69e4b9%40sessionmgr9).
B-REF	Evans, Robert (2002). Raising the Money: Options, Consequences, and Objectives for Financing Health
I-REF	Care in Canada. University of British Columbia, Commission on the Future of Health Care in Canada, Dis-
I-REF	cussion Paper No 27, ISBN 0-662-32791-8 (http://collection.nlc-bnc.ca/100/200/301/pco-bcp/commissions-
I-REF	ef/future_health_care-ef/discussion_paper-e/no27/27_e.pdf).
B-REF	Fahs, Marianne (1992). Physician response to the United Mine Worker’s cost sharing program: the otherside
I-REF	of the coin. H Serv Res 27 (1), S. 25-45
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1069862&blobtype=pdf;;
I-REF	http://www.encyclopedia.com/doc/1G1-12414799.html).
B-REF	Fairman, Kathleen; Motheral, Brenda; Teitelbaum, Fred (2001). Effects of Employee Salary and Chronic
I-REF	Disease on Response to a Drug Co-Payment Increase. Office of Research and Development, Tucson
I-REF	(http://www.express-
I-REF	scripts.com/ourcompany/news/outcomesresearch/onlinepublications/studyfolder4/copaymentIncrease.pdf).
B-REF	Kathleen Fairman, Brenda Motheral Rochelle Henderson, (2003). Retrospective, long-term follow-up study
I-REF	of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utiliza-
I-REF	tion and costs. Clin Ther 25 (12), S. 3147-3161.
B-REF	Families USA (2001). Research Shows the Negativ Impact of Out-of-Pocket Costs on Low-Income People.
I-REF	The Voice for Health Care Consumers, Washington DC (www.familiesusa.org/site/
I-REF	DocServer/6_Cost_sharing.pdf?docID=584).
B-REF	Families USA (2003a). State Budget Cuts: Increased Premiums and Cost-Sharing. The Voice for Health
I-REF	Care Consumers, Washington DC (www.familiesusa.org/site/DocServer/
I-REF	4a_IncreasedCostSharing.pdf?docID=616).
B-REF	Families USA (2003b). Prescription Drug Cost-Sharing and Low-Income People: Five Good Reasons to
I-REF	Keep It Minimal. Health Policy Memo, Washington DC
I-REF	(http://www.familiesusa.org/assets/pdfs/Rx_Cost_Sharing9d2b.pdf).
B-REF	Farmer, Andrew; Wade, Alisha; Goyder, Elizabeth; Yudkin, Patricia; French, David; Craven, Anthea;
I-REF	Holman, Rury; Kinmonth, Ann-Louise; Andrew, Neil (2007). Impact of self monitoring of blood glucose in
I-REF	the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ
I-REF	335 (7611), S. 132-139 (http://www.bmj.com/cgi/reprint/335/7611/132).
B-REF	Federman, Alex; Adams, Alyce; Ross-Degnan, Dennis; Soumerai, Stephen; Ayanian, John (2001). Supple-
I-REF	mental Insurance and Use of Effective Cardiovascular Drugs Among Elderly Medicare Beneficiaries with
I-REF	Coronary Heart Disease. JAMA 286 (14), S. 1732-1739 (http://jama.ama-assn.org/cgi/reprint/286/14/1732).
B-REF	Federman, Alex (2004). Don’tAsk, Don’t Tell. The Status of Doctor-Patient Communication About Health
I-REF	Care Costs. Arch Int Med 164 (16), S. 1723-1724 (http://archinte.ama-
I-REF	assn.org/cgi/content/full/164/16/1723).
B-REF	Federman, Alex; Vladeck, Bruce; Siu Albert (2005). Avoidance Of Health Care Services Because Of Cost:
I-REF	Impact Of The Medicare Savings Program. H Aff 24 (1), S. 263-270
I-REF	(http://content.healthaffairs.org/cgi/reprint/24/1/263).
B-REF	Federman, Alex; Halm, Ethan; Zhu, Carolyn; Hochman, Tsivia; Siu, Albert (2006). Association of Income
I-REF	and Prescription Drug Coverage With Generic Medication Use Among Older Adults With Hypertension. Am
I-REF	J Manag Care 12 (10), S. 611-618 (http://www.ajmc.com/files/articlefiles/AJMC_Federman_611to619.pdf).
B-REF	Felder, Stefan; Werblow, Andreas (2001). Der Einfluss von Zuzahlungen auf die Nachfrage nach medizini-
I-REF	schen Leistungen: Empirische Evidenz aus der Schweiz. Gesundheitswesen 63, A74.
B-REF	Felder, Stefan; Werblow, Andreas (2006). Anreizwirkungen wählbarer Selbstbehalte. Das Selbstbehaltmo-
I-REF	dell der Techniker Krankenkasse. Nomos-Verlagsgesellschaft, Baden Baden.
B-REF	Feldman, Roger; Sloan, Frank (1989). Peply from Feldman and Sloan. J H Polit Pol Law 14 (3), S. 621-625
I-REF	(http://jhppl.dukejournals.org/cgi/reprint/14/3/621).
B-REF	Feldman, Roger; Dowd, Bryan (1991). A New Estimate of the Welfare Loss of Excess Health Insurance.
I-REF	Am Econ Rev 81 (1), S. 297-301 (http://links.jstor.org/sici?sici=0002-
I-REF	8282%28199103%2981%3A1%3C297%3AANEOTW%3E2.0.CO%3B2-E).
B-REF	Feldman, Roger; Morrisey, M. (1990). Health Economics: A Report on the Field. J H Polit Pol Law 15 (3),
I-REF	S. 627-646 (http://jhppl.dukejournals.org/cgi/reprint/15/3/627; ).
B-REF	Feldstein, Martin (1970). The Rising Price of Physician's Services. Rev Econ Stat 52 (2), S. 121-133
I-REF	(http://links.jstor.org/sici?sici=0034-
I-REF	6535%28197005%2952%3A2%3C121%3ATRPOPS%3E2.0.CO%3B2-S).
B-REF	Feldstein, Martin (1973). The Welfare Loss of Excess Health Insurance. J Pol Econ 81 (2, Part 1), S. 251-
I-REF	280 (http://links.jstor.org/sici?sici=0022-
I-REF	3808%28197303%2F04%2981%3A2%3C251%3ATWLOEH%3E2.0.CO%3B2-1).
B-REF	Fendrick, Mark; Smith, Dean; Chernew, Michael; Shah, Sonali (2001). A Benefit-Based Copay for Prescrip-
I-REF	tion Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost. Am J Man Care 7 (9),
I-REF	S. 861-867 (http://www.ajmc.com/files/articlefiles/AJMC2001sepFendrick861_867.pdf).
B-REF	Fendrick, Mark; Chernew, Michael (2006). Value-based Insurance Design: A“Clinically Sensitive” Ap-
I-REF	proach to Preserve Quality of Care and Contain Costs. Am J Manag Care 12 (1), S. 18-20
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_06janFendrickEdit18to20.pdf).
B-REF	Fendrick, Mark; Chernew, Michael (2007). “Fiscally Responsible, Clinically Sensitive” Cost Sharing: Con-
I-REF	tain Costs While Preserving Quality. Am J Man Care 13 (6, Part 2), S. 325-327
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2FendrickIntro325.pdf).
B-REF	Fink, Ulf (2002). Gesundheitsreform 2003. Nomos Verlagsgesellschaft, Baden-Baden.
B-REF	Finkelstein, Amy (2004). The Aggregate Effects of Health Insurance: Evidence from the Introduction of
I-REF	Medicare. Harvard University and NBER (www2.gsb.columbia.edu/divisions/ fi-
I-REF	nance/seminars/micro/fall_04/Finkelstein.pdf).
B-REF	Finkelstein, Joel (2004). Firms embrace cost-sharing; sick pay most. Government & Medicine. AMNews
I-REF	Jan. 2004 (http://www.ama-assn.org/amednews/2004/01/12/gvsc0112.htm).
B-REF	Finkelstein, Murray; Jerrett, Michael; DeLuca, Patrick; Finkelstein, Norm; Verma, Dave; Chapman, Ken-
I-REF	neth; Sears, Malcolm (2003). Relation between income, air pollution and mortality: a cohort study. CMAJ
I-REF	169 (5), S. 397-402 (http://www.cmaj.ca/cgi/reprint/169/5/397).
B-REF	Fischer, Pamela; Strobino, Donna; Pinckney, Carole (1984). Utilization of child health clinics following in-
I-REF	troduction of a copayment. Am J Pub H 74 (12), S. 1401–1403
I-REF	(http://www.ajph.org/cgi/reprint/74/12/1401).
B-REF	Fortess, Eric; Stephen Soumerai, Thomas McLaughlin, Ross-Degnan, Dennis (2001). Utilization of Essen-
I-REF	tial Medications by Vulnerable Older People After a Drug Benefit Cap: Importance of Mental Disorders,
I-REF	Chronic Pain, and Practice Setting. J Am Geriatr Soc 49 (6), S. 793-797 (http://www.blackwell-
I-REF	synergy.com/doi/pdf/10.1046/j.1532-5415.2001.49158.x).
B-REF	Foxman, Betsy; Valdez, Robert; Lohr, Kathleen, Goldberg, George; Newhouse, Joseph; Brook, Robert
I-REF	(1987). The Effect Of Cost Sharing On The Use Of Antibiotics In Ambulatory Care: Results From A Popu-
I-REF	lation-Based Randomized Controlled Trial. J Chron Dis 40 (5), S. 429-439.
B-REF	Frank, Richard (2001). Prescription Drug Prices: Why Do Some Pay More Than Others? H Aff 20 (2), S.
I-REF	115-128 (http://content.healthaffairs.org/cgi/reprint/20/2/115.pdf).
B-REF	Fraser-Institute (1999). The Empirical Evidence. Vancouver
I-REF	(http://oldfraser.lexi.net/publications/critical_issues/1998/msa/evidence.html)
B-REF	Fraser-Institute (2002). Which Countries Other than Canada Don’t have CostSharing? A Look at Co-
I-REF	insurance and Co-payments. Canadian Health Care Aug. 2002, S. 14-21
I-REF	(http://www.fraserinstitute.ca/admin/books/chapterfiles/Part%202-pages14-21.pdf).
B-REF	Freiman, Mark (1984). Cost Sharing Lessons from the Private Sector. H Aff 3 (4), S. 85-93
I-REF	(http://content.healthaffairs.org/cgi/reprint/3/4/85.pdf).
B-REF	French, Eric; Bailey Jones, John (2004). On the Distribution and Dynamics of Health Care Costs. J Appl
I-REF	Econometrics 19 (6), S. 705-721 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/109799428/PDFSTART; http://qed.econ.queensu.ca/jae/2004-v19.6/french-jones/;
I-REF	www.albany.edu/~jbjones/healc32.pdf).
B-REF	Frerich, Johannes; Frey, Matzin (1996). Handbuch der Geschichte der Sozialpolitik in Deutschland Bd. 1, 2.
I-REF	Aufl., Oldenbourg Wissenschaftsverlag, München. (S. 208).
B-REF	Fuchs, Victor; Hahn, Jim (1990). How does Canada do it? A comparison of expenditures for physicians’
I-REF	services in the United States and Canada. N Engl J Med 323 (13), S. 884-890
I-REF	(http://content.nejm.org/cgi/content/abstract/323/13/884).
B-REF	Fuchs, Victor (1996). Economics, Values and Health Care Reform. Am Econ Rev 86 (1), S. 1-23
I-REF	(http://links.jstor.org/sici?sici=0002-8282%28199603%2986%3A1%3C1%3AEVAHCR%3E2.0.CO%3B2-
I-REF	L).
B-REF	Fuchs, Victor (2002). What’s ahead for Health Insurance in the United States? N Engl J Med 346 (23), S.
I-REF	1822-1824 (http://content.nejm.org/cgi/reprint/346/23/1822.pdf).
B-REF	Gabel, Jon; Lo Sasso, Anthony; Rice Thomas (2002a). Consumer-Driven Health Plans: Are They More
I-REF	Than Talk Now? H Aff, Web Excl, S. w2 395-W407
I-REF	(http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.395v1).
B-REF	Gabel, Jon; Levitt, Larry; Holve, Erin; Pickreign, Jeremy; Whitmore, Heidi; Dhont, Kelley; Hawkins,
I-REF	Samantha; Rowland, Diane (2002b). Jobbased health benefits in 2002: some important trends. H Aff 21 (5),
I-REF	S. 143-151 (http://content.healthaffairs.org/cgi/reprint/21/5/143).
B-REF	Gabel, Jon; Claxton, Gary; Holve, Erin; Pickreign, Jeremy; Whitmore, Heidi; Dhont, Kelley; Hawkins,
I-REF	Samantha; Rowland, Diane (2003). Health Benefits In 2003: Premiums Reach Thirteen-Year High As Em-
I-REF	ployers Adopt New Forms of Cost Sharing. H Aff 22 (5), S. 117-126
I-REF	(http://content.healthaffairs.org/cgi/reprint/22/5/117).
B-REF	Galbraith, Alison; Wong, Sabrina; Kim, Sue; Newacheck, Paul (2005). Out-of-pocket financial burden for
I-REF	low-income families with children: socioeconomic disparities and effects of insurance. H Serv Res 40 (6), S.
I-REF	1722-1736 (http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1475-6773.2005.00421.x;
I-REF	http://www.findarticles.com/p/articles/mi_m4149/is_6_40/ai_n16015023).
B-REF	Garber, Alan (2004). Cost-Effectiveness And Evidence Evaluation As Criteria For Coverage Policy. H Aff –
I-REF	Web Excl, S. w4 284-296 (http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.284v1).
B-REF	Garfield, Sarah; Smith, Felicity; Francis, Sally-Anne; Chalmers, Colin (2007). Can patients’ preferences for
I-REF	involvement in decision-making regarding the use of medicines be predicted? Pat Educ Counsel 66 (3) 361–
I-REF	367.
B-REF	Garrison, Lou; Towse, Adrian (2003). The Drug Budget Silo Mentality in Europe: An Overview. Value in
I-REF	Health 6 (s1), S. S1-S9 (http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1524-4733.6.s1.1.x).
B-REF	Gaynor, Martin; Li, Jian; Vogt, William (2005a). Is Drug coverage A Free Lunch? Cross-price Elasticities
I-REF	and the Design of Prescription Drug Benefits. PERC Applied Microeconomics, Department of Economics,
I-REF	Texas A&M University, College Station
I-REF	(http://econweb.tamu.edu/workshops/PERC%20Applied%20Microeconomics/William%20B.%20Vogt.pdf).
B-REF	Gaynor, Martin; Li, Jian; Vogt, William (2005b). Is Drug coverage A Free Lunch?: Cross-price Elasticities
I-REF	and the Design of Prescription Drug Benefits. Working Paper 12758, National Bureau of Economic Re-
I-REF	search, Cambridge (http://www.nber.org/papers/w12758).
B-REF	Gebhardt, Birte (2005). Zwischen Steuerungswirkung und Sozialverträglichkeit – eine Zwischenbilanz zur
I-REF	Praxisgebühr aus Sicht der Versicherten. In: Boecken, Jan; Braun, Bernard; Schnee, Melanie; Amhof, Ro-
I-REF	bert (Hrsg.). Gesundheitsmonitor 2005. Die ambulante Versorgung aus Sicht von Bevölkerung und Ärzte-
I-REF	schaft. Verlag Bertelsmann Stiftung, Gütersloh, S. 11-31.
B-REF	Gehring, Ulrike; Heinrich, Joachim; Kramer, Ursula; Grote, Veit; Hochadel, Matthias; Sugiri, Dorothea;
I-REF	Kraft, Martin; Rauchfuss, Knut; Eberwein, Hans-Georg; Wichmann, Hans-Erich (2006). Long-Term Expo-
I-REF	sure to Ambient Air Pollution and Cardiopulmonary Mortality in Women. Epidemiology 17 (5), S. 545-551.
B-REF	Geißler, Ulich (1980). Erfahrungen mit der Selbstbeteiligung in der gesetzlichen Krankenversicherung in
I-REF	der Bundesrepublik Deutschland. Selbstbeteiligung im Gesundheitswesen. In: Internationale Gesellschaft für
I-REF	Gesundheitsökonomie, S. 37–57.
B-REF	Gemmill, Marin; Costa-Font, Joan; McGuire, Alistair (2007). In search of a corrected prescription drug
I-REF	Elasticity estimate: a meta-regression approach. H Econ 16 (6), S. 627-643
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/114069729/PDFSTART).
B-REF	Geoffard, Pierre-Yves (2000). Dépenses de santé: l’hypothèse d’ „aléa moral“. Économie et Prévision 142,
I-REF	S. 123-135. ISSN 02494744.
B-REF	Gericke, Christian; Wismar, Matthias; Busse, Reinhard (2003). Cost-sharing in the German Health Care
I-REF	System. Department of Health Care Management. Technische Universität Berlin/European Observatory on
I-REF	Health Care Systems. Berlin (http://www.ww.tu-berlin.de/diskussionspapiere/2004/dp04-2004.pdf).
B-REF	Gericke, Christian; Wismar, Matthias; Busse, Reinhard (2004). Finanzielle Selbstbeteiligung der Patienten
I-REF	in Deutschland – Kaum empirische Evidenz. Gesundheitswesen 66 (8/9), (Abstract: http://www.thieme-
I-REF	connect.de/ejournals/abstract/gesu/doi/10.1055/s-2004-833802).
B-REF	Gerken, Lüder; Raddatz, Guido (2002). Deutschland im Reformstau. 3 Maßnahmenkataloge der Stiftung
I-REF	Marktwirtschaft. Argumente zu Marktwirtschaft und Politik 69, Stiftung Marktwirtschaft, Berlin
I-REF	(http://www.insm.de/Downloads/PDF_-
I-REF	_Dateien/Publikationen_Kostenlose_Downloads/Stiftung_Marktwirtschaft/argument69.pdf).
B-REF	Gerlinger, Thomas (2002). Gesundheitspolitik unter SPD und Bündnis 90/Die Grünen – eine Zwischenbi-
I-REF	lanz zu Beginn der 2. Legislaturperiode. Jahrbuch für Kritische Medizin, Bd. 37, Berlin. S. 119-147.
B-REF	Gerlinger, Thomas (2003). Verlagern statt Sparen. Die Folgen der Schweizer Gesundheitsreform von 1996.
I-REF	WZB-Mitteilungen 101, Berlin, S. 11-16.
B-REF	Gerlinger, Thomas (2003). Besserung in Sicht? Anmerkungen zur Gesundheitsreform 2003. WZB-
I-REF	Mitteilungen 101, Berlin (http://www.wz-berlin.de/publikation/pdf/wm101/7.pdf).
B-REF	Gerlinger, Thomas (2003). Das Schweizer Modell der Krankenversicherung. Zu den Auswirkungen der Re-
I-REF	form von 1996. Wissenschaftszentrum Berlin, WZB Papers 2003-301, ISSN 0948 048X (http://skylla.wz-
I-REF	berlin.de/pdf/2003/i03-301.pdf).
B-REF	Gibson, Teresa; McLaughlin, Catherine; Smith, Dean (2001). Cost-Sharing for Prescription Drugs. JAMA
I-REF	285 (18), S. 2328 (http://jama.ama-assn.org/cgi/reprint/285/18/2328).
B-REF	Gibson, Teresa; McLaughlin, Catherine; Smith, Dean (2005a). A Copayment Increase for Prescription
I-REF	Drugs: The Long-Term and Short-Term Effects on Use and Expenditures. Inquiry 42 (3), S. 293–310
I-REF	(http://www.inquiryjournalonline.org/inqronline/?request=acl-login&request_type=get-pdf&file=i0046-
I-REF	9580-042-03-0293.pdf).
B-REF	Gibson, Teresa; Ozminkowski, Ronald; Goetzel, Ron (2005b). The Effects of Prescription Drug Cost Shar-
I-REF	ing: A Review of the Evidence. Am J Manag Care 11 (11), S. 730-740
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC05Nov_Gibson730to740.pdf;
I-REF	http://www.ajmc.com/Article.cfm?Menu=1&ID=3027).
B-REF	Gibson, Teresa; Mark, Tami; McGuigan, Kimberly; Axelsen, Kirsten; Wang, Shaohung (2006a). The Ef-
I-REF	fects of Prescription Drug Copayments on Statin Adherence. Am J Manag Care 12 (9), S. 509-517
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_06sepGibson509to517.pdf).
B-REF	Gibson, Teresa; Tami, Mark; Axelsen, Kirsten; Baser, Onur; Rublee, Dale; McGuigan, Kimberly (2006b).
I-REF	Impact of statin copayments on adherence and medical care utilization and expenditures, Am J Manag Care
I-REF	12 (12 Spec. Issue), S. SP11–SP19
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_06DecspeclGibsonSP11.pdf).
B-REF	Gilman, Boyd; Kautter, John (2007). Consumer Response to Dual Incentives Under Multitiered Prescription
I-REF	Drug Formularies. Am J Man Care 13 (6, Part 2), S. 353-359
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2Gilman353to59.pdf).
B-REF	Ginsburg, Paul (2001). Danger Signs Ahead. Presidents Essay, 2000 Annual Report: Analyzing the changing
I-REF	health system: the path taken and the road beyond. Center for Studying Health System Change, Washington
I-REF	DC (http://www.hschange.org/CONTENT/452/452.pdf).
B-REF	Ginsburg, Paul (2002). Rough Seas Ahead for Purchasers and Consumers. Presidents Essay, 2001 Annual
I-REF	Report: Navigating a Changing Health System: Mapping Today's Markets for Policy Makers. Center for
I-REF	Studying Health System Change, Washington DC (http://www.hschange.org/CONTENT/335/335.pdf).
B-REF	Ginsburg, Paul (2004). Election 2004. Controlling Health Care Costs. N Engl J Med 351 (16), S 1591-1593
I-REF	(http://content.nejm.org/cgi/reprint/351/16/1591.pdf).
B-REF	Ginsburg, Marjorie (2006). Rearranging The Deck Chairs. H Aff Web Excl 25 (6), S. w537-w539
I-REF	(http://content.healthaffairs.org/cgi/content/full/hlthaff.25.w537).
B-REF	Gmündner Ersatzkasse (GEK) (2003). Gesundheitsreport 2003. Ergebnisse der Auswertungen zum Schwer-
I-REF	punktthema "Charakterisierung von Hochnutzern im Gesundheitssystem". Gemünden
I-REF	(http://www.aerzteblatt.de/v4/archiv/zusatz.asp?id=36754).
B-REF	Goldman, Dana; Smith, James (2001). Methodological biases in estimating the burden of out-of-pocket ex-
I-REF	penses. H Serv Res 35 (6), S. 1357-1365
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1089195&blobtype=pdf).
B-REF	Goldman, Dana; Zissimopoulos, Julie (2003). High Out-Of-Pocket Health Care Spending By The Elderly. H
I-REF	Aff 22 (3), S. 194-202 (http://content.healthaffairs.org/cgi/reprint/22/3/194).
B-REF	Goldman, Dana; Joyce, Geoffrey; Escarce, José; Pace, Jennifer; Solomon, Mathew; Laouri, Marianne;
I-REF	Landsman, Pamela; Teutsch, Steven (2004). Pharmacy benefits and the Use of Drugs by the Chronically Ill.
I-REF	JAMA 291 (19), S. 2344-2350 (http://jama.ama-assn.org/cgi/reprint/291/19/2344).
B-REF	Goldman, Dana; Joyce, Geoffrey; Karaca-Mandic Pinar (2006a). Varying Pharmacy Benefits With Clinical
I-REF	Status: The Case of Cholesterol-lowering Therapy. Am J Manag Care 12 (1), S. 21-28
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_06janGoldman21to28.pdf).
B-REF	Goldman, Dana; Joyce, Geoffrey; Karaca-Mandic, Pinar (2006b). Cutting Drug Co-Payments for Sicker Pa-
I-REF	tients on Cholesterol-Lowering Drugs Could Save a Billion Dollars Every Year. RAND Health Fact Sheet
I-REF	(http://www.rand.org/pubs/research_briefs/2006/RAND_RB9169.pdf).
B-REF	Goldman, Dana; Joyce, Geoffrey; Zheng, Yuhui (2007). Increase in Prescription Drug Cost Sharing Associ-
I-REF	ated With Lower Rates of Drug Treatment, Adherence. JAMA 298 (1), S. 61-69 (http://pubs.ama-
I-REF	assn.org/cgi/reprint/298/1/61.pdf).
B-REF	Goldstein, Mary; Lavori, Philip; Coleman, Robert; Advani, Aneel; Hoffman, Brian (2005). Improving Ad-
I-REF	herence to Guidelines for Hypertension Drug Prescribing: Cluster-randomized Controlled Trial of General
I-REF	Versus Patient-specific Recommendations. Am J Manag Care 11 (11), S. 677-668
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC05Nov_Goldstein677to685.pdf).
B-REF	Goodman, John (2006). What Is Consumer-Directed Health Care?. H Aff 25 (6), Web Excl, S. w540–w543
I-REF	(http://content.healthaffairs.org/cgi/content/full/hlthaff.25.w540).
B-REF	Gottlieb, Scott (2000). Medical Bills Account for 40 % of Bankruptcies. BMJ 320 (7243), S. 1295
I-REF	(bmj.bmjjournals.com/cgi/reprint/320/7245/1295/b.pdf).
B-REF	Grabka, Markus (2004). Alternative Finanzierungsmodelle einer sozialen Krankenversicherung in Deutsch-
I-REF	land – Methodische Grundlagen und exemplarische Durchführung einer Mikrosimulationsstudie. Dissertati-
I-REF	on, Fakultät VIII – Wirtschaft und Management, Technische Universität Berlin (http://edocs.tu-
I-REF	berlin.de/diss/2004/grabka_markus.pdf).
B-REF	Grabka, Markus; Schreyögg, Jonas; Busse, Reinhard (2005). Die Einführung der Praxisgebühr und ihre
I-REF	Wirkung auf die Zahl der Arztkontakte und die Kontaktfrequenz - eine empirische Analyse. DIW Diskussi-
I-REF	onspapier 506, Berlin
I-REF	(http://www.diw.de/deutsch/produkte/publikationen/diskussionspapiere/docs/papers/dp506.pdf).
B-REF	Greenwald, Howard (1986). Cost Containment and Initiation of Care for Cancer in a Medicare-Eligible
I-REF	Population. Pub Admin Rev 46 (6), S. 651-656 (http://links.jstor.org/sici?sici=0033-
I-REF	3352%28198611%2F12%2946%3A6%3C651%3ACCAIOC%3E2.0.CO%3B2-M).
B-REF	Greenwald, Howard (1987). HMO membership, copayment, and initiation of care for cancer: a study of
I-REF	working adults. Am J Pub H 77 (4), S. 461–466 (http://www.ajph.org/cgi/reprint/77/4/461).
B-REF	Grembowski, David; Conrad, Douglas; Milgrom, Peter (1987). Dental Care Demand Among Children with
I-REF	Dental Insurance. H Serv Res 21 (6), S. 755-775
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1068988&blobtype=pdf).
B-REF	Greß, Stephan (2000). Allokative und distributive Effekte regulierten Wettbewerbs in sozialen Krankenver-
I-REF	sicherungsSystemen "Wirtschaftstheoretische Fundierung, tatsächliche Auswirkungen und Implementati-
I-REF	onsprobleme am Beispiel der Niederlande". Dissertation am Fachbereich:Wirtschaftswissenschaft, Universi-
I-REF	tät Bremen (elib.suub.uni-bremen.de/publications/dissertations/E-Diss115_Gress_S2001.PDF;
I-REF	http://deposit.d-nb.de/cgi-
I-REF	bin/dokserv?idn=962847291&dok_var=d1&dok_ext=pdf&filename=962847291.pdf).
B-REF	Greß, Stefan; Niebuhr, Dea; Wasem, Jürgen (2005). Marktzugang und Preisbildung auf Arzneimittelmärkten
I-REF	im internationalen Vergleich. Diskussionsbeiträge aus dem Fachbereich Wirtschaftswissenschaften, Alfried
I-REF	Krupp von Bohlen und Halbach-Stiftungslehrstuhl für Medizinmanagement, Universität Duisburg-Essen,
I-REF	Campus Essen (http://www.uni-essen.de/fb5/pdf/142.pdf).
B-REF	Gross, David; Alecxih, Lisa; Gibson, Mary; Corea, John; Caplan, Craig; Brangan, Normandy (1999). Out-
I-REF	of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. H Serv Res 34(1 Pt 2), S.
I-REF	241–254 (http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1088998&blobtype=pdf).
B-REF	Gross, Revital; Brammli-Greenberg, Shuli; Rosen, Bruce (2005). Copayment evaluation: Impact on access
I-REF	and equity. The Myers-JDC-Brookdale Institute/Bertelsmann-Stiftung – Health Policy Monitor, Jerusa-
I-REF	lem/Gütersloh (http://www.healthpolicymonitor.org/result.pdf).
B-REF	Grootendorst, Paul; O'Brien, Bernie; Anderson, Geoffrey (1997). On Becoming 65 in Ontario: Effects of
I-REF	Drug Plan Eligibility on Use of Prescription Medicines. Med Care 35 (4), S. 386-398, 1997.
B-REF	Grootendorst, Paul (2002). Beneficiary cost sharing under Canadian provincial prescription drug benefit
I-REF	programs: history and assessment. Can J Clin Pharmacol 9 (2), S. 79–99
I-REF	(http://www.pulsus.com/members/clin-pha/09_02/Pdf/groo_ed.pdf).
B-REF	Grotendoorst, Paul; Marshall, John; Holbrook, Anne; Dolovich, Lisa; O'Brien, Bernie; Levy, Adrian (2005).
I-REF	The impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic
I-REF	drugs. H Serv Res 40 (5 p1), S. 1297-1317 (http://www.blackwell-synergy.com/doi/full/10.1111/j.1475-
I-REF	6773.2005.00420.x; http://www.findarticles.com/p/articles/mi_m4149/is_5_40/ai_n15874894).
B-REF	Gruber, Jonathan (2006). The Role of Consumer Copayments for Health Care: Lessons from the RAND
I-REF	Health Insurance Experiment and Beyond. The Henry J. Kaiser Family Foundation, Washington DC
I-REF	(http://www.kff.org/insurance/upload/7566.pdf).
B-REF	Grudzen, Corita; Brook, Robert (2007). High-Deductible Health Plans and Emergency Department Use.
I-REF	JAMA 297 (10), S. 1126-1127 (http://jama.ama-assn.org/cgi/content/full/297/10/1126).
B-REF	Gurwitz, Jerry; Field, Terry; Harrold, Leslie; Rothschild, Jeffrey; Debellis, Kristin; Seger, Andrew; Cadoret,
I-REF	Cynthia; Fish, Leslie; Garber, Lawrence; Kelleher, Michael; Bates, David (2003). Incidence and Prevent-
I-REF	ability of Adverse Drug Events Among Older Persons in the Ambulatory Setting. JAMA 289 (9), S. 1107-
I-REF	1116 (http://jama.ama-assn.org/cgi/reprint/289/9/1107).
B-REF	Hajen, Leonhard; Paetow, Holger; Schumacher, Harald (2000). Gesundheitsökonomie. Strukturen – Metho-
I-REF	den – Praxisbeispiele. Kohlhammer-Verlag, Stuttgart-Berlin-Köln.
B-REF	Hajen, Leonhard (2004). Steuerung über Preise erfordert Stewardship. Working Papers on Economic Go-
I-REF	vernance, Arbeitspapier für Staatswissenschaft Nr. 08, Hamburger Universität für Wirtschaft und Politik,
I-REF	Hamburg (http://www.hwp-hamburg.de/fach/fg_vwl/DozentInnen/heise/Materials/WP_StaatsWiss/08-
I-REF	Stewardship.pdf).
B-REF	Hall, Charles Jr. (1966). Deductibles in Health Insurance: An Evaluation. J Risk Ins 33 (2), S. 253-263
I-REF	(http://links.jstor.org/sici?sici=0022-4367%28196606%2933%3A2%3C253%3ADIHIAE%3E2.0.CO%3B2-
B-REF	Halton Social Planning Council & Volunteer Centre, Ontario
I-REF	(http://www.haltonspcvc.on.ca/dispatch/cd0403.htm).
B-REF	Han, Xiaoshu (2007. Measuring the Welfare Cost of Mandatory Employer-provided Health Insurance. De-
I-REF	partment of Economics, University of Texas at Austin
I-REF	(http://www.eco.utexas.edu/~xshan/papers/chap3policy.pdf).
B-REF	Hankin, Janet; Steinwachs, Donald; Elkes, Charmian (1980). The impact on utilization of a copayment in-
I-REF	crease for ambulatory psychiatric care. Med Care 18 (8), S. 807-815 (http://links.jstor.org/sici?sici=0025-
I-REF	7079(198008)18%3A8%3C807%3ATIOUOA%3E2.0.CO%3B2-N).
B-REF	Hardee, James; Platt, Frederic; Kasper, Ilene (2005). Discussing Health Care Costs with Patients. An Oppor-
I-REF	tunity for Empathic Communication. J Gen Int Med 20 (7), S. 666 (http://www.blackwell-
I-REF	synergy.com/doi/pdf/10.1111/j.1525-1497.2005.0125.x).
B-REF	Harris, Brian; Stergachis Andy; Ried, Douglas (1990). The effect of drug co-payments on utilization and
I-REF	cost of pharmaceuticals in a health maintenance organization. Med Care 28 (10), S. 907-917.
B-REF	Harris, Brittany; West, Donna; Johnson, Jill; Hong, Song-Hee; Stowe, Cindy (2004). Effects on the cost and
I-REF	utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a
I-REF	state employee health plan. J Manag Care Pharm 10 (5), S. 449-455
I-REF	(http://www.amcp.org/data/jmcp/2004_V10_I5.pdf).
B-REF	Häusler, Bertram; Berger, Ursula; Mast, Oliver; Thefeld, Wolfgang (2005). Risk and potential risk reduction
I-REF	in diabetes type 2 patients in Germany. Eur J H Econ 6 (2), S. 152-158
I-REF	(http://www.springerlink.com/content/x1hq878494582717/fulltext.pdf).
B-REF	Hauff von, Michael; Sauer, Leonore (2003). Die Leistungsfähigkeit des Sozialstaates aus wirtschaftswissen-
I-REF	schaftlicher Perspektive. In: Siegfried Blasche, Michael von Hauff (Hg.), S. 93-115.
B-REF	Hauser, Heinz (1984). Verstärkung der Selbstbeteiligung in der Schweiz: Alternativen, Auswirkungen und
I-REF	politische Aussichten einer Realisierung. In: Oberender, Peter, S. 99-121.
B-REF	Hay, Phil; Jackson, Stevan (2002). Education and Health. The World Bank, Washington DC.
B-REF	Hay, Joel; Leahy, Michael (2005). Cost and Utilization Impacts of Oral Antihistamines in the California
I-REF	Medi-Cal Program. Value in Health 8 (4), S. 506–516 (http://www.blackwell-
I-REF	synergy.com/doi/pdf/10.1111/j.1524-4733.2005.00042.x).
B-REF	Hayek, Friedrich von (1945). The Use of Knowledge by Society. Am Econ Rev 35 (4), S. 519-534.
B-REF	Haynes, Brian; McDonald, Heather; Garg, Amit (2002). Helping Patients Follow Prescribed Treatment:
I-REF	Clinical Applications. JAMA 288 (22), S 2880-2883 (http://jama.ama-assn.org/cgi/reprint/288/22/2880).
B-REF	Health Policy Consensus Group (2003). Step by Step Reform. Civitas: The Institute for the Study of Civil
I-REF	Society, London (http://www.civitas.org.uk/pdf/hpcgMain.pdf).
B-REF	Hearst, Norman; Blas, Erik (2001). Learning from Experience: research on health sector reform in the de-
I-REF	veloping world. H Pol Plan 16 (Suppl. 2), S. 1-3 (http://heapol.oxfordjournals.org/cgi/reprint/16/suppl_2/1).
B-REF	Hecht, Robert; Overholt, Catherine; Holmberg, Hopkin (1993). Improving the implementation of cost recov-
I-REF	ery for health: lessons from Zimbabwe. H Pol 25 (3), S. 213-242.
B-REF	Hefford, Martin; Crampton, Peter; Foley, Jon (2005). Reducing health disparities through primary care re-
I-REF	form: the New Zealand experiment. H Pol 72 (1), S. 9-23.
B-REF	Hehner, Steffen; Wettke, Jürgen (2003). Perspektiven für Apotheken in Deutschland. McKinsey Health 2, S.
I-REF	6-19
I-REF	(http://www.mckinsey.de/_downloads/kompetenz/healthcare/Health2_03_Apotheken_Perspektiven.pdf).
B-REF	Heisler, Michele; Langa Kenneth; Eby, Elizabeth; Fendrick, Mark; Kabeto, Mohammed; Piette, John
I-REF	(2004). The health effects of restricting prescription medication use because of cost. Med Care 42 (7), S.
I-REF	626-634.
B-REF	Heller, Simon (2007). Self monitoring of blood glucose in type 2 diabetes. Clinicians should Stopp patients
I-REF	doing this if it has no benefit. BMJ 335 (7611), S. 105-106 (http://www.bmj.com/cgi/reprint/335/7611/105).
B-REF	Helms, Jay; Newhouse, Joseph; Phelps, Charles (1978). Copayments and Demand for Medical Care: The
I-REF	California Medicaid Experience. Bell J Econ 9 (1), S. 192-208 (http://links.jstor.org/sici?sici=0361-
I-REF	915X%28197821%299%3A1%3C192%3ACADFMC%3E2.0.CO%3B2-H;
I-REF	http://www.rand.org/pubs/reports/2005/R2167.pdf).
B-REF	Henke, Klaus-Dirk; Borchardt, Katja; Schreyögg, Jonas; Farhauer, Oliver (2002). Reformvorschläge zur Fi-
I-REF	nanzierung der Krankenversorgung in Deutschland unter besonderer Berücksichtigung der Kapitaldeckung.
I-REF	Blaue Reihe 2002-05, Berliner Zentrum Public Health, Berlin (http://bsph.charite.de/stuff/Blaue_Liste/2002-
I-REF	05_ger.pdf).
B-REF	Henke, Klaus-Dirk; Schreyögg, Jonas (2004). Towards sustainable health care systems. Strategies in health
I-REF	insurance schemes in France, Germany, Japan and the Netherlands. A comparative study. International So-
I-REF	cial Security Association, Genf. ISBN 92-843-1166-7 (http://www.wm.tu-
I-REF	berlin.de/~mig/papers/index.html).
B-REF	Henry Kaiser Family Foundation (2003). Medicaid and the uninsured. Key facts, Kaiser commission, Wash-
I-REF	ington DC (http://www.medi-calredesign.org/pdf/elig_Kaiser_fact_sheet_on_cost-sharing.pdf).
B-REF	Hesse, Sebastian; Schlette, Sophia (2005). User charges for physician visits. Health Policy Monitor, Survey
I-REF	6, Bertelsmann Stiftung, Gütersloh
I-REF	(http://www.healthpolicymonitor.org/en/Policy_Survey/Search_for_Policy_Reforms/Survey_Details/User_c
I-REF	harges_for_physician_visits.html?content_id=251&language=en).
B-REF	Hibbard, Judith; Weeks, Edward (1988).Consumers in a Competition-Based Cost Containment Environ-
I-REF	ment. J Pub H Pol 9 (2), S. 233-249 (http://links.jstor.org/sici?sici=0197-
I-REF	5897%28198822%299%3A2%3C233%3ACIACCC%3E2.0.CO%3B2-X).
B-REF	Hibbard, Judy (2003). Engaging Health Care Consumers to Improve the Quality of Care. Med Care 41 (1,
I-REF	supplement), S. I61–70.
B-REF	Hillman, Alan; Pauly, Mark; Escarce, José; Ripley, Kimberly; Gaynor, Martin; Clouse, Jon; Ross, Richard
I-REF	(1999). Financial Incentives And Drug Spending In Managed Care. H Aff 18 (2), S. 189-200
I-REF	(http://content.healthaffairs.org/cgi/reprint/18/2/189).
B-REF	Himmelstein, David; Warren, Elizabeth; Thorne, Deborah; Woolhandler, Steffie (2005). Illness And Injury
I-REF	As Contributors To Bankruptcy. H Aff Web Excl 24 (1), S. w5 63-73
I-REF	(http://content.healthaffairs.org/cgi/reprint/hlthaff.w5.63v1).
B-REF	Himmelstein, David; Woolhandler, Steffie (2005). Hope And Hype: Predicting The Impact Of Electronic
I-REF	Medical Records. H Aff 24 (5), S. 1121-1123 (http://content.healthaffairs.org/cgi/reprint/24/5/1121).
B-REF	Hitiris, Theodore (2004). Prescription Charges In The United Kingdom: A Critical Review. Discussion Pa-
I-REF	pers in Economics No. 2000/04, Department of Economics and Related Studies, University of York, York
I-REF	(http://www.york.ac.uk/depts/econ/dp/0004.pdf).
B-REF	Hjertqvist, Johan (2002). User Fees For Health Care In Sweden. A two-tier threat or a tool for solidarity?
I-REF	Swedish Healthcare in Transition, an AIMS Health Care Commentary, Atlantic Institute for Market Studies
I-REF	(AIMS), Halifax (http://www.aims.ca/library/newsletter6.pdf).
B-REF	Ho, Michael; Spertus, John; Masoudi, Frederick; Reid, Kimberly; Peterson, Eric; Magid, David; Krumholz,
I-REF	Harlan; Rumsfeld, John (Ho et al. 2006a). Impact of Medication Therapy Discontinuation on Mortality Af-
I-REF	ter Myocardial Infarction. Arch Intern Med 166 (17), S. 1842-1847 (http://archinte.ama-
I-REF	assn.org/cgi/reprint/166/17/1842).
B-REF	Ho, Michael; Rumsfeld, John; Masoudi, Frederick; McClure, David; Plomondon, Mary; Steiner, John;
I-REF	Magid, David (Ho et al. 2006b). Effect of Medication Nonadherence on Hospitalization and Mortality
I-REF	Among Patients With Diabetes Mellitus. Arch Intern Med 166 (17), S. 1836-1841 (http://archinte.ama-
I-REF	assn.org/cgi/reprint/166/17/1836).
B-REF	Hodgkin, Dominic; Horgan, Constance; Garnick, Deborah; Merrick, Elizabeth (2003). Cost Sharing for Sub-
I-REF	stance Abuse and Mental Health Services in Managed Care Plans. Med Care Res Rev 3 (60), S. 101-116
I-REF	(http://mcr.sagepub.com/cgi/reprint/60/1/101).
B-REF	Hoel, Michael (2005). Concerns for Equity and the Optimal Co-Payments for Publicly Provided Health
I-REF	Care. CESIFO Working Paper No. 1620, Category 1: Public Finance, University of Oslo/Ifo-Institut
I-REF	München
I-REF	(http://www.cesifo.de/pls/guestci/download/CESifo%20Working%20Papers%202005/CESifo%20Working
I-REF	%20Papers%20December%202005/cesifo1_wp1620.pdf).
B-REF	Hoffman, Sharona (2003). Unmanaged Care: Towards Moral Fairness in Health Care Coverage. Indiana
I-REF	Law Journal 78 (2), S. 659-721 (http://www.law.indiana.edu/ilj/volumes/v78/no2/hoffman.pdf).
B-REF	Hoffmann, Barbara; Moebus, Susanne; Möhlenkamp, Stefan; Stang, Andreas; Lehmann, Nils; Dragano,
I-REF	Nico; Schmermund, Axel; Memmesheimer, Michael; Mann, Klaus; Erbel, Raimund; Jöckel, Karl-Heinz;
I-REF	Heinz Nixdorf Recall Study Investigative Group (2007). Residential Exposure to Traffic Is Associated With
I-REF	Coronary Atherosclerosis. Circ 116 (5), S. 489-496 (http://circ.ahajournals.org/cgi/reprint/116/5/489).
B-REF	Hohmann, Jürgen (1998). Gesundheits-, Sozial- und Rehabilitationssysteme in Europa. Gesellschaftliche So-
I-REF	lidarität auf dem Prüfstand. Verlag Hans Huber. Bern.
B-REF	Höhn, Werner (1986). Selbstbeteiligung – Nicht nur ein gesundheitsökonomisches, sondern auch ein ge-
I-REF	sundheitspolitisches Thema. Mensch, Medizin, Gesellschaft 11 (1), S. 23-31.
B-REF	Holgate, Stephen (2005). Mechanisms by which Air Pollution Injures the Chuild’s Respiratory System. In:
I-REF	Krzyzanowski, Michael, Kuna-Dibbert, Birgit; Schneider, Jürgen: S. 29-43.
B-REF	Holst, Jens (2001). Krankenversicherungen in Chile. Ein Modell für andere Länder? Hans-Jacobs-Verlag,
I-REF	Lage.
B-REF	Holst, Jens (2004). Gesundheitswesen in Chile. Selektion und soziale Ausgrenzung. VAS – Verlag für Aka-
I-REF	demische Schriften, Frankfurt/Main. ISBN 3-88864-387-2.
B-REF	Holst, Jens (2004). Modalitäten und Effekte von Zuzahlungen im Gesundheitswesen. Arbeitspapier Nr. 24-
I-REF	2004, Institut für Medizinische Soziologie, Wolfgang-von-Goethe-Universität, Frankfurt
I-REF	(http://www.kgu.de/zgw/medsoz/ArbPap%5CHolst_Modalit_24.pdf; http://www.gtz.de/de/dokumente/de-
I-REF	eigenbeteiligung-gesundheitswesen.pdf).
B-REF	Holst, Jens; Laaser, Ulrich (2003). Zuzahlungen im Gesundheitswesen. Unsozial, diskriminierend und inef-
I-REF	fektiv. Dt Ärztebl 100 (51-52), S. 3358-3361 (http://www.aerzteblatt.de/v4/archiv/artikel.asp?id=39869).
B-REF	Holst, Jens; Laaser, Ulrich; Hohmann, Jürgen (2004). Chilean health insurance system: a source of inequity
I-REF	and selective social insecurity. J Publ H 12, 4, S. 271-282
I-REF	(www.springerlink.com/index/M416VUG85EWXGYNQ.pdf; http://dx.doi.org/10.1007/s10389-004-0026-
I-REF	5).
B-REF	Holst, Jens (2006). Gesundheitsfinanzierung: Risikomischung und soziale Gerechtigkeit. In: Razum, Oliver;
I-REF	Zeeb, Hajo; Laaser, Ulrich. Globalisierung – Gerechtigkeit – Gesundheit. Verlag Hans Huber, Bern, S. 135-
I-REF	149.
B-REF	Holst, Jens (2007). Therapietreue: „Auch eine Bringschuld des Versorgungssystems“. Dt Ärztebl 104 (15),
I-REF	S. A-996-998/B-886-888/C-843-845 (http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=55242).
B-REF	Hong, Song, Shepherd, Marvin (1996). Outpatient prescription drug use by children enrolled in five drug
I-REF	benefit plans. Clin Therapeut 18 (3), S. 528-545.
B-REF	Horev, Tuvia; Babad Yair (2005). Healthcare reform implementation: stakeholders and their roles – the Is-
I-REF	raeli experience. H Pol 71 (1), S. 1-21.
B-REF	Horgan, Constance; Levy Merrick, Elizabeth; Garnick, Deborah; Hodgkin, Dominic; Cenczyk, Robert;
B-REF	Lusenhop, William; Bhalotra Sarita (2003). The Provision of Mental Health Services in Managed Care Or-
I-REF	ganizations. Special Report, US Department of Health and Human Services. Rockville, MD
I-REF	(http://media.shs.net/ken/pdf/sma03-3797/sma03-3797.pdf).
B-REF	Horn, Susan; Sharkey, Phoebe; Gassaway, Julie (1996a). Managed Care Outcomes Project: Study Design,
I-REF	Baseline Patient characteristics, and Outcome Measure. Am J Man Care 2 (3), S. 237-247
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC1996MarHorn237_247.pdf).
B-REF	Horn, Susan; Sharkey, Phoebe; Tracy, Diane; Horn, Corinne; James, Blair; Goodwin, Frederick (1996b). In-
I-REF	tended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed
I-REF	Care Outcomes Project. Am J Man Care 2 (3), S. 253-264
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC1996MarHorn253_264.pdf;
I-REF	http://www.npcnow.org/resources/PDFs/P7.PDF).
B-REF	Horn, Susan; Sharkey, Phoebe; Philips-Harris, Cheryl (1998). Formulary Limitations and the Elderly: Re-
I-REF	sults from the Managed Care Outcomes Project. Am J Man Care 4 (8), S. 1105-1113
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC1998AugHorn1105_1113.pdf).
B-REF	Hsu, John; Reed, Mary; Brand, Richard; Fireman, Bruce; Newhouse, Joseph; Selby, Joseph (2004). Cost
I-REF	sharing: Patient knowledge and effects on seeking emergency department care. Med Care 42 (3), S. 290-296.
B-REF	Hsu, John; Price, Mary; Huang, Jie; Brand, Richard; Fung, Vicki; Hui, Rita; Fireman, Bruce; Newhouse, Jo-
I-REF	seph; Selby, Joseph (2006a). Unintended Consequences of Caps on Medicare Drug Benefits. N Engl J Med
I-REF	354 (22), S. 2349-2359 (http://content.nejm.org/cgi/reprint/354/22/2349.pdf).
B-REF	Hsu, John; Price, Mary; Brand, Richard; Ray, Thomas; Fireman, Bruce; Newhouse, Joseph; Selby, Joseph
I-REF	(2006b). Cost-Sharing for Emergency Care and Unfavorable Clinical Events: Findings from the Safety and
I-REF	Financial Ramifications of ED Copayments Study. H Serv Res 41 (5), S. 1801-1820 (http://www.blackwell-
I-REF	synergy.com/doi/full/10.1111/j.1475-6773.2006.00562.x).
B-REF	Hsu, John; Reed, Mary; Fireman, Bruce; Selby, Joseph (2002). Emergency Department Cost-Sharing: Pa-
I-REF	tient Awareness and Delayed Access. Abstr Acad H Serv Res Health Policy Meet 19, S. 17
I-REF	(http://gateway.nlm.nih.gov/MeetingAbstracts/102273702.html).
B-REF	Hulten, Eddie; Jackson, Jeffrey; Douglas, Kevin; George, Susan; Villines, Todd (2006). The Effect of Early,
I-REF	Intensive Statin Therapy on Acute Coronary Syndrome. A Meta-analysis of Randomized Controlled Trials.
I-REF	Arch Intern Med 166 (17), S. 1814-1821 (http://archinte.ama-assn.org/cgi/reprint/166/17/1814).
B-REF	Hunterlink Customer Support. Sydney (http://users.hunterlink.net.au/~ddhrg/econ/moral_hazard.html#6.
B-REF	Hummels, Thomas; Jäckers, Andreas (2003). Prozentuale Zuzahlungen bei Arzneimitteln. Ein Weg zu mehr
I-REF	Transparenz und Wettbewerb im Arzneimittelmarkt – Das Konzept des Deutschen Generika-Verbandes.
I-REF	Teil 1. Pharm Ind 65 (4), S. 298-301.
B-REF	Huskamp, Haiden; Rosenthal, Meredith; Frank, Richard; Newhouse, Joseph (2000). The Medicare prescrip-
I-REF	tion drug benefit: How will the game be played. H Aff 19 (2), S. 8-23
I-REF	(http://www.healthaffairs.org/cgi/reprint/19/2/8).
B-REF	Huskamp, Haiden; Epstein, Arnold; Blumenthal, David (2003a). The Impact Of A National Prescription
I-REF	Drug Formulary On Prices, Market Share, And Spending: Lessons For Medicare? H Aff 22 (3), S. 149-158
I-REF	(http://content.healthaffairs.org/cgi/reprint/22/3/149).
B-REF	Huskamp, Haiden; Deverka, Patricia; Epstein, Arnold; Epstein, Robert; McGuigan, Kimberly; Frank, Rich-
I-REF	ard (2003b). The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending. N
I-REF	Engl J Med 349 (23), S. 2224-2232 (http://content.nejm.org/cgi/reprint/349/23/2224.pdf).
B-REF	Huskamp, Haiden; Deverka, Patricia; Epstein, Arnold; Epstein, Robert; McGuigan, Kimberly; Muriel,
I-REF	Anna; Frank, Richard (2005). Impact of 3-Tier Formularies on Drug Treatment of Attention-
I-REF	Deficit/Hyperactivity Disorder in Children. Arch Gen Psych 62 (4), S. 435 – 441 (http://archpsyc.ama-
I-REF	assn.org/cgi/reprint/62/4/435).
B-REF	Huskamp, Haiden; Deverka, Patricia; Landrum, Mary Beth; Epstein, Robert; McGuigan, Kimberly (2007).
I-REF	The Effect of Three-Tier Formulary Adoption on Medication Continuation and Spending among Elderly Re-
I-REF	tirees. H Serv Res 42 (5), S. 1926-1942 (http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1475-
I-REF	6773.2007.00722.x).
B-REF	Huttin, Christine (1994). The use of prescription charges. H Pol 27 (1), S. 53-73.
B-REF	Initiative Neue Soziale Marktwirtschaft (ISNM) (o.J.). Eigeninitiative und Solidarität. Der zukunftssichere
I-REF	Sozialstaat. Themenheft Nr. 5, Köln (http://www.insm.de/Downloads/PDF_-
I-REF	_Dateien/Publikationen_Kostenlose_Downloads/Soziales_Themenheft5.pdf).
B-REF	Internationale Gesellschaft für Gesundheitsökonomie (1980). Selbstbeteiligung im Gesundheitswesen. Be-
I-REF	standsaufnahme – Materialien – Denkanstöße. Gustav Fischer Verlag, Stuttgart.
B-REF	Irvine, Benedict; Green, David (2003). International Medical Outcomes: How Does the UK Compare? Civi-
I-REF	tas (Institute for the Study of Civil Society), London (http://www.civitas.org.uk/pdf/hpcgOutcomes.pdf).
B-REF	Jackevicius, Cynthia; Mamdani, Muhammad; Tu, Jack (2002). Adherence With Statin Therapy in Elderly
I-REF	Patients With and Without Acute Coronary Syndromes. JAMA 288 (4), S. 462-467 (http://jama.ama-
I-REF	assn.org/cgi/reprint/288/4/462).
B-REF	Jakobs, Klaus; Langer, Bernhard; Pfaff, Anita; Pfaff, Martin (2003). Bürgerversicherung versus Kopfpau-
I-REF	schale. Alternative Finanzierungsgrundlagen für die Gesetzliche Krankenversicherung. Friedrich-Ebert-
I-REF	Stiftung, Bonn (wido.de/fileadmin/wido/downloads/
I-REF	pdf_gesundheitssystem/wido_ges_fes_bv_vs_kp_1104.pdf).
B-REF	Jemiai, Nadia; Thomson, Sarah; Mossialos, Elias (2004). An overview of cost sharing for health services in
I-REF	the European Union. Euro Observer 6 (3) (http://www.euro.who.int/Document/Obs/EuroObserver6_3.pdf).
B-REF	Jessen, Jens (1999). Selbstbeteiligung: Noch nicht ausgereizt. Dt. Ärztebl 96 (15), S. B-738 – 738
I-REF	(http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=suche&id=16587).
B-REF	Jinnett, Kimberly; Parry, Thomas; Lu, Yifan (2007). A Broader Reach for Pharmacy Plan Design. The Dis-
I-REF	ability Effects of Cost Shifting. Integrated Benefit Institute, San Francisco
I-REF	(http://www.ibiweb.org/publications/download/637).
B-REF	Johnson, Richard; Penner, Rudolph (2004). Will Health Care Costs Erode Retirement Security? Issue Brief
I-REF	23, Center for Retirement Research Boston College (www.bc.edu/centers/crr/issues/ib_23.pdf).
B-REF	Johnson, Richard; Goodman, Michael; Hornbrook, Mark; Eldredge Michael (1997). The Effect of Increased
I-REF	Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance
I-REF	Organization Members. Med Care 35 (11), S. 1119-1131.
B-REF	Jones, Kenneth; Vischi, Thomas (1979). Impact of alcohol, drug abuse and mental health treatment on
I-REF	medical care utilization. A Review of the Research Literature. Med Care 17 (Dec suppl), S. i-ii+iv-vi+1-82
I-REF	(http://links.jstor.org/sici?sici=0025-7079(197912)17%3A12%3Ci%3AIOADAA%3E2.0.CO%3B2-2).
B-REF	Jones, David; Kroenke, Kurt; Landry, Frank; Tomich, David; Ferrel, Richard (1996). Cost savings using a
I-REF	stepped-care prescribing protocol for nonsteroidal anti-inflammatory drugs. JAMA 275 (12), S. 926-930
I-REF	(Abstract: http://jama.ama-assn.org/cgi/content/abstract/275/12/926).
B-REF	Joseph, Hyman (1972). Hospital Insurance and Moral Hazard. J Hum Res 7 (2), S. 152-161
I-REF	(http://links.jstor.org/sici?sici=0022-166X%28197221%297%3A2%3C152%3AHIAMH%3E2.0.CO%3B2-
I-REF	T).
B-REF	Joyce, Geoffrey; Escarce, José; Solomon, Mathew; Goldman, Dana (2002). Employer Drug Benefit Plans
I-REF	and Spending on Prescription Drugs. JAMA 288 (14), S. 1733-1739 (http://jama.ama-
I-REF	assn.org/cgi/reprint/288/14/1733).
B-REF	Jung, Ki-Taig (1998). Influence of the Introduction of a Per-Visit Copayment on Health Care Use and Ex-
I-REF	penditures: The Korean Experience. J Risk Insur 65 (1), S. 33-56 (http://links.jstor.org/sici?sici=0022-
I-REF	4367%28199803%2965%3A1%3C33%3AIOTIOA%3E2.0.CO%3B2-%23).
B-REF	Kaczmarek, Stephen (1999). A Quantitative Analysis of Factors Affecting Formulary Compliance in Pre-
I-REF	scription Drug Card Programs. Fellowship Credit Research Paper 99-1; S. 215-250
I-REF	(http://www.soa.org/library/research/actuarial-research-clearing-house/2000-09/2000/arch-2/arch00v29.pdf).
B-REF	Kaelble, Hartmut; Schmid, Günther (Hrsg.) (2004). Das europäische Sozialmodell. Auf dem Weg zum
I-REF	transnationalen Sozialstaat. Jahrbuch 2004, Wissenschaftszentrum Berlin.
B-REF	Kaiser, Arvid (2003). Finanzielle Selbstbeteiligung in der Gesundheitsversorgung. Untersuchung zur Vertei-
I-REF	lungswirkung bei der Inanspruchnahme von Gesundheitsleistungen in der EU. Arbeitspapiere für Staatswis-
I-REF	senschaften/Working Papers on Economic Governance, Universität für Wirtschaft und Politik, Hamburg
I-REF	(http://www.hwp-hamburg.de/fach/fg_vwl/DozentInnen/heise/Materials/WP_StaatsWiss/06-
I-REF	GesundhVersorgg.pdf).
B-REF	Kamal-Bahl, Sachin; Briesacher, Becky (/2004). How Do Incentive-Based Formularies Influence Drug Se-
I-REF	lection And Spending For Hypertension? H Aff 23 (1), S. 1227-236
I-REF	(http://content.healthaffairs.org/cgi/reprint/23/1/227).
B-REF	Karter, Andrew; Stevens, Mark; Herman, William, Ettner, Susan; Marrero, David; Engelgau, Michael Curb,
I-REF	David; Brown, Arleen (2003). Out-of-Pocket Costs and Diabetes Preventive Services. Diab Care 26 (8), S.
I-REF	2294-2299 (http://care.diabetesjournals.org/cgi/reprint/26/8/2294).
B-REF	Karter, Andrew; Parker, Melissa; Moffet, Howard; Ahmed, Ameena; Chan, James; Spence, Michele; Selby,
I-REF	Joe; Ettner, Susan (2007). Effect of Cost-sharing Changes on Self-monitoring of Blood Glucose. Am J Man
I-REF	Care 13 (7), S. 408-416 (http://www.ajmc.com/files/articlefiles/AJMC_07julyKarter_408to416.pdf).
B-REF	Kasje, Willeke; Timmer, J. W.; Boendermaker, Peter; Haaijer-Ruskamp, Flora (2002). Dutch GPs’ percep-
I-REF	tions: the influence of out-of-pocket costs on prescribing. Soc Sci Med 55 (9), S. 1571-1578.
B-REF	Katz, David (2001). A Solution for Rising Drug Costs. Employers may start to move away from fixed co-
I-REF	payments. CFO Publishing Corporation, New York (http://www.cfo.com/article.cfm/2991456?f=related).
B-REF	Katz, Michael; Rosen, Richard (1994). Microeconomics. 2. Ausg., McGraw-Hill, Irwin, Illinios. ISBN 0-
I-REF	256-17176-9.
B-REF	Kaufmann, Franz-Xaver (1997). Herausforderungen des Sozialstaates. Frankfurt a. M.
B-REF	Kaufmann, Stephan (2004). Der Problemlöser. Berliner Zeitung 6.3.2004, S. M04/05
I-REF	(http://www.berlinonline.de/berliner-zeitung/archiv/.bin/dump.fcgi/2004/0306/magazin/0002/).
B-REF	Keeler, Emmett; Newhouse, Joseph; Phelps, Charles (1974). Deductibles and the Demand for Medical Ser-
I-REF	vices. The Theory of the Consumer Facing a Variable Price Schedule Under Uncertainty. R1514 OEO NC,
I-REF	Rand Corporation, Santa Monica (http://www.rand.org/pubs/reports/2005/R1514.pdf).
B-REF	Keeler, Emmett; Brook, Robert; Goldberg, George; Kamberg, Caren; Newhouse, Joseph (1985). How free
I-REF	care reduced hypetension in the health insurance experiment. JAMA 254 (14), S. 1926-1931 (Abstract:
I-REF	http://jama.ama-assn.org/cgi/content/abstract/254/14/1926).
B-REF	Keeler, Emmett; Sloss, Elizabeth; Brook; Robert; Operskalski, Belinda; Goldberg, George; Newhouse, Jo-
I-REF	seph (1987). Effects of Cost Sharing on Physiological Health, Health Practices, and Worry. H Serv Res 22
I-REF	(3), S. 279-306 (http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1065439&blobtype=pdf).
B-REF	Kenagy, John; Berwick, Donald; Shore, Miles (1999). Service Quality in Health Care. JAMA 281 (7), S.
I-REF	661–665 (http://jama.ama-assn.org/cgi/reprint/281/7/661).
B-REF	Kennedy, Jae; Erb, Christopher (2002). Prescription Noncompliance due to Cost Among Adults With Dis-
I-REF	abilities in the United States. Am J Publ H 92 (7), S. 1120-1124
I-REF	(http://www.ajph.org/cgi/reprint/92/7/1120).
B-REF	Kephart, George: Skedgel, Chris; Sketris, Ingrid; Grootendorst, Paul; Hoar, John; Sommers, Emily (2003).
I-REF	The Effect of Changes in Co-payment and Premium Policies on the Use of Prescription Drugs in the Nova
I-REF	Scotia Seniors' Pharmacare Program. CHRSF/FCRSS, Ottawa
I-REF	(http://www.chsrf.ca/final_research/ogc/kephart_e.php).
B-REF	Kephart, George; Skedgel, Chris; Sketris, Ingrid; Grootendorst, Paul; Hoar, John (2007). Effect of Copay-
I-REF	ments on Drug Use in the Presence of Annual Payment Limits. Am J Man Care 13 (6, Part 2), S. 328-334
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC07junPrt2_Kephart328to34.pdf).
B-REF	Kern, Axel; Kupsch, Stephan (2002). Internationale Vergleiche von Gesundheitssystemen und die Neube-
I-REF	stimmung des Leistungskatalogs in der gesetzlichen Krankenversicherung. Was bringt ein Blick über die
I-REF	Grenzen? Arbeitspapier 217, Wirtschaftswissenschaftliches Institut, Universität Augsburg
I-REF	(http://www.wiwi.uni-augsburg.de/vwl/institut/paper/217.pdf).
B-REF	Kleinke, JD. (2000). Just what the HMO ordered: the paradox of increasing drug costs. H Aff 19 (2), S. 78-
I-REF	91 (http://content.healthaffairs.org/cgi/reprint/19/2/78).
B-REF	Kleinke, J.D. (2004a). Re-Naming And Re-Gaming: Medicare’s Doomed Attempt To Reform Reimburse-
I-REF	ment For Injectable Drugs. H Aff Web Excl 23 (6), S. w4 561-571
I-REF	(http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.561v1).
B-REF	Kleinke, J.D. (2004b). Access Versus Excess: Value-Based Cost Sharing For Prescription Drugs. Health Aff
I-REF	23 (1), S. 34-47 (http://content.healthaffairs.org/cgi/reprint/23/1/34).
B-REF	Klingenberger, David (2005). Steuerungs- und Verteilungswirkungen der Praxisgebühr im Bereich der
I-REF	zahnmedizinischen Versorgung – eine Kosten-Nutzen-Analyse. Das Gesundheitswesen 67, S. 196-203
I-REF	(http://www.thieme-connect.de/ejournals/pdf/gesu/doi/10.1055/s-2005-857957.pdf).
B-REF	Klose, Joachim; Schellschmidt, Henner (2001). Finanzierung und Leistungen der Gesetzlichen Krankenver-
I-REF	sicherung. Einnahmen- und ausgabenbezogene Gestaltungsvorschläge im Überblick. WIdO-Materialien 45,
I-REF	Wissenschaftliches Institut der AOK, Bonn.
B-REF	Knappe, Eckhard; Fritz, Wilhelm (1984). Direktbeteiligung im Gesundheitswesen – Steuerungswirkungen
I-REF	des Selbstbehalts bei ambulanten medizinischen Leistungen und beim Zahnersatz. Deutscher Ärzte-Verlag,
I-REF	Köln.
B-REF	Knappe, Eckhard (2003). Selbstbeteiligung der Patienten als Finanzierungs- und Steuerungsinstrument. In:
I-REF	Albring, Manfred; Wille, Eberhard (Hrsg.) (2003). Die GKV zwischen Ausgabendynamik, Einnahmeschwä-
I-REF	che und Koordinierungsproblemen. Verlag Peter Lang, Frankfurt/M., Berlin, Bern, Brüssel, New York, Ox-
I-REF	ford, Wien
B-REF	Kozyrskyj, Anita; Mustard, Cameron; Cheang, Mary; Simons, Estelle (2001). Income-based drug benefit
I-REF	policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma. CMAJ
I-REF	165 (7), S. 897-902 (http://www.cmaj.ca/cgi/reprint/165/7/897).
B-REF	Kraft, Kornelius; Schulenburg, Matthias Graf von der (1984). Einie empirische Ergebnisse zur Beurteilung
I-REF	der Wirkungen von Selbstbeteiligungsregelungen in der Krankenversicherung. In: Oberender, Peter, S. 123-
I-REF	147.
B-REF	Kravitz, Richard; Epstein, Ronald; Feldman, Mitchell; Franz, Carol; Azari, Rahman; Wilkes, Michael; Hin-
I-REF	ton, Ladson; Franks, Peter (2005). Influence of Patients’ Requests for Direct-to-Consumer Advertised Anti-
I-REF	depressants: A Randomized Controlled Trial. JAMA 293 (16), S. 1995-2002 (http://jama.ama-
I-REF	assn.org/cgi/reprint/293/16/1995).
B-REF	Krohmal, Benjamin; Emanuel, Ezekiel (2007). Access and Ability to Pay: The Ethics of a Tiered Health
I-REF	Care System. Arch Intern Med 167 (5), S. 433-437 (http://pubs.ama-
I-REF	assn.org/media/controlled/archinte/pdf/433.pdf).
B-REF	Krzyzanowski, Michael, Kuna-Dibbert, Birgit, Schneider, Jürgen (eds.) (2005). Effects of air pollution on
I-REF	children’s health and development – a review of the evidence. WHO Regional Office for Europe, Copenha-
I-REF	gen (http://www.euro.who.int/document/E86575).
B-REF	Ku, Leighton (2003). Charging the Poor more for Health Care: Cost-Sharing in Medicaid. Center on Budget
I-REF	an Policy Priorities. Washington DC (http://www.cbpp.org/5-7-03health.pdf).
B-REF	Ku, Leighton; Broaddus, Mathew (2005). Out-of-Pocket Medical Expenses for Medicaid Beneficiaries are
I-REF	Substantial and Growing. Center on Budget and Policy Priorities, Washington DC (http://www.cbpp.org/5-
I-REF	31-05health.pdf).
B-REF	Ku, Leighton; Wachino, Victoria (2005). The Effect of Increased Cost-Sharing in Medicaid: A Summary of
I-REF	Research Findings. Center on Budget and Policy Priorities, Washington DC (http://www.cbpp.org/5-31-
I-REF	05health2.pdf).
B-REF	Kühn, Hagen (2006). Der Ethikbetrieb in der Medizin. Korrektur oder Schmiermittel der Kommerzialisie-
I-REF	rung? In: Hagemann, Ulrich; Simon, Ingeborg (Hg)., Pharmazie im Gesundheitswesen heute, Berlin Reihe:
I-REF	Berichte und Dokumente zur Zeitgeschichte der Medizin, Charité – Universitätsmedizin Berlin: 11-31
I-REF	(http://www.wz-berlin.de/ars/ph/download/ethikbetriebmedizin.pdf).
B-REF	Kupor, Scott; Liu, Yong-chuan; Lee, Jungwoo; Yoshikawa, Aki (1995). The Effect of Copayments and In-
I-REF	come on the Utilization of Medical Care By Subscribers to Japan's National Health Insurance System. Int J
I-REF	H Serv 25 (2), S. 295-312 (Abstract:
I-REF	http://baywood.metapress.com/app/home/contribution.asp?referrer=parent&backto=issue,9,11;journal,50,14
I-REF	7;linkingpublicationresults,1:300313,1).
B-REF	Kurth, Ann; Bielinski, Lori; Graap, Kris; Conniff, John; Connell, Frederick (2001).Reproductive and Sexual
I-REF	Health Benefits in Private Health Insurance Plans in Washington State. Fam Plan Perspect 33 (4), S. 153-
I-REF	160, 179 (http://www.guttmacher.org/pubs/journals/3315301.html;
I-REF	http://www.guttmacher.org/pubs/journals/3315301.pdf).
B-REF	Laaser, Ulrich; Holst, Jens (2004). Unsozial, diskriminierend und ineffektiv. Zuzahlungen im Gesundheits-
I-REF	wesen. Frankfurter Rundschau Nr. 5/2, 60. Jg., 7.1.2004, S. 9.
B-REF	Laditka, Sarah; Mastanduno, Melanie; Laditka, James (2001). Health Care Use of Individuals With Diabetes
I-REF	in an Employer-Based Insurance Population. Arch Intern Med 161 (10), S. 1301-1308 (http://archinte.ama-
I-REF	assn.org/cgi/reprint/161/10/1301).
B-REF	Lagoe, Ronald; Aspling, Deborah; Westert, Gert (2005). Current and Future Developments in Managed
I-REF	Care in the United States and Implications for Europe. H Res Pol Syst 3 (4) (http://www.health-policy-
I-REF	systems.com/content/3/1/4).
B-REF	Lamiraud, Karine; Geoffard, Pierre-Yves (2007). Therapeutic Non-Adherence: A Ratinal Behavior Reveal-
I-REF	ing Patient Preferences? H Econ 16 (11), pp. 1185-1205 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/114122877/PDFSTART).
B-REF	Landon, Bruce; Rosenthal, Meredith; Normand, Sharon-Lise; Spettell, Claire; Lessler, Adam; Underwood,
I-REF	Howard; Newhouse, Joseph (2007). Incentive Formularies and Changes in Prescription Drug Spending. Am
I-REF	J Man Care 13 (6, Part 2), S. 360-369
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2_Landon360to369.pdf).
B-REF	Langa, Kenneth; Fendrick, Mark; Chernew, Michael; Kabeto, Mohammed; Paisley, Kerry; Hayman, James
I-REF	(2004). Out-of-Pocket Health-Care Expenditures among Older Americans with Cancer. Value in Health 7
I-REF	(2), S. 186-194 (http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1524-4733.2004.72334.x).
B-REF	Langer, Bernhard; Pfaff, Anita; Kern, Axel Olaf (2006). Steuerung des GKV-Arzneimittelmarktes – Aus-
I-REF	wirkungen von Selbstbeteiligungen und Härtefallregelungen. Volkswirtschaftliche Diskussionsreihe, Wirt-
I-REF	schaftswissenschaftliche Fakultät, Universität Augsburg (http://www.wiwi.uni-
I-REF	augsburg.de/vwl/institut/paper/285.pdf).
B-REF	LaRosa John; Grundy, Scott; Waters, David; Shear, Charles; Barter, Philip; Fruchart, Jean-Charles; Gotto,
I-REF	Antonio; Greten, Heiner; Kastelein, John; Shepherd, James; Wenger, Nanette (2005). Intensive lipid lower-
I-REF	ing with atorvastatin in patients with stable coronary disease. N Engl J Med 352 (14), S. 1425–1435
I-REF	(http://content.nejm.org/cgi/reprint/352/14/1425.pdf).
B-REF	Laufs, Ulrich; Hamm, Christian; Böhm, Michael (2006). Übersicht: Statintherapie bei koronarer Herzkrank-
I-REF	heit (Statin treatment in coronary heart disease). Dt Ärztebl 103 (41), 13.10.2006, S. A-2714
I-REF	(http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=53060; Literatur:
I-REF	http://www.aerzteblatt.de/v4/archiv/lit.asp?id=53060).
B-REF	Laurent, Olivier; Bard, Denis; Filleul, Laurent; Segala, Claire (2007). Effect of socioeconomic status on the
I-REF	relationship between atmospheric pollution and mortality. J Epid Comm H 61 (8), S. 665-675
I-REF	(http://jech.bmj.com/cgi/reprint/61/8/665).
B-REF	Lauterbach, Karl; Gandjour, Afschin; Schnell, Gerald (2000). Zuzahlungen bei Arzneimitteln. Institut für
I-REF	Gesundheitsökonomie und Klinische Epidemiologie, Universität Köln (http://www.medizin.uni-
I-REF	koeln.de/kai/igmg/stellungnahme/zuzahlungen/sld001.htm).
B-REF	Leader, Shelah; Yang, Harry; DeVincenzo, John; Jacobson, Phillip; Marcin, James; Murray, Dennis (2003).
I-REF	Time and Out-of-Pocket Costs Associated with Respiratory Syncytial Virus Hospitalization of Infants.
I-REF	Value in Health 6 (2), S. 100-106 (http://www.blackwell-synergy.com/doi/full/10.1046/j.1524-
I-REF	4733.2003.00220.x).
B-REF	Lee, Thomas; Zapert, Kinga (2005). Do High-Deductible Health Plans Threaten Quality of Care? N Engl J
I-REF	Med 353 (12), S. 1202-1204 (http://content.nejm.org/cgi/reprint/353/12/1202.pdf).
B-REF	Lee, Peter; Hoo, Emma (2006). Beyond Consumer-Driven Health Care: Purchasers’ Expectations of all
I-REF	Plans. H Aff 25 (6), S. W544-W548 (http://content.healthaffairs.org/cgi/content/full/hlthaff.25.w544).
B-REF	Lee, Jeannie; Grace, Karen; Taylor, Allen (2006). Effect of a Pharmacy Care Program on Medication Ad-
I-REF	herence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Con-
I-REF	trolled Trial. JAMA 296 (21), S. 2563-2571 (http://jama.ama-assn.org/cgi/reprint/296/21/2563).
B-REF	Leibowitz, Arleen; Manning, Willard; Newhouse, Joseph (1983). The Demand for Prescription of Drug as a
I-REF	Function of Cost Sharing. Soc Sci Med 21 (10), S. 1063-1069.
B-REF	Leibowitz, Arleen; Manning, Jr, Willard; Keeler, Emmett; Duan, Naihua; Lohr, Kathleen; Newhouse, Jo-
I-REF	seph (1985). Effect of Cost-Sharing on the Use of Medical Services by Children: Interim Results from a
I-REF	Randomized Controlled Trial. Pediatrics 75 (5), S. 942-951
I-REF	(http://pediatrics.aappublications.org/cgi/reprint/75/5/942).
B-REF	Leslie, Douglas; Rosenheck, Robert (1999). Shifting to Outpatient Care? Mental Health Care Use and Cost
I-REF	Under Private Insurance. Am. J. Psychiatry 156 (8), S. 1250–1257.
B-REF	Levaggi, Laura;_Levaggi, Rosella (2005). Optimal copayment strategies in a public health care system.
I-REF	SSRN Working Paper, New York
I-REF	(http://papers.ssrn.com/sol3/papers.cfm?abstract_id=734923#PaperDownload).
B-REF	Levinson, Wendy; Kao, Audiey; Kuby, Alma; Thisted, Ronald (2005). Not all patients want to participate in
I-REF	decision making. A national study of patient preferences. J Gen Intern Med 20 (6), S. 531–535
I-REF	(http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1525-1497.2005.04101.x).
B-REF	Levit, Katherine; Cowan, Cathy; Lazenby, Helen; Sensenig, Arthur; McDonnell, Patricia; Stiller, Jean; Mar-
I-REF	tin, Anne (2000). Health spending in 1998: signals of change. The Health Accounts Team. H Aff 19 (1), S.
I-REF	124-132 (http://content.healthaffairs.org/cgi/reprint/19/1/124).
B-REF	Lewis, Steven (1998). Still here, still flawed, still wrong: the case against the case for taxing the sick.
I-REF	CMAJ/JAMC 159 (5), S. 497-499 (http://www.cmaj.ca/cgi/reprint/159/5/497.pdf).
B-REF	Lexchin, Joel (1992). Prescribing and Drug Costs in the Province of Ontario. Int J H Serv 22 (3), S. 471-487
I-REF	(Abstract:
I-REF	http://baywood.metapress.com/app/home/contribution.asp?referrer=parent&backto=issue,8,13;journal,61,14
I-REF	7;linkingpublicationresults,1:300313,1).
B-REF	Lexchin, Joel; Grootendorst, Paul (2002). The effects of prescription drug user fees on drug and health ser-
I-REF	vices use and health status: A review of evidence. Draft. Universität Toronto
I-REF	(http://www.thecem.net/Downloads/draft.pdf).
B-REF	Lexchin; Joel, Grootendorst, Paul (2004). Effects of Prescription Drug User Fees on Drug and Health Ser-
I-REF	vices Use and on Health Status in Vulnerable Populations: A Systematic Review of the Evidence. Int J H
I-REF	Serv 34 (1), S. 101-122
I-REF	(http://baywood.metapress.com/media/m5uc84pnnp4qukf91h1k/contributions/4/m/3/e/4m3el0yfw1tdekg0.p
I-REF	df).
B-REF	Liang, Su-Ying; Phillips, Kathryn; Tye, Sherilyn; Haas, Jennifer; Sakowski, Julie (2004). Does Patient Cost
I-REF	Sharing Matter? Its Impact on Recommended Versus Controversial Cancer Screening Services. Am J Manag
I-REF	Care 10 (2), S. 99-107 (http://www.ajmc.com/files/articlefiles/AJMC2004febLiang99-107.pdf).
B-REF	LIPID Study Group (The Long-Term Intervention with Pravastatin in Ischaemic Disease) (1998). Preven-
I-REF	tion of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad
I-REF	range of initial cholesterol levels. N Engl J Med 339 (19), S. 1349–57
I-REF	(http://content.nejm.org/cgi/reprint/339/19/1349.pdf).
B-REF	Lloyd-Sherlock, Peter (2000). Population ageing in developed and developing regions: implications for
I-REF	health policy. Soc Sc Med 51 (6), S. 887-895.
B-REF	Lo Sasso, Anthony; Lyons, John (2004). The Sensitivity of Substance Abuse Treatment Intensity to Co-
I-REF	Payment Levels. J Behav H Serv Res 31 (1), S. 50-65.
B-REF	Lohr, Kathleen; Brook, Robert; Kamberg, Caren; Goldberg, George; Leibowitz, Arleen; Keesey, Joan; Re-
I-REF	boussin, David; Newhouse, Joseph (1986a). Use of medical care in the Rand Health Insurance Esperiment:
I-REF	Diagnosis- and Service-specific Analyses in a Randomised Controlled Trial. Med Care 24 (Suppl. 9), S. S1-
I-REF	S87 (http://www.rand.org/pubs/reports/2006/R3469.pdf).
B-REF	Lohr, Kathleen; Kamberg, Caren; Keeler, Emmett; Goldberg, George; Calabro, Thomas; Brook, Robert
I-REF	(1986b). Chronic Disease in a General Adult Population: Findings from The RAND Health Insurance Ex-
I-REF	periment. West J Med 145 (4), S. 537-545
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1307010&blobtype=pdf).
B-REF	López-Bastida, Julio; Mossialos, Elias (2000). Pharmaceutical Expenditure in Spain: Cost and Control. Int J
I-REF	H Serv 30 (3), S. 597-616
I-REF	(http://baywood.metapress.com/media/h07c757ywk0vvh95hh1k/contributions/y/l/3/j/yl3jqk9b0nmqkmvk.pd
B-REF	Lostao, Lourdes; Regidor, Enrique; Geyer, Siegfried; Aïach, Pierre (2007). Patient cost sharing and social
I-REF	inequalities in access to health care in three western European countries. Soc Sci Med 65 (2), S. 367-376.
B-REF	Lostao, Lourdes; Regidor, Enrique; Geyer, Siegfried; Aïach, Pierre (2007). Patient cost sharing and physi-
I-REF	cian visits by socioeconomic position: findings in three Western European countries. J Epidemiol Comm
I-REF	Health 61 (5), S. 416-420 (http://jech.bmj.com/cgi/reprint/61/5/416).
B-REF	Lundberg, Lars, Johannesson, Maj-Britt; Isacson, Dag; Borgquist L. (1998). Effects of user charges on the
I-REF	use of prescription medicines in different socio-economic groups. H Pol 44 (2), S. 123-134.
B-REF	Lurie, Nicole; Manning, Willard; Peterson, Chris; Goldberg, George; Phelps, Charles; Lillard, Lee (1987).
I-REF	Preventive care: do we practice what we preach? Am J Publ H 77 (7), S. 801-804 (Abstract:
I-REF	http://www.ajph.org/cgi/content/abstract/77/7/801).
B-REF	Lurie, Nicole; Kamberg, Caren; Brook, Robert; Keeler, Emmett; Newhouse, Joseph (1989). Ho free care
I-REF	improved vision in the health insurance experiment. Am J Public Health 79 (5), S. 640-642
I-REF	(http://www.ajph.org/cgi/content/cgi/reprint/79/5/640).
B-REF	Maarse, Hans (2004). User charges in The Netherlands. European Observatory on Health Systems and Poli-
I-REF	cies, Euro Observer 6 (3), S. 4-5 (http://www.euro.who.int/document/Obs/EuroObserver6_3.pdf).
B-REF	Jones, David; Kroenke, Kurt; Landry, Frank; Tomich, David; Ferrel, Richard (1996). Cost savings using a
I-REF	stepped-care prescribing protocol for nonsteroidal anti-inflammatory drugs. JAMA 275 (12), S. 926-930
I-REF	(Abstract: http://jama.ama-assn.org/cgi/content/abstract/275/12/926).
B-REF	Mabasa, Vincent; Ma, Johnny (2006). Effect of a therapeutic maximum allowable cost (MAC) program on
I-REF	the cost and utilization of proton pump inhibitors in an employersponsored drug plan in Canada. J Manag
I-REF	Care Pharm 12 (5), S. 371-376 (http://www.amcp.org/data/jmcp/June_06JMCP.pdf).
B-REF	Magee, Mike (2005). Tiered Cost Sharing: What Does It Mean for Hospital Use? Health Politics, Pfizer
I-REF	Medical Humanities Initiative, New York
I-REF	(http://www.healthpolitics.com/media/prog_58/transcript_prog_58.pdf).
B-REF	Mager, Douglas; Cox, Emily (2007). Relationship Between Generic and Preferred-brand Prescription Co-
I-REF	payment Differentials and Generic Fill Rate. Am J Man Care 13 (6, Part 2), S. 347-352
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2Mager347to52.pdf).
B-REF	Magid, David; Koepsell, Thomas; Every, Nathan; Martin, Jenny; Siscovick, David; Wagner, Edward;
I-REF	Weaver, Douglas (1997). Absence of Association between Insurance Copayments and Delays in Seeking
I-REF	Emergency Care among Patients with Myocardial Infarction. N Engl J Med 336 (24), S. 1722-1729
I-REF	(http://content.nejm.org/cgi/reprint/336/24/1722.pdf).
B-REF	Maio, Vittorio; Pizzi, Laura; Roumm, Adam; Clarke, Janice; Goldfarb, Neil; Nash, David; Chess, David
I-REF	(2005). Pharmacy Utilization and the Medicare Modernization Act. Milb Quart 83 (1), S. 101–130
I-REF	(http://www.blackwell-synergy.com/doi/pdf/10.1111/j.0887-378X.2005.00337.x).
B-REF	Managerkreis der Friedrich-Ebert-Stiftung (2005). Staatshaushalt, Wachstum, Demographie. Friedrich-
I-REF	Ebert-Stiftung, Bonn
I-REF	(http://fesportal.fes.de/pls/portal30/docs/FOLDER/STABSABTEILUNG/MANAGERKREIS/THESEN_ST
I-REF	AATSHAUSHALT_WACHSTUM.PDF).
B-REF	Manning, Willard Jr.; Phelps, Charles (1979). The Demand for Dental Care. Bell J Econ 10 (2), S. 503-525
I-REF	(http://links.jstor.org/sici?sici=0361-
I-REF	915X%28197923%2910%3A2%3C503%3ATDFDC%3E2.0.CO%3B2-I).
B-REF	Manning, Willard; Bailit, Benjamin; Newhouse, Joseph (1985). The demand for dental care: evidence from
I-REF	a randomized trial in health insurance. J Am Dent Assoc 110 (6), S. 895-902 (Abstract:
I-REF	http://jada.ada.org/cgi/content/abstract/110/6/895?ck=nck).
B-REF	Manning, William; Wells, Kenneth; Duan, Naihua; Newhouse, Joseph; Ware, John (1986). How cost shar-
I-REF	ing affects the use of ambulatory mental health services. JAMA 256 (14), S.1930-1934 (Abstract:
I-REF	http://jama.ama-assn.org/cgi/content/abstract/256/14/1930).
B-REF	Manning, Willard; Newhouse, Joseph; Duan, Naihua; Keeler, Emmett; Leibowitz, Arleen; Marquis, Susan
I-REF	(1987). Health Insurance and the Demand for Medical Care: Evidence from a randomized experiment. Am
I-REF	Econ Rev 77 (3), S. 251-277 (http://links.jstor.org/sici?sici=0002-
I-REF	8282%28198706%2977%3A3%3C251%3AHIATDF%3E2.0.CO%3B2-S).
B-REF	Manning, Willard; Marquis, Susan (1996). Health insurance: The tradeoff between risk pooling and moral
I-REF	hazard. J H Econ 15 (5), S. 609-639.
B-REF	Manning, Willard; Marquis, Susan (2001). Health insurance: tradeoffs revisited. J H Econ 20 (2), S. 289-
I-REF	293.
B-REF	Manski, Richard; Moeller, John; Maas, William (2001). Dental services. An analysis of utilization over 20
I-REF	years. J Am Dent Ass 131 (5), S. 655-664 (http://jada.ada.org/cgi/reprint/132/5/655).
B-REF	Markus, Anne; Rosenbaum, Sara; Dylan, Roby (1998). CHIP, Health Insurance Premiums and Cost-Sharing:
I-REF	Lessons from the Literature. Health Resources and Services Administration Department of Health and Hu-
I-REF	man Services, Medical Center, George Washington University, Washington DC
I-REF	(http://www.gwhealthpolicy.org/downloads/cost_sharing_litreview_overview.pdf).
B-REF	Marmor, Theodore; Mashaw Jerry; Harvey, Philipp (Eds) (1990). America’s Misunderstood Welfare State.
I-REF	Persisting Myths, Enduring Realities. Basic Books, Calgary.
B-REF	Marmot, Michael (2001). Inequalities in Health. N Engl J Med 345 (2), S. 134-136
I-REF	(http://content.nejm.org/cgi/reprint/345/2/134.pdf; http://www.mindfully.org/Health/Inequalities-In-Health-
I-REF	Marmot.htm).
B-REF	Marmot, Michael (2003). Self esteem and health. BMJ 327 (7415), S. 574-575
I-REF	(http://bmj.com/cgi/content/full/327/7415/574).
B-REF	Marmot, Michael (2005). Social determinants of health inequalities. Lancet 365 (9464), S. 1099-1104
I-REF	(http://www.thelancet.com/journals/lancet/article/PIIS0140673605711466/fulltext;
I-REF	http://www.upenn.edu/ldi/paper-marmot-one.pdf).
B-REF	Marmot, Michael (2006). Health in an Unequal World. Lancet 368 (9552), S. 2081-2094
I-REF	(http://www.thelancet.com/journals/lancet/article/PIIS0140673604168335/fulltext).
B-REF	Marquis, Susan (1985). Cost-sharing and provider choice. J H Econ 4 (2), S. 137-157.
B-REF	Marstedt, Gerd (2002). Solidarität und Wahlfreiheit in der GKV. Böcken, Jan; Braun, Bernard; Schnee, Me-
I-REF	lanie (Hrsg.). Gesundheitsmonitor, Bertelsmannstiftung Gütersloh, S. 112-129.
B-REF	Mastilica, Miroslav; Božikov, Jadranka; Štampar, Andrija (1999). Out-of-Pocket Payments for Health Care
I-REF	in Croatia: Implications for Equity. Croat Med J 40 (2), S. 152-159 (www.cmj.hr/1999/40/2/10234056.htm).
B-REF	Mastilica Miroslav; Babić-Bosanac, Sanja (2002). Citizens’ views on health insurance in Croatia. Croatian
I-REF	Med J 43 (4), S. 417-424 (http://www.cmj.hr/2002/43/4/12187519.pdf).
B-REF	Mastilica, Miroslav; Kusec, Sanja (2005). Croatian healthcare system in transition, from the perspective of
I-REF	users. BMJ 331 (7510), S. 223-226 (http://bmj.com/cgi/content/full/331/7510/223).
B-REF	Matsumoto, Katsuaki (2003). Erfahrung mit der japanischen Pflegeversicherung. Informationsdienst / Ge-
I-REF	sellschaft für Versicherungswissenschaft und -gestaltung e.V. – GVG, Köln (http://www.gvg-koeln.de/cgi-
I-REF	bin/deutsch//view.cgi?a_path=http://www.gvg-
I-REF	koeln.de//dokumente/deutsch/164/ID_294.pdf&name=ID_294.pdf&quelle=http://www.gvg-
I-REF	koeln.de/deutsch/publikationen.html).
B-REF	Maus, Josef (2005). Praxisgebühren: Draufgezahlt. Dt. Ärztebl 102 (9), S. A537
I-REF	(http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=45639).
B-REF	McArdle, Frank; Neuman, Patricia; Kitchman, Michelle; Kirland, Kerry; Yamamoto, Dale (2004). Large
I-REF	Firms’ Retiree Health Benefits Before Medicare Reform: 2003 Survey Results. H Aff, Web Excl, S. w4 7-19
I-REF	(http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.7v1).
B-REF	McDevitt, Roland; Gabel, Jon; Gandolfo, Laura; Lore, Ryan; Pickreign, Jeremy (2007). Financial Protection
I-REF	Afforded by Employer-Sponsored Health Insurance: Current Plan Designs and High-Deductible Health
I-REF	Plans. Med Care Res Rev 64 (2), S. 212-228 (http://mcr.sagepub.com/cgi/reprint/64/2/212).
B-REF	McDonald, Heather; Garg, Amit; Haynes, Brian (2002). Interventions to enhance patient adherence to medi-
I-REF	cation prescriptions: scientific review. JAMA 288 (22), S. 2868-2879 (http://jama.ama-
I-REF	assn.org/cgi/reprint/288/22/2868).
B-REF	McGlynn, Elisabeth; Asch, Steven; Adams, John; Keesey, Joan; Hicks, Jennifer; de Cristofaro, Alison;
I-REF	Kerr, Eve (2003). The Quality of Health Care Delivered to Adults in the United States. N Engl J Med 348
I-REF	(26), S. 2635-2645 (http://content.nejm.org/cgi/reprint/348/26/2635.pdf).
B-REF	Mckinstry, Brian (2000). Do patients wish to be involved in decision making in the consultation? A cross
I-REF	sectional survey with video vignettes. BMJ 321(7265), S. 867–871
I-REF	(http://www.bmj.com/cgi/reprint/321/7265/867).
B-REF	McManus, Peter; Donnelly, Neil; Henry, David; Hall, Wayne; Primrose, John; Lindner, Julie (1996). Pre-
I-REF	scription Drug Utilization Following Patient Co-Payment Changes in Australia. Pharmacoepidem Drug
I-REF	Safety 5 (6), S. 385-392 (http://www3.interscience.wiley.com/cgi-bin/fulltext/23832/PDFSTART).
B-REF	McNeill, Dwight (2004). Do Consumer-Directed Health Benefits Favor The Young And Healthy? H Aff 23
I-REF	(1), S. 186-193 (http://content.healthaffairs.org/cgi/reprint/23/1/186).
B-REF	MEDPAC (Medicare Payment Advisory Commission) (2000). Medicare beneficiaries and prescription drug
I-REF	coverage. Report to the Congress: Selected Medicare Issues June 2000
I-REF	(http://www.medpac.gov/publications/congressional_reports/Jun00%20Ch1.pdf).
B-REF	MEDPAC (Medicare Payment Advisory Commission) (2004). Benefit Design and Cost Sharing in Medicare
I-REF	Advantage Plans. Report to the Congress
I-REF	(http://www.medpac.gov/publications/congressional_reports/Dec04_CostSharing.pdf).
B-REF	Meessen, Bruno; Zhenzhong, Zhang; van Damme Wim; Devadasan, Narayanan; Criel, Bart; Bloom, Gerald
I-REF	(2003). Editorial: Iatrogenic poverty. Trop Med Int H 8 (7), S. 581-584 (http://www.blackwell-
I-REF	synergy.com/doi/full/10.1046/j.1365-3156.2003.01081.x).
B-REF	Meiners, Frank (2003a). DAK-Gesundheitsbarometer 10/03: Gesundheitsreform (Forsa-Studie). DAK Pres-
I-REF	se Server, Hamburg
I-REF	(http://www.presse.dak.de/ps.nsf/sblArchiv/988037DCD1F4BA74C1256D32002E6648?open).
B-REF	Meiners, Frank (2003b). DAK-Umfrage – jeder Zweite meint: Der Hausarzt ist der Erste. Der Hausarzt
I-REF	14/03, S. 23 (http://www.medizin-online.de/cda/DisplayContent.do?cid=104075&fid=107664&type=pdf).
B-REF	Mielck, Andreas (2005). Soziale Ungleichheit und Gesundheit. Empirische Ergebnisse, Er-klärungsansätze,
I-REF	Interventionsmöglichkeiten, Verlag Hans Huber, Bern-Göttingen-Toronto-Seattle.
B-REF	Miller, Tony (2006). Getting On The Soapbox: Views Of An Innovator In Consumer-Directed Care. H Aff
I-REF	25 (6), S. w549–w551 (http://content.healthaffairs.org/cgi/content/full/hlthaff.25.w549v1/DC1).
B-REF	Miller, Kristin; Siscovick, David; Sheppard, Lianne; Shepherd, Kristen; Sullivan, Jeffrey; Anderson, Garnet;
I-REF	Kaufman, Joel (2007). Long-Term Exposure to Air Pollution and Incidence of Cardiovascular Events in
I-REF	Women. N Engl J Med 356 (5), S. 447-458 (http://content.nejm.org/cgi/reprint/356/5/447.pdf).
B-REF	Milstein, Arnold; Chassin, Mark (2004). Pro & Con: does patient cost sharing lead to better care? (Opinion).
I-REF	Intern Med News 37, S. 13.
B-REF	Moise, Pierre; Jacobzone, Stéphane, and the ARD-IHD Experts Group (2003).OECD Study of Cross-
I-REF	National Differences in the Treatment, Costs and Outcomes of Ischaemic Heart Disease. OECD Health
I-REF	Working Paper No. 3, Directorate for Employment, Labour and Social Affairs Employment, Labour and So-
I-REF	cial Affairs Committee, OECD, Paris (http://www.oecd.org/dataoecd/30/56/2511003.pdf;
I-REF	http://www.olis.oecd.org/olis/2003doc.nsf/3dce6d82b533cf6ec125685d005300b4/c3949eecb0ba78cec1256d
I-REF	10004aaa95/$FILE/JT00143165.PDF).
B-REF	Mojtabai, Ramin; Olfson Mark (2003). Medication Costs, Adherence, And Health Outcomes Among Medi-
I-REF	care Beneficiaries. H Aff 22 (4), S. 220-229 (http://content.healthaffairs.org/cgi/reprint/22/4/220).
B-REF	Montenegro-Torres, Fernando; Engelhardt, Timothy; Thamer, Mae; Anderson, Gerard (2001). Are Fortune
I-REF	100 companies responsive to chronically ill workers? H Aff 20 (4), S. 209-219
I-REF	(http://content.healthaffairs.org/cgi/reprint/20/4/209).
B-REF	Moran, John; Simon, Kosali (2005). Income and the Use of Prescription Drugs by the Elderly: Evidence
I-REF	from the Notch Cohorts. Department of Economics and Center for Policy Research, Syracuse University/
I-REF	Department of Policy Analysis and Management, Cornell University, Ithaka
I-REF	(http://academics.hamilton.edu/economics/home/moran.simon.pdf#search=%22%22International%20Longe
I-REF	vity%20Center%22%20%22Merck%20Company%20Foundation%22%22).
B-REF	Mossialos, Elias; Dixon, Anna; Figueras, Josep; Kutzin, Joe (Hrsg.) (2002). Funding health care: options for
I-REF	Europe. European Observatory on Health Care Systems. Buckingham, Open University Press
I-REF	(http://www.euro.who.int/document/e74485.pdf).
B-REF	Mossialos, Elias; Oliver, Adam (2005). An overview of pharmaceutical policy in four countries: France,
I-REF	Germany, the Netherlands and the United Kingdom. Int J H Plan Mgmt 20 (4), S. 291–306
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/112140373/PDFSTART).
B-REF	Motheral, Brenda; Fairman, Kathleen (2001). Effect of a Three-Tier Prescription Copay on Pharmaceutical
I-REF	and Other Medical Utilization. Med Care 39 (12), S, 1293-1304.
B-REF	Müller, Edda; Stolterfoht, Barbara; Trauernicht, Gitta; Wiesehügel, Klaus (2003). Solidarisch, leistungsfä-
I-REF	hig und gerecht. Wege zur Förderung von Solidarität und Nachhaltigkeit in der Finanzierung der sozialen
I-REF	Krankenversicherung. Diskussionspapier für die Kommission zur Sicherung der Nachhaltigkeit in der Fi-
I-REF	nanzierung der Sozialen Sicherungssysteme, Bundesministerium für Arbeit und Soziales, Berlin
I-REF	(http://www.bmas.bund.de/BMAS/Redaktion/Pdf/Publikationen/Ruerup-Bericht/diskussionspapiere-
I-REF	1,property=pdf,bereich=bmas,sprache=de,rwb=true.pdf;
I-REF	http://pdf.bmas.bund.de/bmas/temp/diskussionspapiere2d12cproperty3dpdf2cbereich3dbmas2csprache3dde
I-REF	2crwb3dtrue2epdf/parse.php?d=0001).
B-REF	Müller, Joachim (1984). GKV-Finanzierung über Zwecksteuern? Mensch, Medizin, Gesellschaft 9 (4), S.
I-REF	260-265.
B-REF	Mullins, Daniel (2003). Rising copayments and the kinked demand curve. Clin Ther 25 (12), S. 3144-3146.
B-REF	Mullins, Daniel; Palumbo, Francis; Saba, Mojdeh (2007). Formulary Tier Placement for Commonly Pre-
I-REF	scribed Branded Drugs: Benchmarking and Creation of a Preferred Placement Index. Am J Man Care 13 (6,
I-REF	Part 2), S. 377-384 (http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2_Mullins377to84.pdf).
B-REF	Mumford, Emily; Schlesinger, Herbert; Glass, Gene; Patrick, Cathleen; Cuerdon, Timothy (1998). A New
I-REF	Look at Evidence About Reduced Cost of Medical Utilization Following Mental Health Treatment. J Psy-
I-REF	chother Pract Res 7 (1), S. 67-86 (http://jppr.psychiatryonline.org/cgi/reprint/7/1/65.pdf).
B-REF	Mundinger, Mary; Thomas, Edwidge; Smolowitz, Janice; Honig, Judy (2004). Essential Health Care: Af-
I-REF	fordable for All? Nursing Economics 22 (5), S. 239-244 (http://www.medscape.com/viewarticle/492824).
B-REF	Musil, Antje (2003). Stärkere Eigenverantwortung in der Gesetzlichen Krankenversicherung. Eine agency-
I-REF	theoretische Betrachtung. Deutscher Universitäts-Verlag, Wiesbaden.
B-REF	Nair, Kavita; Wolfe, Pamela; Valuck, Robert; McCollum, Marianne; Ganther, Julie; Lewis, Sonya (2003).
I-REF	Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with
I-REF	chronic disease. J Manag Care Pharm 9 (2), S. 123-133 (http://www.amcp.org/data/jmcp/2003_V9_I2.pdf).
B-REF	Nakatani, Hiroki; Kondo, Takefumi (2003). Characteristics of a medical care program for specific diseases
I-REF	in Japan in an era of changing cost-sharing. H Pol 64 (3), S. 377-389.
B-REF	Nelson, Alan; Reeder, Claiborne; Dickson, Michael (1984). The effect of a Medicaid drug copayment pro-
I-REF	gram on the utilization and cost of prescription services. Med Care 22 (8), S. 724-736.
B-REF	Neukirch, Benno (2004). Zuzahlung – Verbesserung der Ressourcenallokation. Dt Ärztebl 101 (11), S. A702
I-REF	(http://www.aerzteblatt.de/v4/archiv/artikeldruck.asp?id=40970).
B-REF	Neuman, Patricia; Rice, Thomas (2003). Medicare Cost-Sharing: Implications for Beneficiaries. Statement
I-REF	Prepared for Hearing on Medicare Cost-Sharing and Medigap, Committee on Ways and Means, Subcommit-
I-REF	tee on Health, The United States House of Representatives. Washington DC
I-REF	(http://waysandmeans.house.gov/hearings.asp?formmode=view&id=338;
I-REF	http://www.kff.org/medicare/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=14375).
B-REF	Newbrander, William; Sacca, Stephen (1996). Cost Sharing and Access to Health Care for the Poor: Equity
I-REF	Experiences in Tanzania. World Bank, Human Development 31057, Washington DC
I-REF	(http://www1.worldbank.org/devoutreach/march04/article.asp?id=237).
B-REF	Newbrander, William; Collins, David; Gilson, Lucy (eds) (2001). User fees for health services: guidelines
I-REF	for protecting the poor. Management Sciences for Health, King Printing Company, Boston. ISBN 0-913723-
I-REF	80-0.
B-REF	Newhouse, Joseph; Taylos, Vincent (1970). Medical Costs, Health Insurance, and Public Policy. RAND
I-REF	Corporation, Santa Monica.
B-REF	Newhouse, Joseph; Rolph, John; Mori, Bryant; Murphy, Maureen (1978). An Estimate of the Impact of De-
I-REF	ductibles on the Demand for Medical Care Services. RAND Corporation, Santa Monica. ISBN 0-8330-0065-
I-REF	9.
B-REF	Newhouse, Joseph; Manning, Willard; Morris, Carl; Orr, Larry; Duan, Naihua; Keeler, Emmett; Leibowitz,
I-REF	Arleen; Marquis, Kent; Marquis, Susan; Phelps, Charles; Brook; Robert (1981). Some interim results from a
I-REF	controlled trial of cost sharing in health insurance. N Engl J Med 305 (25), S. 1501-1507
I-REF	(http://content.nejm.org/cgi/content/abstract/305/25/1501).
B-REF	Newhouse, Joseph; Manning, Willard; Morris, Carl; Orr, Larry; Duan, Naihua; Keeler, Emmett; Leibowitz,
I-REF	Arleen; Marquis, Kent; Marquis, Susan; Phelps, Charles; Brook, Robert (1982). Some Interim Results from
I-REF	a Controlled Trial of Cost Sharing in Health Insurance R-2847-HHS. Health Insurance Experiment Series,
I-REF	Rand Corporation, Santa Monica.
B-REF	Newhouse, Joseph (1992). Medical Care Costs: How Much Welfare Loss? J Econ Persp 6 (3), S. 3-21
I-REF	(http://links.jstor.org/sici?sici=0895-3309%28199222%296%3A3%3C3%3AMCCHMW%3E2.0.CO%3B2-
I-REF	M).
B-REF	Newhouse, Joseph (1993). Free for all? Lessons from the RAND Health Insurance Experiment. A RAND
I-REF	study. RAND, The Insurance Experiment Group/Harvard University Press, Cambridge. ISBN 0-674-31846-
I-REF	3/ 0-674-31914-1.
B-REF	Newhouse, Joseph (2004a). How Much Should Medicare Pay for Drugs? H Aff 23 (1), S. 89-102
I-REF	(http://content.healthaffairs.org/cgi/reprint/23/1/89).
B-REF	Newhouse, Joseph (2004a). Consumer-directed health plans and the RAND Health Insurance Experiment. H
I-REF	Aff 23 (6), S. 107-113 (http://content.healthaffairs.org/cgi/reprint/23/6/107).
B-REF	Nichols, Len; Ginsburg, Paul; Berenson, Robert: Christianson, Jon; Hurley, Robert (2004). Are Market
I-REF	Forces Strong Enough To Deliver Efficient Health Care Systems? Confidence Is Waning. H Aff 23 (2), S. 8-
I-REF	21 (http://content.healthaffairs.org/cgi/reprint/23/2/8).
B-REF	Nink, Katrin; Schröder, Helmut (2004a). Ökonomische Aspekte des deutschen Arzneimittelmarktes 2003.
I-REF	In: Schwabe, Ulrich; Paffrath, Dieter (2004). Arzneiverordnungsreport 2004. Aktuelle Daten, Kosten,
I-REF	Trends und Kommentare, Springer Verlag, Berlin, S. 137-175.
B-REF	Nink, Katrin; Schröder, Helmut (2004b). Arzneimittelverordnungen nach Alter und Geschlecht. In: Schwa-
I-REF	be, Ulrich; Paffrath, Dieter (2004). Arzneiverordnungsreport 2004. Aktuelle Daten, Kosten, Trends und
I-REF	Kommentare, Springer Verlag, Berlin, S. 1099-1111.
B-REF	Nissen, Steven; Tuzcu, Murat; Schoenhagen, Paul; Brown, Greg; Ganz, Peter; Vogel, Robert; Crowe, Tim;
I-REF	Howard, Gail; Cooper, Christopher; Brodie, Bruce; Grines, Cindy; DeMaria, Anthony (2004). Effect of in-
I-REF	tensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a ran-
I-REF	domized controlled trial. JAMA 291 (3), S. 1071–1080 (http://jama.ama-assn.org/cgi/reprint/291/9/1071).
B-REF	Nixon, John;·Ulmann, Philippe (2006). The relationship between health care expenditure and health out-
I-REF	comes. Evidence and caveats for a causal link. Eur J H Econ 7 (1), S. 7-18
I-REF	(http://www.springerlink.com/content/y00147rq18r72p77/fulltext.pdf).
B-REF	Normand, Charles; Busse, Reinhard (2002). Social health insurance (SHI) financing. In: Mossialos, Elias;
I-REF	Dixon, Anne; Figueras, Josep; Kutzin, Joseph (Eds). Funding Health Care: Options for Europe, pp. 59–79.
I-REF	Buckingham: Open University Press (http://www.euro.who.int/document/e74485.pdf).
B-REF	Norwegian Board of Health (2003). Quality in Health Care – the Role of Government in Supervision and
I-REF	Monitoring in Norway. Report 8/2002. ISSN 1503-4798
I-REF	(http://www.helsetilsynet.no/upload/Publikasjoner/Rapporter2002/quality_health_care_role_government_su
I-REF	pervision_monitoring_norway_rapport_082002.pdf).
B-REF	Nowack, Nicolas (2004). Zuzahlungen: Sozialhilfeempfänger in Heimen überfordert. Dt Ärztebl 101 (3), S.
I-REF	C70 (http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=40100).
B-REF	Nuijten, Mark; Szende, Agota; Kosa, Jozsef; Mogyorosy, Zsolt; Kramberger, Boris; Nemecek, Karel; To-
I-REF	mek, Dominik; Oreskovic, Stjepan; Laskowska, Monika (2003). Health care reform in six Central European
I-REF	countries. A focus on health economic requirements in the drug pricing and reimbursement processes. Eur J
I-REF	H Econ 4 (4), S. 286–291 (http://www.springerlink.com/content/rapdf9xpnqc7ge6h/fulltext.pdf).
B-REF	Nyman, John (1999a). The value of health insurance: the access motive. J H Econ 18 (2), S. 141-152.
B-REF	Nyman, John (1999b). The economics of moral hazard revisited. J H Econ 18 (6), S. 811-824.
B-REF	Nyman, John (2003). Health Insurance Theory: The Case of the Vanishing Welfare Gain. Division of Health
I-REF	Services Research and Policy, University of Minnesota, Minneapolis
I-REF	(http://www.econ.umn.edu/workingpapers/Nyman319.pdf).
B-REF	Nyman, John (2004). Is ‘Moral Hazard’ Inefficient? The Policy Implications Of A New Theory. H Aff 23
I-REF	(5), S. 194-199 (http://content.healthaffairs.org/cgi/reprint/23/5/194).
B-REF	Nyman, John (2006). Health Insurance Theory: The Case of the Missing Welfare Gain. University of Min-
I-REF	nesota, Minneapolis (http://www.econ.ucsb.edu/seminar/papers/f06/nyman.pdf).
B-REF	Oberender, Peter (1984). Gesundheitswesen im Wandel. Reihe Gesundheitsökonomie und Sozialrecht Bd. 2,
I-REF	Verlag René F. Wilfer, Spardorf.
B-REF	Oberlander, Jonathan (2003). The Political Life of Medicare. The University of Chicago Press, Chi-
I-REF	cago/London. ISBN 0-226-61595-2.
B-REF	O’Brien, Mary Jo; Archdeacon, Meghan; Barrett, Midge; Crow, Sarah; Janicki, Sarah; Rousseau, David;
I-REF	Williams, Claudia (2000). State Experiences With Cost-Sharing Mechanisms in Children’s Health Insurance
I-REF	Expansions. The Commonwealth Fund, New York (http://www.cmwf.org/usr_doc/lewin_cost_fr_385.pdf).
B-REF	O’Connor, Patrick (2006). Improving Medication Adherence. Challenges for Physicians, Payers, and Policy
I-REF	Makers. Arch Int Med 165 (18), S. 1802-1804 (http://archinte.ama-assn.org/cgi/reprint/166/17/1802).
B-REF	Office of Technology Assessment (OTA) (1993). Benefit Design in Health Care Reform: Patient Cost-
I-REF	Sharing. Congress of the United States, Princeton (www.wws.princeton.edu/cgi-bin/ byte-
I-REF	serv.prl/~ota/disk1/1993/9310/9310.PDF).
B-REF	O’Grady, Kevin; Manning, Willard; Newhouse, Joseph; Brook, Robert (1985). The Impact of Cost Sharing
I-REF	on Emergency Department Use. N Engl J Med 313 (8), S. 484-490
I-REF	(http://content.nejm.org/cgi/content/abstract/305/25/1501).
B-REF	Organisation for Economic Co-operation and Development (OECD) (2004a). Towards High-Performing
I-REF	Health Systems. The OECD Health Project, Paris (http://skylla.wz-berlin.de/fulltext/buch-vt/2004/DD-
I-REF	90483.pdf).
B-REF	Organisation for Economic Co-operation and Development (OECD) (2004b). Towards High-Performing
I-REF	Health Systems. Summary Report. The OECD Health Project, Paris
I-REF	(http://www.oecd.org/dataoecd/7/58/31785551.pdf).
B-REF	Organisation for Economic Co-operation and Development (OECD) (2004c). Auf dem Weg zu leistungs-
I-REF	starken Gesundheitssystemen. Kurzbericht. OECD Gesundheitsprojekt, Paris
I-REF	(http://www.oecd.org/dataoecd/7/56/31785622.pdf).
B-REF	Organisation for Economic Co-operation and Development (OECD) (2004d). OECD Economic Survey of
I-REF	Canada 2004: Institutional Changes to Health Care System. OECD, Paris
I-REF	(http://www.oecd.org/dataoecd/41/63/33851206.pdf).
B-REF	Organisation for Economic Co-operation and Development (OECD) (2005). Health at a Glance. The OECD
I-REF	Health Project, Paris
I-REF	(https://www.oecd.org/secure/pdfDocument/0,2834,en_21571361_33622309_35630037_1_1_1_1,00.pdf).
B-REF	Osende, Julio; Ruiz-Ortega, Marta; Blanco-Colio, Luis Miguel; Egido, Jesus (2004). Statins to prevent car-
I-REF	diovascular events in hypertensive patients. The ASCOT-LLA study. Nephrol Dial Transplant 19 (3), S.
I-REF	528-531 (http://ndt.oxfordjournals.org/cgi/reprint/19/3/528).
B-REF	O’Shea, Sofie (2004). User charges in Ireland. European Observatory on Health Systems and Policies, Euro
I-REF	Observer 6 (3), S. 6-7 (http://www.euro.who.int/document/Obs/EuroObserver6_3.pdf).
B-REF	Osterkamp, Rigmar (2003a). German Public Health Insurance: Higher Co-payments and Everybody is Better
I-REF	off – the Case for Differentiated Co-payment Rates. Ifo Diskussionsbeiträge, ifo-Institut für Wirtschaftsfor-
I-REF	schung, München (http://gemini.econ.umd.edu/cgi-
I-REF	bin/conference/download.cgi?db_name=IIPF59&paper_id=97).
B-REF	Osterkamp, Rigmar (2003b). Public health insurance. Pareto-efficient allocative improvements through dif-
I-REF	ferentiated copayment rates. Eur J H Econ 4 (2), S. 79-84
I-REF	(http://springerlink.metapress.com/content/91ckpkb0urdeqphg/fulltext.pdf).
B-REF	Östlin, Piroska (2005). What evidence is there about the effects of health care reforms on gender equity, par-
I-REF	ticularly in health? WHO Regional Office for Europe’s Health Evidence Network (HEN), World Health Or-
I-REF	ganization, Kopenhagen (http://www.euro.who.int/Document/E87674.pdf).
B-REF	Ozminkowski, Ronald; Marder, William; Hawkins, Kevin; Wang, Shaohung; Stallings, Sarah; Finkelstein,
I-REF	Stan; Sinskey, Anthony; Wierz, David (2004). The use of disease-modifying new drugs for multiple sclero-
I-REF	sis treatment in private-sector health plans. Clin Ther 26 (8), S. 1341-1354.
B-REF	Padula, Cynthia (1992). Self-Care and the Elderly: Review and Implications. Pub Health Nurs 9 (1), S. 22-
I-REF	28 (http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1525-1446.1992.tb00068.x).
B-REF	Parakh, Kapil; Bush, David; Ziegelstein, Roy; Thombs, Brett; Fauerbach, James (2007). Mortality and Ad-
I-REF	herence to Pharmacotherapy After Acute Myocardial Infarction. JAMA 297 (17), S. 1877 (http://jama.ama-
I-REF	assn.org/cgi/reprint/297/17/1877).
B-REF	Parente, Stephen; Feldman, Roger; Christianson, Jon (2004a). Employee Choice of Consumer-Driven Health
I-REF	Insurance in a Multiplan, Multiproduct Setting. H Serv Res 39 (4 Part 2), S. 1091–1112
I-REF	(http://www.blackwell-synergy.com/doi/full/10.1111/j.1475-6773.2004.00275.x;
I-REF	http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1361055&blobtype=pdf).
B-REF	Parente, Stephen; Feldman, Roger; Christianson, Jon (2004b). Evaluation of the Effect of a Consumer-
I-REF	Driven Health Plan on Medical Care Expenditures and Utilization. H Serv Res 39 (4 Part 2), S. 1189-1209
I-REF	(http://www.blackwell-synergy.com/doi/full/10.1111/j.1475-6773.2004.00282.x;
I-REF	http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1361062&blobtype=pdf).
B-REF	Paris, Valérie (2005). Pharmaceutical regulation in France 1980-2003. Int J H Plan Mgmt 20 (4), S. 307-328
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/112140374/PDFSTART)
B-REF	Pauly, Mark (1968). The Economics of Moral Hazard: Comment. Am Econ Rev 58 (3-1), S. 531-537
I-REF	(http://links.jstor.org/sici?sici=0002-
I-REF	8282%28196806%2958%3A3%3C531%3ATEOMHC%3E2.0.CO%3B2-A).
B-REF	Pauly, Mark (1983). More on moral hazard. J H Econ 2 (1), S. 81-86.
B-REF	Pauly, Mark (1986). Taxation, Health Insurance, and Market Failure in the Medical Economy. J Econ Lit 24
I-REF	(2), S. 629-675 (http://links.jstor.org/sici?sici=0022-
I-REF	0515%28198606%2924%3A2%3C629%3ATHIAMF%3E2.0.CO%3B2-4).
B-REF	Pauly, Mark (1997). Who Was That Straw Man Anyway? A Comment on Evans and Rice. J H Polit Pol Law
I-REF	22 (2), S. 467-473 (http://jhppl.dukejournals.org/cgi/reprint/22/2/467;
I-REF	http://web.ebscohost.com/ehost/pdf?vid=3&hid=117&sid=9cdebcdb-c06d-47bf-92dc-
I-REF	a6184db93386%40sessionmgr107).
B-REF	Pauly, Mark (2002). Can Insurance Cause Medical Care Spending to Grow too Rapidly? Vierteljahrshefte
I-REF	zur Wirtschaftsforschung 71 (4), S. 468–476
I-REF	(http://www.diw.de/deutsch/produkte/publikationen/vierteljahrshefte/docs/papers/v_02_4_9.pdf).
B-REF	Pauly, Mark; Scott Ramsey, (1999). Would you like suspenders to go with that belt? An analysis of optimal
I-REF	combinations of cost sharing and managed care. J H Econ 18 (4), S. 443-458.
B-REF	Pauly, Mark; Blavin, Fredric (2007). Value Based Cost Sharing Meets the Theory of Moral Hazard: Medical
I-REF	Effectiveness in Insurance Benefits Design. NBER Working Paper No. 13044, Washington DC
I-REF	(http://www.nber.org/papers/w13044).
B-REF	Pavcnik, Nina (2002). Do Pharmaceutical Prices Respond to Potential Patient Out-of-Pocket Expenses?
I-REF	RAND J Econ 33 (3), S. 469-487 (http://links.jstor.org/sici?sici=0741-
I-REF	6261%28200223%2933%3A3%3C469%3ADPPRTP%3E2.0.CO%3B2-6).
B-REF	Pedan, Alexander; Varasteh, Laleh; Schneeweiss, Sebastian (2007). Analysis of Factors Associated With
I-REF	Statin Adherence in a Hierarchical Model Considering Physician, Pharmacy, Patient, and Prescription Char-
I-REF	acteristics. J Man Care Pharm 13 (6), S. 487-496 (http://www.amcp.org/data/jmcp/pages%20487-96.pdf).
B-REF	Petermann, Franz (2004). Non-Compliance: Merkmale, Kosten und Konsequenzen. Managed Care Zeit-
I-REF	schrift 4, S. 30-32 (http://www.forummanagedcare.ch/archiv/2004/4/14-non-compliance.neu.pdf).
B-REF	Petty, François (1998). Un français de quatre renonce aux soins faute d’argent. Impact Quotidien 2,
I-REF	2.April.1998.
B-REF	Pfaff, Anita; Langer, Bernhard; Mamberer, Florian; Freund, Florian; Kern, Axel; Pfaff, Martin (2003). Zu-
I-REF	zahlungen nach dem GKV-Modernisierungsgesetz (GMG) unter Berücksichtigung von Härtefallregelungen.
I-REF	Volkswirtschaftliche Diskusionsreihe Beitrag Nr. 253, Institut für Volkswirtschaftslehre, Universität Augs-
I-REF	burg/Internationales Institut für Empirische Sozialökonomie (INIFES) (http://opus.zbw-
I-REF	kiel.de/volltexte/2004/1411/pdf/253.pdf).
B-REF	Pfaff, Anita; Langer, Bernhard; Freund, Florian (2005). Bürgerversicherung vs. Gesundheitsprämie – Ver-
I-REF	gleich der Reformoptionen zur Finanzierung der Gesetzlichen Krankenversicherung. Volkswirtschaftliche
I-REF	Diskussionsreihe Beitrag Nr. 277, Institut für Volkswirtschaftslehre, Universität Augsburg
I-REF	(http://www.wiwi.uni-augsburg.de/vwl/institut/paper/277.pdf).
B-REF	Pfaff, Martin (1985). Kann die Selbstbeteiligung gleichzeitig "sozial tragbar" und "kostendämpfendf" sein?
I-REF	Sozialer Fortschritt 34 (12), S. 272-276.
B-REF	Phelps, Charles; Newhouse, Joseph (1972). Effect of Co-insurance: A Multivariate Analysis. Soc Sec Bull
I-REF	35 (6), S. 20-28.
B-REF	Piette, John; Heisler, Michele; Wagner, Todd (2004). Cost-Related Medication Underuse. Do Patients With
I-REF	Chronic Illnesses Tell Their Doctors? Arch Intern Med 164 S. 1749-1755 (http://archinte.ama-
I-REF	assn.org/cgi/content/full/164/16/1749).
B-REF	Piette, John; Heisler, Michele; Wagner, Todd (2004). Problems Paying Out-of-Pocket Medication Costs
I-REF	Among Older Adults With Diabetes. Diab Care 27 (2), S. 384–391
I-REF	(http://care.diabetesjournals.org/cgi/reprint/27/2/384).
B-REF	Piette, John (2005). Medication Cost-Sharing: Helping Chronically Ill Patients Cope. Med Care 43 (10), S.
I-REF	947-950.
B-REF	Pilote, Louise; Beck, Christine; Hughues, Richard; Eisenberg, Marc (2002). The effects of cost-sharing on
I-REF	essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in
I-REF	elderly patients. CAMJ 167 (3), S. 246-252 (http://www.cmaj.ca/cgi/reprint/167/3/246).
B-REF	Poisal; John; Chulis, George (2000). Medicare beneficiaries and drug coverage. H Aff 19 (2), S. 248-256
I-REF	(http://content.healthaffairs.org/cgi/reprint/19/2/248).
B-REF	Poisal, John; Murray, Laureen (2001). Growing differences between Medicare beneficiaries with and with-
I-REF	out drug coverage. H Aff 20 (2), S. 74-85 (http://content.healthaffairs.org/cgi/reprint/20/2/74).
B-REF	Prada, Gabriela; Roberts, Glen; Vail, Stephen; Andersen, Malcolm; Down, Erin; Fooks, Cathy; Howatson,
I-REF	Al; Grimes, Kelly; Morgan, Steve; Parent, Karen; Sinclair, Duncan; Thompson, Vivian; Yalnizyan, Armine
I-REF	(2004). Understand Health Care Cost Drivers and Escalators. Health, Health Care and Wellness, Report
I-REF	March 2004, The Conference Board of Canada, Ottawa (www.conferenceboard.ca).
B-REF	Prentice, Julia; Pizer, Steven (2007). Delayed Access to Health Care and Mortality. H Serv Res 42 (2), S.
I-REF	644–662 (http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1475-6773.2006.00626.x).
B-REF	Probst, Josef (2004). Selbstbehalt – Sozialer und gesundheitspolitischer Widerspruch. In: Wurzer et al.
I-REF	2004, S. 21-30.
B-REF	Provost Peters, Christie (2004). Fundamentals of the Prescription Drug Market. NHPF Background Paper,
I-REF	National Health Policy Forum, George Washington University, Washington DC
I-REF	(http://www.nhpf.org/pdfs_bp/BP_RxIndustry_08-24-04.pdf).
B-REF	Pütz, Claudia (2003). Selbstbehalttarife für die gesetzliche Krankenversicherung. 1. Aufl., Nomos Verlags-
I-REF	gesellschaft, Baden-Baden. ISBN 3-8329-0187-6.
B-REF	Rahimi, Ali; Spertus, John; Reid, Kimberly; Bernheim, Susannah; Krumholz, Harlan (2007). Financial Bar-
I-REF	riers to Health Care and Outcomes After Acute Myocardial Infarction. JAMA 297 (10), S. 1063-1072
I-REF	(http://jama.ama-assn.org/cgi/reprint/297/10/1063).
B-REF	Ramsay, Cynthia (1998). Medical Savings Accounts. Universal, Accessible, Portable, Comprehensive
I-REF	Health Care for Canadians. Critical Issues Bulletin, Fraser Institute, Vancouver
I-REF	(http://www.fraserinstitute.org/admin/books/files/MedicalSavingsAccounts.pdf).
B-REF	Ramsay, Cynthia (2002). A Framework for Determinating the Extent of Public Financing of Programs and
I-REF	Services. Commission on the Future of Health Care in Canada, Discussion Paper No. 16. Vancouver
I-REF	(http://dsp-psd.communication.gc.ca/Collection/CP32-79-16-2002E.pdf).
B-REF	Ramsay, Cynthia; Esmail, Nadeem (2004). The Alberta Health Care Advantage: An Accessible, High Qual-
I-REF	ity, and Sustainable System. Occasional Paper No. 81, Public Policy Sources, The Fraser Institute/Elm Con-
I-REF	sulting, Fraser Institute, Vancouver (http://www.fraserinstitute.ca/admin/books/files/ABHealth.pdf).
B-REF	RAND (2000). Access to HIV Care – Initial Results from the HIV Cost and Services Utilization Study. Pol-
I-REF	icy Brief, RAND Corporation, Santa Monica
I-REF	(http://www.rand.org/pubs/research_briefs/RB4530/index1.html).
B-REF	Rand Health (2002). Cost Sharing Cuts Employers' Drug Spending—but Employees Don't Get the Savings.
I-REF	Research Highlights, RAND Corporation, Santa Monica
I-REF	(http://www.rand.org/pubs/research_briefs/RB4553/index1.html).
B-REF	Rand Health (2005). How Cost Sharing Affects by the Chronically Ill. Fact Sheet. RAND Corporation,
I-REF	Santa Monica (http://www.rand.org/pubs/research_briefs/RB9109/RAND_RB9109.pdf).
B-REF	Rasell, Edith (1995). Cost Sharing in Health Insurance – a Reexamination. N Engl J Med 332 (17), S. 1164-
I-REF	1168 (http://content.nejm.org/cgi/content/full/332/17/1164).
B-REF	Rasell, Edith; Bernstein, Jared; Tang, Kainan (1993). The impact of health care financing on family budgets.
I-REF	Briefing Paper, Economic Policy Institute, Washington DC
I-REF	(http://www.epinet.org/briefingpapers/1993_bp_impact.pdf).
B-REF	Rasell, Edith; Bernstein, Jared; Tang, Kainan (1994). The impact of health care financing on family budgets.
I-REF	Int J H Serv 24 (4), S. 691-714
I-REF	(http://baywood.metapress.com/(0vkbmwaqi0yh0gmsofhwbj45)/app/home/contribution.asp?referrer=parent
I-REF	&backto=issue,9,12;journal,46,141;linkingpublicationresults,1:300313,1).
B-REF	Rasmussen, Jeppe; Chong, Alice; Alter, David (2007). Relationship Between Adherence to Evidence-Based
I-REF	Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction. JAMA 297 (2), S. 177-186
I-REF	(http://jama.ama-assn.org/cgi/reprint/297/2/177).
B-REF	Ratiopharm (2005). Gesundheitskosten-Monitor. Ulm
I-REF	(http://www2.ratiopharm.com/de/de/dep/magazin/gesundheitskosten_monitor_2005/gesundheitskosten_mon
I-REF	itor__gra.cfm).
B-REF	Rau, Ferdinand (1992). Selbstbeteiligungsregelungen im Gesundheitswesen. Empirische Wirksamkeitsana-
I-REF	lysen im internationalen Vergleich. Konstanzer Schriften zur Sozialwissenschaft, Hartung-Gorre Verlag,
I-REF	Konstanz.
B-REF	Rector, Thomas; Finch, Michael; Danzon, Patricia; Pauly, Mark; Bharati, Manda (2003). Effect of Tiered
I-REF	Prescription Copayments on the Use of Preferred Brand Medications. Med Care 41 (3), S. 398-406.
B-REF	Recke, Dieter Baron von der (1980). Die Einstellung der Bevölkerung zur Selbstbeteiligung. In: Internatio-
I-REF	nale Gesellschaft für Gesundheitsökonomie, S. 79-84.
B-REF	Redaktionsbüro Gesundheit (2005a). Die Gesundheitsreform: Neue Zuzahlungs- und Finanzierungsregelun-
I-REF	gen – die wichtigsten Veränderungen auf einen Blick. BMGS, Bonn/Berlin (http://www.die-
I-REF	gesundheitsreform.de/themen_az/tabellen/pdf/tabelle_zuzahlungen.pdf?param=u).
B-REF	Redaktionsbüro Gesundheit (2005b). Zuzahlungsbefreiung. So berechnen Sie Ihre Belastungsgrenze im Jahr
I-REF	2006. BMGS, Bonn/Berlin (http://www.die-
I-REF	gesundheitsre-
I-REF	form.de/themen_az/gesundheit_kompakt/pdf/gesundheit_kompakt_zuzahlungen.pdf?param=u).
B-REF	Redelmeier, Donald; Fuchs, Victor (1993). Hospital expenditures in the United States and Canada. N Engl J
I-REF	Med 328 (11), S. 772-778 (http://content.nejm.org/cgi/content/full/328/11/772).
B-REF	Reed, Mary; Fung, Vicky; Brand, Richard; Fireman, Bruce; Newhouse, Joseph; Selby, Joseph; Hsu, John
I-REF	(2005). Care-seeking behavior in response to emergency department copayments. Med Care 43 (8), S. 810-
I-REF	816.
B-REF	Reggler, Jonathan (1998). User fees would both yield money and encourage more responsible use of NHS.
I-REF	BMJ 316 (7124), S. 70 (http://bmj.bmjjournals.com/cgi/content/full/316/7124/70/a).
B-REF	Reichelt, Herbert (1985). Sozial tragbare Selbstbeteiligung oder statistische Artefakte? Sozialer Fortschritt
I-REF	34 (12), S. 265-271.
B-REF	Reichelt, Herbert (1994). Steuerungswirkungen der Selbstbeteiligung im Arzneimittelmarkt Gustav Fischer
I-REF	Verlag, Stuttgart.
B-REF	Reichmann, Gerhard; Sommersguter-Reichmann, Margit (2004). Co-payments in the Austrian social health
I-REF	insurance system. Analysing patient behaviour and patient’s views of the effects of co-payments. H Pol 67
I-REF	(1), S. 75-92.
B-REF	Reiners, Hartmut (2006). Der Homo oeconomicus im Gesundheitswesen. WZB Discussion Paper, Berlin,
I-REF	ISSN 1860-8884 (http://skylla.wz-berlin.de/pdf/2006/i06-305.pdf).
B-REF	Reiners, Hartmut; Schnee, Melanie (2007). Hat die Praxisgebühr eine nachhaltige Steuerungswirkung? Die
I-REF	Praxisgebühr – ein Kernstück des GKV-Modernisierungsgesetzes (GMG). In: Böcken, Jan; Braun, Bernard;
I-REF	Amhof, Robert. Gesundheitsmonitor 2007, Bertelsmann-Stiftung, Gütersloh, S. 133-154.
B-REF	Reinhardt, Uwe (1989). Economists in Health Care: Saviors, or Elephants in a Porcelain Shop? Am Econ
I-REF	Rev 79 (2), S. 337-342 (http://links.jstor.org/sici?sici=0002-
I-REF	8282%28198905%2979%3A2%3C337%3AEIHCSO%3E2.0.CO%3B2-S).
B-REF	Reinhardt, Uwe (2001). Can Efficiency in Health Care Be Left to the Market? J H Polit Pol Law 26 (5), S.
I-REF	967-992 (http://jhppl.dukejournals.org/cgi/reprint/26/5/967;
I-REF	http://web.ebscohost.com/ehost/pdf?vid=3&hid=115&sid=b703f69b-1851-4b45-892a-
I-REF	d3bc2e69e4b9%40sessionmgr9).
B-REF	Remler, Dahlia; Atherly, Adam (2003). Health status and heterogeneity of cost-sharing responsiveness: how
I-REF	do sick people respond to cost-sharing? H Econ 12 (4), S. 269-280 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/99015409/PDFSTART).
B-REF	Reuveni, Haim; Sheizaf, Boaz; Elhayany, Asher; Sherf, Michael; Limoni, Yehuda; Scharff, S.; Peled, Ronit
I-REF	(2002). The effect of drug co-payment policy on the purchase of prescription drugs for children with infec-
I-REF	tions in the community. H Pol 62 (1), S. 1-13.
B-REF	Rice, Thomas (1997). Can Markets Give Us the Health System We Want? J H Polit Pol Law 22 (2), S. 381-
I-REF	426 (http://jhppl.dukejournals.org/cgi/reprint/22/2/383;
I-REF	http://web.ebscohost.com/ehost/pdf?vid=3&hid=115&sid=b703f69b-1851-4b45-892a-
I-REF	d3bc2e69e4b9%40sessionmgr9).
B-REF	Rice, Thomas; Labelle, Roberta (1989). Do physicians induce demand for medical services? J H Polit Pol
I-REF	Law 14 (3), S. 587-600 (http://jhppl.dukejournals.org/cgi/reprint/14/3/587).
B-REF	Rice, Thomas; Thorpe, Keneth (1993). Income-related Cost Sharing in Health Insurance. H Aff 12 (1), S.
I-REF	21-39 (http://content.healthaffairs.org/cgi/reprint/12/1/21).
B-REF	Rice, Thomas (2004). Stichwort: Gesundheitsökonomie. Eine kritische Auseinandersetzung. KomPart Ver-
I-REF	lagsgesellschaft, Bonn.
B-REF	Rice, Thomas; Matsuoka, Karen (2004). Book Review: The Impact of Cost-Sharing on Appropriate Utiliza-
I-REF	tion and Health Status: A Review of the Literature on Seniors. Med Care Res Rev 61 (4), S. 415-452
I-REF	(http://mcr.sagepub.com/cgi/reprint/61/4/415).
B-REF	Richardson, Jeff (1991). The Effects of Consumer Co-payments in Medical Care. National Health Strategy
I-REF	Background Paper No 5. Australian Government, Calgary
I-REF	(http://www.health.gov.au/archive/nhs/documents/nhs6.pdf).
B-REF	Richardson, Jeff (2005). Priorities of health policy: cost shifting or population health. Austr N Zeal H Pol 2
I-REF	(1) (http://www.anzhealthpolicy.com/content/2/1/1).
B-REF	Rieser, Sabine (2004). GKV-Modernisierungsgesetz: Praxisgebühr im Praxistest. Dt Ärztebl 101 (3), S. A-
I-REF	79/B-69/C-69 (http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=suche&id=40099).
B-REF	Robbins, Brett (2005). Patients with Chronic Illnesses Underuse Medications Because of Cost. American
I-REF	Association of Pediatrics, AAP Grand Rounds 13 (1), S. 6
I-REF	(http://aapgrandrounds.aappublications.org/cgi/reprint/13/1/6).
B-REF	Robinson, James (2002). Renewed Emphasis On Consumer Cost Sharing In Health Insurance Benefit De-
I-REF	sign. H Aff, Web Excl, S. W2 139-154 (http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.139v1;
I-REF	http://www.chcf.org/documents/insurance/HAmarch2002Robinson.pdf).
B-REF	Robinson, James (2003). Hospital Tiers In Health Insurance: Balancing Consumer Choice With Financial
I-REF	Incentives. H Aff, Web Excl, S. w3 135-146 (http://content.healthaffairs.org/cgi/reprint/hlthaff.w3.135v1).
B-REF	Robinson, James (2004). Reinvention of Health Insurance in the Consumer Era. JAMA 291 (15), S. 1880-
I-REF	1886 (http://jama.ama-assn.org/cgi/reprint/291/15/1880.pdf).
B-REF	Robinson, Ray (1999). Perspectives on Cost Sharing. Eurohealth 5 (3). Geneva: World Health Organization,
I-REF	S. 24 (http://www.euro.who.int/document/obs/EuroHealth5_3.pdf).
B-REF	Robinson, Ray (2002). User charges for health care. In: Mossialos, Elias; Dixon, Anne; Figueras, Josep;
I-REF	Kutzin, Joseph (Eds). Funding Health Care: Options for Europe, pp. 161–183
I-REF	(http://www.euro.who.int/document/e74485.pdf).
B-REF	Roblin, Douglas; Platt, Richard; Goodman, Michael; Hsu, John; Nelson, Winnie; Smith, David; Andrade,
I-REF	Susan; Soumerai, Stephen (2005). Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five
I-REF	Managed Care Organizations: How Much Is Too Much? Med Care 43 (10), S. 951-959.
B-REF	Roddy, Paul; Wallen, John; Meyers, Sanford (1986). Cost sharing and use of health services. The United
I-REF	Mine Workers of America Health Plan. Med Care 24 (9), S. 873–876 (http://links.jstor.org/sici?sici=0025-
I-REF	7079%28198609%2924%3A9%3C873%3ACSAUOH%3E2.0.CO%3B2-2).
B-REF	Rodwin, Victor; Le Pen, Claude (2004). Health Care Reform in France – The Birth of State-Led Managed
I-REF	Care. N Engl J Med 351 (22), S. 2259-2262 (http://content.nejm.org/cgi/reprint/351/22/2259.pdf).
B-REF	Roemer, Milton, Hopkins, Carl; Carr, Lockwood; Gartside, Foline (1975). Copayments for Ambulatory
I-REF	Care: Penny-Wise and Pound-Foolish. Med Care 13 (6), S. 457-466.
B-REF	Roos, Noralou; Forget, Evelyn; Walld, Randy; MacWilliam, Leonard (2004). Does universal comprehensive
I-REF	insurance encourage unnecessary use? Evidence from Manitoba says “no”. CMAJ 170 (21), S. 209–214
I-REF	(http://www.cmaj.ca/cgi/reprint/170/2/209).
B-REF	Ros, Corina; Groenewegen, Peter; Delnoij, Diana (2000). All rights reserved, or can we just copy? Cost
I-REF	sharing arrangements and characteristics of health care systems. H Pol 52 (1), S. 1-13.
B-REF	Rosen, Bruce (2003). In: Thomson, Sarah; Mossialos, Elias (Ed.). Health care systems in transition: Israel.
I-REF	European Observatory on Health Care Systems, 5 (1), Copenhagen
I-REF	(http://www.euro.who.int/document/E81826.pdf).
B-REF	Rosen, Bruce; Gross, Revital; Brammli-Greenberg, Shuli; Feldman, Roger; Manning, Willard; Zwanziger,
I-REF	Jack (2003). Co-Payments for Physician Visits: How Large is the Burden and Who Bears Its Brunt? Presen-
I-REF	tation IHEA, JDC-Brookdale Institute Jerusalem.
B-REF	Rosen, Allison; Hamel, Mary Beth; Weinstein, Milton; Cutler, David; Fendrick, Mark; Vijan, Sandeep
I-REF	(2005). Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for
I-REF	Beneficiaries with Diabetes. Ann Intern Med 143 (2), S. 89-99
I-REF	(http://www.annals.org/cgi/reprint/143/2/89.pdf).
B-REF	Rosenthal, Meredith; Milstein, Arnold (2004). Awakening Consumer Stewardship of Health Benefits:
I-REF	Prevalence and Differentiation of New Health Plan Models. H Serv Res 39 (4, Part 2), S. 1055–1070
I-REF	(http://www.blackwell-synergy.com/doi/full/10.1111/j.1475-6773.2004.00273.x;
I-REF	http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1361053&blobtype=pdf).
B-REF	Rosian, Ingrid; Mildschuh, Stephan; Vogler, Sabine; Winkler, Petra (2002). Selbstbeteiligung. Internationa-
I-REF	ler Vergleich und Implikationen für Österreich. Österreichisches Bundesinstitut für Gesundheitswesen
I-REF	(ÖBIG), Wien.
B-REF	Ross, Murray (2006). Consumer-Directed Health Care: It’s Not Whether The Glass Is Half-Empty, But
I-REF	Why. H Aff 25 (6), S. w552–w554 (http://content.healthaffairs.org/cgi/content/full/hlthaff.25.w552).
B-REF	Rothman, Max (1992). Cost-Sharing and the Future of Fees for Service for Frail Elders in State Programs. J
I-REF	Appl Geront 11 (4), S. 441-456 (http://jag.sagepub.com/cgi/reprint/11/4/441).
B-REF	Rouleau, Jean; Moye, Lemuel; Pfeffer, Marc; Arnold, Malcolm; Bernstein, Victoria; Cuddy, Thomas; Da-
I-REF	genais, Gilles; Geltman, Edward; Goldman, Steven; Gordon, David; Hamm, Peggy; Klein, Marc; Lamas,
I-REF	Gervasio; McCans, John; McEwan, Patricia; Menapace, Francis; Parker, John; Sestier, François; Sussex,
I-REF	Bruce; Braunwald, Eugene (1993). A comparison of management patterns after acute myocardial infarction
I-REF	in Canada and the United States. N Engl J Med 328 (11), S. 779-784
I-REF	(http://content.nejm.org/cgi/content/full/328/11/779).
B-REF	Rubin, Robert; Mendelson, Daniel (1995). A framework for cost sharing policy analysis. Mattison, Nancy
I-REF	(Hrsg.) (1995). Sharing the costs of health: A multi-country perspective. Pharmaceutical Partners for Better
I-REF	Health. Basel.
B-REF	Ruf, Thomas (1982). Zur Selbstbeteiligung der Versicherten. Eine Studie zu ihren Grenzen und Möglichkei-
I-REF	ten. PKV-Dokumentation 8, Verband der privaten Krankenversicherung e.V., Köln.
B-REF	Saaddine, Jinan; Cadwell, Betsy; Gregg, Edward; Engelgau, Michael; Vinicor, Frank; Imperatore, Giuseppi-
I-REF	na; Narayan, Venkat (2006). Improvements in Diabetes Processes of Care and Intermediate Outcomes:
I-REF	United States, 1988–2002. Ann Int Med 144 (7), S. 465-474
I-REF	(http://www.annals.org/cgi/content/full/144/7/465).
B-REF	Sachs, Jeffrey (Ed.) (2001). Macroeconomics and Health: Investing in Health for Economic Developing.
I-REF	WHO, Genf (http://www.cmhealth.org,
I-REF	http://www.un.org/esa/coordination/ecosoc/docs/RT.K.MacroeconomicsHealth.pdf).
B-REF	Sachverständigenrat für die konzertierte Aktion im Gesundheitswesen (SVR) (2003a). Finanzierung, Nut-
I-REF	zerorientierung und Qualität. Bd. I, II, Kurzfassung (http://www.svr-
I-REF	gesundheit.de/gutacht/gutalt/gutaltle.htm) (SVR 2003a)
B-REF	Sachverständigenrat für die konzertierte Aktion im Gesundheitswesen (SVR) (2003b). Finanzierung, Nut-
I-REF	zerorientierung und Qualität. Bd. I: Finanzierung und Nutzerorientierung. Nomos Verlag, Baden-Baden
I-REF	2003, ISBN - 3-8329-0408-5.
B-REF	Sachverständigenrat für die konzertierte Aktion im Gesundheitswesen (SVR) (2003c). Finanzierung, Nut-
I-REF	zerorientierung und Qualität Bd. II: Qualität und Versorgungsstrukturen. Nomos Verlag, Baden-Baden,
I-REF	ISBN - 3-8329-0409-3 (SVR 2003c).
B-REF	Sacks, Frank; Pfeffer, Marc; Moye, Lemuel; Rouleau, Jean; Rutherford, John; Cole,Thomas; Brown, Lisa;
I-REF	Warnica, Wayne; Arnold, Malcolm; Chuan-Chuan, Wun; Davis, Barry; Braunwald, Eugene (1996). The ef-
I-REF	fect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.
I-REF	Cholesterol and Recurrent Events Trial investigators. N Engl J Med 335 (14), S. 1001-1009
I-REF	(http://content.nejm.org/cgi/reprint/335/14/1001.pdf).
B-REF	Saltman, Richard; Figueras, Josep (1996). European Health Care Reforms. The Ljubljana Charter on Re-
I-REF	forming Health Care. World Health Organisation, Regional Office for Europe, Kopenhagen.
B-REF	Saltman, Richard; Figueras, Josep (1998). Analyzing The Evidence On European Health Care Reforms. H
I-REF	Aff 17 (2), S. 85-108 (http://content.healthaffairs.org/cgi/reprint/17/2/85).
B-REF	Saltman, Richard; Busse, Reinhard; Mossialos, Elias (2002). Regulating Entrepreneurial Behaviour in Euro-
I-REF	pean Health Care Systems. Open University Press, Buckingham.
I-REF	(http://www.who.dk/document/OBS/REBC01.pdf - …/REBC11.pdf).
B-REF	Saltman, Richard (2002). The Western European Experience with Health Care Reform. World Health
I-REF	Organisation, Regionalbüro Europa, Kopenhagen
I-REF	(http://www.euro.who.int/observatory/Studies/20021223_2).
B-REF	Sapelli, Claudio; Vial, Bernadita (1998). Utilización de prestaciones de salud en Chile: ¿Es diferente entre
I-REF	grupos de ingreso? Cuadernos de Trabajo No 106, S. 343-382
I-REF	(http://www.economia.puc.cl/index/paginas_profesor.asp?id_subsecciones=117&id_seccion=4&id_profesor
I-REF	=19&id_pagina=64).
B-REF	Sapelli, Claudio; Torche, Arístides (1998). El Seguro Previsional de Salud: Determinantes de la Elección
I-REF	entre Seguro Público y Privado, 1990-1994. Cuadernos de Economía 35 (106), S. 383-406. Santiago.
B-REF	Sapelli, Claudio; Vial, Bernadita (2001). Self-selection and moral hazard in Chilean health insurance.
I-REF	Documento de Trabajo No 195, Instituto de Economía, Päpstliche Katholische Universität Chile, Santiago
I-REF	(http://www.economia.puc.cl/index/paginas_profesor.asp?id_subsecciones=117&id_seccion=4&id_profesor
I-REF	=19&id_pagina=64;
I-REF	http://www.economia.puc.cl/index/detalle_publica.asp?id_publicacion=928&id_subsecciones=123&id_secc
I-REF	ion=3).
B-REF	Sapelli, Claudio; Vial, Bernadita (2003). Self-selection and moral hazard in Chilean health insurance. J H
I-REF	Econ 22 (3), S. 459-476.
B-REF	Sari; Nazi, Langenbrunner, John; Lewis, Maureen (2000). Affording Out-of-Pocket Payments for Health
I-REF	Care Services: Evidence from Kazakhstan. Euroheath 6 (2), Special Spring 2000. Geneva: World Health Or-
I-REF	ganization, S. 37-39
I-REF	(http://www.lse.ac.uk/collections/LSEHealthAndSocialCare/pdf/eurohealth/vol6no2.pdf).
B-REF	Sari, Nazmi; Langenbrunner, John (2001). Consumer out-of-pocket spending for pharmaceuticals in Ka-
I-REF	zakhstan: implications for sectoral reform. H Pol Plan 16 (4), S. 428-434
I-REF	(http://dcc2.bumc.bu.edu/richardl/DPI02/Additional%20Mats/Richard/Kazhak%20Pharms.pdf).
B-REF	Saver, Barry; Doescher, Mark; Jackson, Elizabeth; Fishman, Paul (2004). Seniors with Chronic Health Con-
I-REF	ditions and Prescription Drugs: Benefits, Wealth, and Health. Value in Health 7 (2), S. 133-143
I-REF	(http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1524-4733.2004.72325.x).
B-REF	Sax, Philip (2001). Changes in Drug Economy in Israel's Health Maintenance Organizations in the Wake of
I-REF	the National Health Insurance Law. Isr Med Ass J 3 (8), S. 605-609 (http://www.ima.org.il/imaj/ar01aug-
I-REF	13.pdf).
B-REF	Schachenhofer, Barbara (1997). Gesundheitsbewußtsein versus Selbstbeteiligung. Über die Notwendigkeit
I-REF	einer Bewußtseinserweiterung hinsichtlich unserer Gesundheit. Schriften der Johannes-Keßler-Universität
I-REF	Linz, Reihe B – Wirtschafts- und Sozialwissenschaften, Nr. 23. Universitätsverlag Rudolf Trauner, Linz.
B-REF	Schaffenberger, Eva (1989). Der Spitalskostenbeitrag. Einhebungspraxis, Soziale Aspekte und Akzeptanz.
I-REF	Sozialwissenschaftliche Abteilung, Kammer für Arbeiter und Angestellte für Wien. Wien.
B-REF	Schafheutle, Ellen; Hassell, Karen; Noyce, Peter; Weiss, Marjorie (2002). Access to medicines: cost as an
I-REF	influence on the views and behaviour of patients. H Soc Care Comm 10 (3), S. 187-195
I-REF	(http://www.blackwell-ynergy.com/doi/pdf/10.1046/j.1365-2524.2002.00356.x).)
B-REF	Schauffler, Helen Halpin; McMenamin, Sara (2001). Assessing PPO Performance on Prevention and Popu-
I-REF	lation Health. Med Care Res Rev 12 (58), S. 112-136 (http://mcr.sagepub.com/cgi/reprint/58/suppl_1/112).
B-REF	Schellhorn, Martin (2001). The effect of variable health insurance deductibles on the demand for physician
I-REF	visits. H Econ 10 (5), S. 441-456 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/85005213/PDFSTART).
B-REF	Schellhorn, Martin (2002). Auswirkungen wählbarer Selbstbehalte in der Krankenversicherung: Lehren aus
I-REF	der Schweiz? Vierteljahreshefte zur Wirtschaftsforschung 71 (4), S. 411-426
I-REF	(http://www.diw.de/deutsch/produkte/publikationen/vierteljahrshefte/docs/papers/v_02_4_2.pdf).
B-REF	Schlander, Michael (2005). Kosteneffektivität und Ressourcenallokation: Gibt es einen normativen An-
I-REF	spruch der Gesundheitsökonomie? In: Kick, Hermes Andreas; Taupitz, Jochen: Gesundheitswesen zwischen
I-REF	Wirtschaftlichkeit und Menschlichkeit. LIT-Verlag, Münster
I-REF	(http://www.michaelschlander.com/ofnote/docs/Schlander-Normativer_Anspruch-2005.pdf).
B-REF	Schlesinger, Herbert; Mumford, Emily; Glass, Gene; Patrick, Cathleen; Sharfstein, Steven (1983). Mental
I-REF	health treatment and medical care utilization in a fee-for-service system: outpatient mental health treatment
I-REF	following the onset of a chronic disease. Am J Pub H 73 (4), S. 422-429
I-REF	(http://www.ajph.org/cgi/reprint/73/4/422).
B-REF	Schmid, Heinz (1980). Selbstbeteiligung in der Schweizerischen Krankenversicherung. In: Internationale
I-REF	Gesellschaft für Gesundheitsökonomie, S. 61-66.
B-REF	Schneeweiss, Sebastian; Schöffski, Oliver; Selke, Gisbert (1998). What is Germany's experience on refer-
I-REF	ence based drug pricing and the etiology of adverse health outcomes or substitution? H Pol 44 (3), S. 253-
I-REF	260.
B-REF	Schneeweiss, Sebastian; Maclure, Malcolm; Walker, Alexander; Grootendorst, Paul; Soumerai, Stephen
I-REF	(2001). On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's
I-REF	versus the clinician's perspective. H Pol 55 (2), S. 97-109.
B-REF	Schneeweiss, Sebastian; Walker, Alexander; Lynn, Robert; Maclure, Malcolm; Dormuth, Colin; Soumerai,
I-REF	Stephen (2002a). Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors. N Engl J
I-REF	Med 346 (11), S. 822-829 (http://content.nejm.org/cgi/reprint/346/11/822.pdf).
B-REF	Schneeweiss, Sebastian; Maclure, Malcolm; Soumerai, Stephen (2002b). Prescription duration after drug
I-REF	copay changes in older people: Methodological aspects. J Am Ger Soc 50 (3), S. 521-525
I-REF	(http://www.blackwell-synergy.com/doi/pdf/10.1046/j.1532-5415.2002.50120.x).
B-REF	Schneeweis, Sebastian; Patrick, Amanda; Maclure, Malcolm; Dormuth, Colin; Glynn, Robert (2007). Ad-
I-REF	herence to Statin Therapy Under Drug Cost Sharing in Patients With and Without Acute Myocardial Infarc-
I-REF	tion: A Population-Based Natural Experiment. Circ 115 (16), S. 2128-2135
I-REF	(http://circ.ahajournals.org/cgi/reprint/115/16/2128).
B-REF	Schneider, Markus (1988). Möglichkeiten und Auswirkungen der Förderung der Zahnprophylaxe und Zahn-
I-REF	erhaltung durch Bonussysteme, Materialienreihe Bd. 5, Institut der Deutschen Zahnärzte (IZK), Deutscher
I-REF	Ärzteverlag, Köln.
B-REF	Schneider, Pia; Hanson, Kara (2006). Horizontal equity in utilisation of care and fairness of health financ-
I-REF	ing: a comparison of micro-health insurance and user fees in Rwanda. H Econ 15 (1), S. 19-31
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/111089543/PDFSTART).
B-REF	Schnell, Gerald (2002). Zuzahlung für Arzneimittel. Josef Eul Verlag, Lohmar/Köln. ISBN 3-89012-960-9.
B-REF	Schoen, Cathy; Osborn, Robin; Huynh, Phuong Trang; Doty, Michelle; Zapert, Kinga; Peugh, Jordon; Da-
I-REF	vis, Karen (2005). Taking The Pulse Of Health Care Systems: Experiences Of Patients With Health Prob-
I-REF	lems In Six Countries. H Aff Web Excl 24 (6), S. W5 509-525
I-REF	(http://content.healthaffairs.org/cgi/reprint/hlthaff.w5.509).
B-REF	Schoen, Cathy; Doty, Michelle (2004). Inequities in Accces to Medical Care in Five Countries. Pub. #733,
I-REF	The Commonwealth Fund, New York / H Pol 67 (3), S. 309–22
I-REF	(http://www.commonwealthfund.org/usr_doc/733_Schoen_Doty_inequities_ITL.pdf?section=4039).
B-REF	Schreyer, Christoph; Maibach, Markus; Sutter, Daniel; Doll, Claus; Bickel, Peter (2007). Externe Kosten
I-REF	des Verkehrs in Deutschland, Aufdatierung 2005. Schlussbericht, INFRAS, Zürich (Kurzfassung:
I-REF	http://www.allianz-pro-schiene.de/cms/upload/pdf-Dateien/Publikationen/070300_Externe-
I-REF	Kosten_Management_Summary.pdf).
B-REF	Schroeder, Steven; Cantor, Joel (1991). On Squeezing Balloons: Cost Control Fails. N Engl J Med 325 (15),
I-REF	S. 1099-1100.
B-REF	Schulenburg, Johann-Matthias Graf von der (1984a). Möglichkeiten und Probleme der Steuerung der Nach-
I-REF	frage nach Gesundheitsleistungen. Medizin, Mensch, Gesellschaft 9 (4), S. 251-259.
B-REF	Schulenburg, Johann-Matthias Graf von der (1984b). Economic Aspects of Cost-Sharing in Medical Insur-
I-REF	ance. A Theoretical and Empirical Investigation. In: Eimeren, W. van; Engelbrecht, R., Flaggle Ch. D.
I-REF	(Hrsg.). Third International Conference on System Science in Health Care. Springer Berlin, S. 1278-1281.
B-REF	Schulenburg, Johann-Matthias Graf von der (1984c). Deregulation of Statutory Health Insurance. The Ef-
I-REF	fects of Increased Cost-Sharing Arrangements. Forschungebericht, Wissenschaftszentrum für Sozialfor-
I-REF	schung, Berlin.
B-REF	Schulenburg, Johann-Matthias Graf von der (1984d). Deregulation of Statutory Health Insurance. The Ef-
I-REF	fects of Increased Cost-Sharing Arrangements. Forschungebericht, Wissenschaftszentrum für Sozialfor-
I-REF	schung, Berlin.
B-REF	Schulenburg, Johann-Matthias Graf von der (1987). Selbstbeteiligung. Theoretische und empirische Kon-
I-REF	zepte für die Analyse ihrer Allokations- und Verteilungswirkungen. Schriften zur angewandten Wirtschafts-
I-REF	forschung Nr. 51, Mohr-Verlag, Tübingen.Schulenburg, Matthias Graf von der (2007). Leuchttürme einer
I-REF	rationalen Gesundheitspolitik. Institut für Versicherungsbetriebslehre, Leibniz Universität Hannover
I-REF	(http://www.ivbl.uni-hannover.de/~ivbl/forschung/material/Leuchttuerme2.pdf).
B-REF	Schulenburg, Johann-Matthias von der; Frommknecht, Heinrich (1984). Versicherungsschutz und Selbstbe-
I-REF	teiligung in der Individualversicherung aus der Sicht der ökonomischen Theorie. Formen der Selbstbeteili-
I-REF	gung in der Personenversicherung. Erfahrungen und Perspektiven. Frankfurter Vorträge zum Versiche-
I-REF	rungswesen Nr. 9, Verlagsgesellschaft Versicherungswirtschaft, Karlsruhe.
B-REF	Schulenburg, Johann-Matthias Graf von der; Wieland, Klaus (1984). Selbstbeteiligung in der Krankenversi-
I-REF	cherung. Rhein Ärztebl (13), S. 630-634.
B-REF	Schultz, Jennifer; O’Donnell, John; McDonough, Ken; Sasane, Rahul; Meyer, Jay (2005). Determinants of
I-REF	compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care
I-REF	population. Am J Manag Care 11 (5), S.306-312
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC05May_Schultz306to312.pdf).
B-REF	Schwartz, Gregory; Olsson, Anders; Ezekowitz, Michael; Ganz, Peter; Oliver, Michael; Waters, David; Zei-
I-REF	her, Andreas; Chaitman, Bernard; Leslie, Sally; Stern, Theresa for the Myocardial Ischemia Reduction with
I-REF	Aggressive Cholesterol Lowering Study Investigators (2001). Effects of atorvastatin on early recurrent
I-REF	ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285
I-REF	(13), S. 1711–1718 (http://jama.ama-assn.org/cgi/reprint/285/13/1711).
B-REF	Schwarz, Eli (1996). Changes in Utilization and Cost Sharing within the Danish Health Insurance Dental
I-REF	Program 1975-90. Acta Odontol Scand 54 (1), S. 29-35.
B-REF	Schwartz, Gregory; Olsson, Anders; Ezekowitz, Michael; Ganz, Peter; Oliver, Michael; Waters, David; Zei-
I-REF	her, Andreas; Chaitman, Bernard; Leslie, Sally; Stern, Theresa for the Myocardial Ischemia Reduction with
I-REF	Aggressive Cholesterol Lowering Study Investigators (2001). Effects of atorvastatin on early recurrent
I-REF	ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285
I-REF	(13), S. 1711–1718 (http://jama.ama-assn.org/cgi/reprint/285/13/1711).
B-REF	Schwermann, Tim; Greiner, Wolfgang; Schulenburg, J.M. Graf v.d. (2003). Using Disease Management and
I-REF	Market Reforms to Address the Adverse Economic Effects of Drug Budgets and Price and Reimbursement
I-REF	Regulations in Germany. Value in Health 6 (s1), S. S20–S30 (http://www.blackwell-
I-REF	synergy.com/doi/pdf/10.1046/j.1524-4733.6.s1.3.x).
B-REF	Scitovsky, Anne; Snyder, Nelda (1972). The effects of coinsurance on the use of physician services. Social
I-REF	Security Bulletin 35 (6), S. 3-19.
B-REF	Selby, Joseph; Fireman, Bruce; Swain, Bix (1996). Effect of Copayment on Use of the Emergency Depart-
I-REF	ment in a Health Maintenance Organization. N Engl J Med 334 (10), S. 635-640
I-REF	(http://content.nejm.org/cgi/reprint/334/10/635.pdf).
B-REF	Selby, Joseph (1997). Cost Sharing in the Emergency Department — Is It Safe? Is It Needed? N Engl J Med
I-REF	336 (24), S: 1750-1751 (http://content.nejm.org/cgi/content/full/336/24/1750).
B-REF	Selby, Jow; Fireman, Bruce; Swain, Bix (1996). Effect of a Copayment on Use of the Emergency Depart-
I-REF	ment in a Health Maintenance Organization. N Engl J Med 334 (10), S. 635-641
I-REF	(http://content.nejm.org/cgi/reprint/334/10/635.pdf).
B-REF	Sen, Amartya (1982). Choice, Welfare, and Measurement. Basil Blackwell, Oxford.
B-REF	Shang, Baoping (2005). The Cost and Health Effects of Prescription Drug Coverage and Utilization in the
I-REF	Medicare Population. Dissertation, Pardee RAND Graduate School (www.rand.org/pubs/
I-REF	rgs_dissertations/2005/RAND_RGSD197.pdf).
B-REF	Shapiro, Martin; Ware John, Sherbourne, Cathy (1986). Effects of cost sharing on seeking care for serious
I-REF	and minor symptoms: results of a randomized controlled trial. Ann Intern Med 104 (4), S. 246-51.
B-REF	Shapiro, Martin; Hayward, Rodney; Freeman, Howard; Sudman, Seymour; Corey, Christopher (1989). Out-
I-REF	of-pocket payments and use of care for serious and minor symptoms. Results of a national survey. Arch Int
I-REF	Med 149 (7), S. 1645-1648 (Abstract: http://archinte.ama-assn.org/cgi/content/abstract/149/7/1645).
B-REF	Shapiro, Martin, Morton, Sally, McCaffrey, Daniel; Senterfitt, Walton; Fleishman, John; Perlman, Juduth
I-REF	Athey; Leslie; Keesey, Joan; Goldman, Dana; Berry, Sandra; Bozzette, Samuel (2000). Access to HIV Care:
I-REF	Initial Results from the HIV Cost and Services Utilization Study.
B-REF	Shapiro, Robert (2003). Premium Blend. Why is it so difficult to provide universal health care? Slate, The
I-REF	Dismail Science (http://www.slate.com/id/2082988/).
B-REF	Sharkey, Joseph; Ory, Marcia; Browne, Barry (2005). Determinants of Self-Management Strategies to Re-
I-REF	duce Out-of-Pocket Prescription Medication Expense in Homebound Older people. J Am Ger Soc 53 (4), S.
I-REF	666-674 (http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1532-5415.2005.53217.x).
B-REF	Shea, Dennis; Terza, Joseph; Stuart, Bruce; Briesacher, Becky (2007). Estimating the Effects of Prescription
I-REF	Drug Coverage for Medicare Beneficiaries. H Serv Res 42 (3p1), S. 933–949 (http://www.blackwell-
I-REF	synergy.com/doi/pdf/10.1111/j.1475-6773.2006.00659.x).
B-REF	Sheehan, Pete (2006). Charities helping seniors navigate rivers of bureaucratic paperwork. Long Island
I-REF	Catholic 45 (18) (http://www.licatholic.org/archive/072606/Charities%20Helping%20Seniors.htm).
B-REF	Shekelle, Paul; Rogers, William; Newhouse, Joseph (1996). The Effect of Cost Sharing on the Use of Chi-
I-REF	ropractic Services. Med Care 34 (9), S. 863-872.
B-REF	Shen, Yu-Chu; McFeeters, Joshua (2006). Out-of-Pocket Health Spending Between Low- and Higher-
I-REF	Income Populations: Who is at Risk of Having High Expenses and High Burdens? Med Care 44 (3), S. 200-
I-REF	209.
B-REF	Shepherd, James; Cobbe, Stuart; Ford, Ian; Isles, Christopher; Lorimer, Ross; Macfarlane, Peter; McKillop,
I-REF	James; Packard, Christopher (1995). Prevention of coronary heart disease with pravastatin in men with hy-
I-REF	percholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333 (20), S.1301-
I-REF	1307 (http://content.nejm.org/cgi/reprint/333/20/1301.pdf).
B-REF	Shih, Ya-chen (1999). Effect of insurance on Prescription Drug Use by ESRD beneficiaries. H Care Finan
I-REF	Rev 20 (3), S. 39-54 (http://www.cms.hhs.gov/review/99Spring/99Springpg39.pdf)
B-REF	Shrank,William (2004). Effect of Incentive-Based Formularies on Drug Utilization and Spending. N Engl J
I-REF	Med 350 (10), S. 1057 (http://content.nejm.org/cgi/reprint/350/10/1057.pdf).
B-REF	Shrank, William; Joseph, George; Choudhry, Niteesh; Young, Henry; Ettner, Susan; Glassman, Peter; Asch,
I-REF	Steven; Kravitz, Richard (2006). Physicians’ Perceptions of Relevant Prescription Drug Costs: Do Costs to
I-REF	the Individual Patient or to the Population Matter Most? Am J Manag Care 12 (10), S. 545-551
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_06sepShrank545to551.pdf).
B-REF	Silverman, Ed (2006). Copayments: Too much, not yet Enough? Biotechnology Healthcare April 2006, S.
I-REF	21-26 (http://www.biotechnologyhealthcare.com/journal/fulltext/3/2/BH0302020.pdf).
B-REF	Simon, Gregory; Korff, Michael von; Durham, Mary (1994). Predictors of outpatient mental health utiliza-
I-REF	tion by primary health care patients in a health maintenance organization. Am J Psych 151 (6), S. 908-913
I-REF	(http://ajp.psychiatryonline.org/cgi/reprint/151/6/908).
B-REF	Simon, Gregory; Grothaus, Louis; Durham, Mary; Korff, Michael von; Pabiniak, Chester (1996). Impact of
I-REF	visit copayments on outpatient mental health utilization by members of a health maintenance organization.
I-REF	Am J Psych 153 (3), S. 331-338 (http://ajp.psychiatryonline.org/cgi/reprint/153/3/331).
B-REF	Simonet, Daniel (2005). Where does the US experience of managed care currently stand? Int J H Plan Mgmt
I-REF	20 (2), S. 137-157 (http://www3.interscience.wiley.com/cgi-bin/fulltext/110528954/PDFSTART).
B-REF	Simpson, Scot; Eurich, Dean; Majumdar, Sumit; Padwal, Rajdeep Tsuyuki, Ross; Varney, Janice; Johnson
I-REF	Jeffrey (2006). A meta-analysis of the association between adherence to drug therapy and mortality. BMJ
I-REF	333 (7557), S. 15-18 (http://bmj.bmjjournals.com/cgi/reprint_abr/333/7557/15.pdf).
B-REF	Simpson, Ross (2006). Challenges for Improving Medication Adherence. JAMA 296 (21), S. 2614-2615
I-REF	(http://jama.ama-assn.org/cgi/reprint/296/21/2614).
B-REF	Sipkoff, Martin (2004). Not So Much of a Reach: Let Sick Pay Less for Drugs. Man Care 13 (10), S. 22-24
I-REF	(http://www.managedcaremag.com/archives/0410/0410.benefitbased.html).
B-REF	Siu, Albert; Sonnenberg, Frank; Manning, Willard; Goldberg, George; Bloomfield, Ellyn; Newhouse, Jo-
I-REF	seph; Brook Robert (1986). Inappropiate use of hospitals in a randomized trial of health insurance plans. N
I-REF	Engl J Med 315 (18), S. 1259-1266 (Abstract: http://171.66.123.143/cgi/content/abstract/315/20/1259).
B-REF	Skinner, Brett (2002). Improving Canadian Health Care. Better Ways to finance Medicare. Health Care Re-
I-REF	form, Background Paper No. 12, Atlantic Institute for Medical Studies
I-REF	(http://www.aims.ca/Publications/improving/improving.pdf).
B-REF	Slade, Eric; Salkever, David; Rosenheck, Robert; Swanson, Jeffrey; Swartz, Marvin; Shern, David; Gal-
I-REF	lucci, Gerard; Harding, Courtenay; Palmer, Liisa; Russo, Patricia (2005). Cost-Sharing Requirements and
I-REF	Access to Mental Health Care Among Medicare Enrollees With Schizophrenia. Psychiatr Serv 56:960-966
I-REF	(http://psychservices.psychiatryonline.org/cgi/content/full/56/8/960).
B-REF	Smith, Cynthia; Cowan, Cathy; Sensenig, Art; Catlin, Aaron; Health Accounts Team (2005). Health Spend-
I-REF	ing Growth Slows In 2003. H Aff 24 (1), S. 185-194 (http://content.healthaffairs.org/cgi/reprint/24/1/185).
B-REF	Smith, Dennis (1993). The effects of co-payments and generic substitution on the use and costs of prescrip-
I-REF	tion drugs. Inquiry 30 (2), S. 189-198.
B-REF	Smith, Peter; Witter, Sophie (2001). Risk Pooling in Health Care Finance. Report Prepared für the World-
I-REF	bank Workshop „Resource Allocation and Purchasing in health: Value for Money, Reaching the Poor.“ Uni-
I-REF	versity of York, York/Washington D.C. (http://www.york.ac.uk/inst/che/pooling.pdf).
B-REF	Smith, Peter (2005). User charges and priority setting in health care: balancing equity and efficiency. J H
I-REF	Econ 24 (5), S. 1018-1029.
B-REF	Smith-Conway, Karen; Kutinova, Andrea (2006). Maternal health: does prenatal caremake a difference?. H
I-REF	Econ 15 (5), S. 461–488 (http://www3.interscience.wiley.com/cgi-bin/fulltext/112471134/PDFSTART).
B-REF	Smithson, Paul; Asamoa-Baah, A; Mills, Anne (1997). The case of the health sector in Ghana. The Role of
I-REF	Government in Adjusting Economies Research Programme, Paper 26, Development Administration Group,
I-REF	University of Birmingham
I-REF	(http://www.idd.bham.ac.uk/research/Projects/Role_of_gov/workingpapers/paper26.htm).
B-REF	Sokol, Michael; McGuigan, Kimberly; Verbrugge, Robert; Epstein, Robert (2005). Impact of Medication
I-REF	Adhere nce on Hospitalization Risk and Healthcare Cost. Med Care 43 (6), S. 521-530.
B-REF	Solanki, Geetesh; Schauffler, Helen (1999). Cost-sharing and the utilization of clinical preventive services.
I-REF	Am J Prev Med 17 (2), S. 127-133 (http://www.ajpm-online.net/article/PIIS0749379799000574/pdf;
I-REF	http://chpps.berkeley.edu/publications/Schauffler%20papers/Cost_Sharing_&_Utilization.pdf).
B-REF	Solanki, Geetesh; Schauffler, Helen; Miller, Leonard (2000). The Direct and Indirect Effects of Cost-
I-REF	Sharing on the Use of Preventive Services. H Serv Res 6 (1), S. 44–55
I-REF	(http://www.findarticles.com/p/articles/mi_m4149/is_6_34/ai_59629770).
B-REF	Solomon, Matthew (2005). The Effect of Cost-Sharing on the Utilization of Prescription Drugs for Chroni-
I-REF	cally Ill Patients. Dissertation, Pardee RAND Graduate School (PRGS), Santa Monica
I-REF	(https://rand.org/pubs/rgs_dissertations/2005/RAND_RGSD193.pdf).
B-REF	Somkin, Carol; McPhee, Stephen; Nguyen, Tung; Stewart, Susan; Shema, Sarah; Nguyen, Bang; Pasick,
I-REF	Rena (2004). The Effect of Access and Satisfaction on Regular Mammogram and Papanicolaou Test Screen-
I-REF	ing in a Multiethnic Population. Med Care 42 (9), S. 914-926.
B-REF	Soumerai, Stephen; Ross-Degnan, Dennis; Avorn, Jerry; McLaughlin, Thomas; Choodnovskiy, Igor (1991).
I-REF	Effects of Medicaid Drug-Payment. Limits on Admission to Hospitals and Nursing Homes. N Engl J Med
I-REF	325 (15), S. 1072-1077 (http://content.nejm.org/cgi/content/abstract/325/15/1072).
B-REF	Soumerai, Stephen; McLaughlin, Thomas; Ross-Degnan, Dennis; Casteris, Christina; Bollini, Paola (1994).
I-REF	Effects of Limiting Medicaid Drug-Re-Impbursement Benefits on the Use of Pychotropic Agents and Acute
I-REF	Mental Health Services by Patients with Schizophrenia. N Engl J Med 331 (10), S. 650-655
I-REF	(http://content.nejm.org/cgi/content/full/331/10/650).
B-REF	Soumerai, Steven; McLaughlin, Thomas; Spiegelman, Donna; Hertzmark, Ellen; Thibault, George;
I-REF	Goldman, Lee (1997). Adverse Outcomes of Underuse of ß-Blockers in Elderly Survivors of Acute Myocar-
I-REF	dial Infarction. JAMA 277 (2), S. 115-121 (Abstract: http://jama.ama-
I-REF	assn.org/cgi/content/abstract/277/2/115).
B-REF	Soumerai, Stephen; Ross-Degnan, Dennis (1999). Inadequate Prescription-Drug Coverage for Medicare En-
I-REF	rollees — A Call to Action. N Engl J Med 340 (9), S. 722-728
I-REF	(http://content.nejm.org/cgi/content/full/340/9/722).
B-REF	Soumerai, Stephen (2004). Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In
I-REF	Medicaid. H Aff 23 (1), S. 135-146 (http://content.healthaffairs.org/cgi/reprint/23/1/135).
B-REF	Soumerai, Stephen; Pierre-Jacques, Marsha; Zhang, Fang; Ross-Degnan, Dennis; Adams, Alyce; Gurwitz,
I-REF	Jerry; Adler, Gerald; Safran, Dana (2006). Cost-Related Medication Nonadherence Among Elderly and Dis-
I-REF	abled Medicare Beneficiaries. A National Survey 1 Year Before the Medicare Drug Benefit. Arch Intern
I-REF	Med 166 (17), S. 1829-1835 (http://archinte.ama-assn.org/cgi/reprint/166/17/1829).
B-REF	Spiegel online (2006a). Gesundheit: Arbeitgeber fordern Fünf-Euro-Gebühr pro Arztbesuch. 8.5.2006, Ham-
I-REF	burg (www.spiegel.de/wirtschaft/0,1518,414937,00.html).
B-REF	Spiegel online (2006b). Gesundheit: Haushalte bezahlen 14 Prozent der Kosten selbst. 16.8.2006, Hamburg
I-REF	(www.spiegel.de/wirtschaft/0,1518,432018,00.html).
B-REF	Standing, Hillary (1997). Gender and equity in health sector reform programmes: a review. H Pol Plan 12
I-REF	(1), S. 1-18 (http://heapol.oxfordjournals.org/cgi/reprint/12/1/1).
B-REF	Standing, Hillary (2000a). Gender Impacts of Health Reforms – The Current State of Policy and Implemen-
I-REF	tation. Institute of Development Studies, Universität Sussex, Brighton. Beitrag zum ALAMES-Treffen 3.-7.
I-REF	Juli 2000 in Havanna (http://www.eldis.org/cache/DOC8307.pdf).
B-REF	Standing, Hillary (2000b). Gender Impacts of Health Reforms – The Current State of Policy and Implemen-
I-REF	tation. Women’s Health Journal 3-4, Latin American and Caribbean Women’s Health Network, Santiago
I-REF	(http://www.reddesalud.org/english/datos/ftp/standing_eng.pdf).
B-REF	Standing, Hillary (2004). Understanding the 'demand side' in service delivery. Definitions, frameworks and
I-REF	tools from the health sector. Issues Paper Private Sector, DFID Health Systems Resource Centre, London
I-REF	(http://www.dfidhealthrc.org/Shared/publications/Issues_papers/private-sector/Standing.pdf).
B-REF	Starfield, Barbara; Dutton, Diana (1985). Care, Costs, and Health: Reactions to and Reinterpretation of the
I-REF	Rand Findings. Pediatrics 76 (4), S. 614-621 (http://pediatrics.aappublications.org/cgi/reprint/76/4/614).
B-REF	Stanton, Bonita; Clemens, John (1989). User Fees for Health Care in Developing Countries: a Case Study of
I-REF	Bangladesh. Soc Sc Med 29 (10), S. 1199-1205.
B-REF	Stanton, Mark; Rutherford, Margaret (2002). Reducing costs in the health care system: learning from what
I-REF	has been done. Research in Action, Issue 9. AHRQ Pub. No. 02-0046, Agency for Healthcare Research and
I-REF	Quality, Rockville (MD) (www.ahrq.gov/research/costsria.pdf).
B-REF	Statistisches Bundesamt (Hrsg.) (2006). Datenreport 2006. Schriftenreihe Band 544, Bundeszentrale für Po-
I-REF	litische Bildung, Köln (http://www.wz-berlin.de/wzb/pdf/dr06/datenreport-2006.pdf).
B-REF	Ståhl, Ingemar (1980). Kostenbeteiligung im Schwedischen Gesundheitswesen. In: Internationale Gesell-
I-REF	schaft für Gesundheitsökonomie, S. 67-74.
B-REF	Steinbrook, Robert (2002). The Prescription-Drug Problem. N Engl J Med 346 (11), S. 790
I-REF	(http://content.nejm.org/cgi/reprint/346/11/790.pdf).
B-REF	Steinbrook, Robert (2004). The Cost of Admission – Tiered Copayments for Hospital Use. N Engl J Med
I-REF	350 (25), S.2539-2542 (http://content.nejm.org/cgi/reprint/350/25/2539.pdf).
B-REF	Steffen, Wolfgang; Tempka, Almut; Klute, Gesine (2007). Falsche Patientenanreize in der Ersten Hilfe der
I-REF	Krankenhäuser (Unhelpful incentives in hospital emergency departments). Dt Ärztebl 104 (16), S. A-1088-
I-REF	1091/B-969-972/C-921-924 (http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=55340).
B-REF	Stein, Bradley (2003). Drug and Alcohol Treatment Services Among Privately Insured Individuals in Man-
I-REF	aged Behavioral Health Care. RAND Graduate School, Santa Monica
I-REF	(http://www.rand.org/publications/RGSD/RGSD170/RGSD170.pdf).
B-REF	Steinbach, Kerstin; Oorschot, Birgitt van; Anselm, Rainer; Leppert, Karena; Schweitzer, Susanne; Haus-
I-REF	mann, Christopher; Köhler, Norbert. (2004). Patienten als Partner: Wer soll entscheiden? Dt Ärztebl 101
I-REF	(41), S. A-2741 / B-2309 / C-2216 (http://www.aerzteblatt.de/v4/archiv/ao.asp?id=43750; Online-
I-REF	Langfassung 08.10.2004: (http://www.aerzteblatt.de/v4/archiv/artikel.asp?id=43699;
I-REF	www.aerzteblatt.de/aufsaetze/0403).
B-REF	Steinman, Michael; Sands, Laura; Covinsky, Kenneth (2001). Self-restriction of Medications Due to Cost in
I-REF	Seniors without Prescription Coverage. J Gen Intern Med 16, S. 793-799 (http://www.blackwell-
I-REF	synergy.com/doi/pdf/10.1046/j.1525-1497.2001.10412.x?cookieSet=1).
B-REF	Stiggelbout, Anne; Kiebert, Gwendoline (1997). Patient preferences regarding information and participation
I-REF	in clinical decision-making. Can Med Assoc J 157 (4), S. 383–389
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1243812&blobtype=pdf).
B-REF	Stoddart, Greg; Barer, Morris; Evans, Robert; Bhatia, Vandha (1993). Why Not Users Charges? The real is-
I-REF	sues. HPRU, 93. 12D, Centre for Health Services and Policy Research, University of British Columbia,
I-REF	Vancouver(http://www.chspr.ubc.ca/hpru/pdf/hpru93-12D.pdf).
B-REF	Stone, Erin; Morton, Sally; Hulscher, Marlies; Maglione, Margaret; Roth, Elizabeth; Grimshaw, Jeremy;
I-REF	Mittman, Brian; Rubenstein, Lisa; Rubenstein, Laurence; Shekelle, Paul (2002). Interventions That Increase
I-REF	Use of Adult Immunization and Cancer Screening Services: A Meta-Analysis. Ann Int Med 136, S. 641-651
I-REF	(http://www.annals.org/cgi/reprint/136/9/641.pdf).
B-REF	Street, Andrew; Jones, Andrew; Furuta, Aya (1999). Cost-sharing and pharmaceutical utilisation and expen-
I-REF	diture in Russia. J H Econ 18 (4) pp. 459-472.
B-REF	Strunk, Bradley; Ginsburg, Paul; Gabel, Jon (2002). Tracking Health Care Costs: Growth Accelerates Again
I-REF	In 2001. H Aff, Web Excl, S. w2 299-310 (http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.299v1).
B-REF	Stuart, Bruce; Stockton, Ronald (1973).Control over the Utilization of Medical Services. Milbank Mem
I-REF	Fund Quarterly. Health and Society 51 (3), S. 341-394 (http://links.jstor.org/sici?sici=0160-
I-REF	1997%28197322%2951%3A3%3C341%3ACOTUOM%3E2.0.CO%3B2-1).
B-REF	Stuart, Bruce; Grana, James (1995). Are prescribed and over-the-counter medicines economic substitutes? A
I-REF	study of the effects of health insurance on medicine choices by the elderly. Med Care 33 (5), S. 487-501.
B-REF	Stuart, Bruce; Grana, James (1998). Ability to Pay and the Decision to Medicate. Med Care 36 (2), S. 202-
I-REF	211.
B-REF	Stuart, Bruce; Grana, James (1999). Who bears the burden of Medicaid drug copayment policies? H Aff 18
I-REF	(2), S. 201-212 (http://content.healthaffairs.org/cgi/reprint/18/2/201).
B-REF	Stuart, Bruce; Briesacher, Becky (2002).Medication Decisions – Right and Wrong. Med Care Res Rev 6
I-REF	(59), S. 123-145 (http://mcr.sagepub.com/cgi/reprint/59/2/123).
B-REF	Su, Tin Tin; Pokhrel, Subhash; Gbangou, Adjima; Flessa, Steffen (2006). Determinants of household health
I-REF	expenditure on western institutional health care. Eur J H Econ 7 (3), pp. 199-207
I-REF	(http://www.springerlink.com/content/050870g56x414583/fulltext.pdf).
B-REF	Sugden, Robert (1993). Welfare, Resources and Capabilities.: A review of Inequality Reexamined by Amar-
I-REF	tya Sen. J Econ Lit 31, S. 1947-1962 (http://links.jstor.org/sici?sici=0022-
I-REF	0515%28199312%2931%3A4%3C1947%3AWRACAR%3E2.0.CO%3B2-C).
B-REF	Suk Danik, Jacqueline; Rifai, Nader; Buring, Julie; Ridker, Paul (2006). Lipoprotein(a), Measured With an
I-REF	Assay Independent of Apolipoprotein(a) Isoform Size, and Risk of Future Cardiovascular Events Among
I-REF	Initially Healthy Women. JAMA 296 (11), S. 1363-1370 (http://jama.ama-assn.org/cgi/reprint/296/11/1363).
B-REF	Szilagyi, Peter; Humiston, Sharon; Shone, Laura Pollard; Kolasa, Maureen; Rodewald, Lance (2000). De-
I-REF	cline in physician referrals to health department clinics for immunizations: The role of vaccine financing.
I-REF	Am J Prev Med 18 (4), S. 318-324.
B-REF	Taira, Deborah; Wong, Ken; Frech-Tamas, Feride; Chung, Richard (2006). Copayment Level and Compli-
I-REF	ance With Antihypertensive Medication: Analysis and Policy Implications for Managed Care. Am J Man
I-REF	Care 12 (11), S. 678-683 (http://www.ajmc.com/files/articlefiles/AJMC_06novTaira678to683.pdf).
B-REF	Tamblyn, Robyn; Laprise, Rejean; Hanley, James; Abrahamowicz, Michael; Scott, Susan; Mayo, Nancy;
I-REF	Hurley, Jerry; Grad, Roland; Latimer, Eric; Perreault, Robert; McLeod, Peter; Huang, Allen; Larochelle, Pi-
I-REF	erre; Mallet, Louise (2001). Adverse Events Associated with Prescription Drug Cost-Sharing Among Poor
I-REF	and Elderly Persons. JAMA 285 (4), S. 421-429 (http://jama.ama-assn.org/cgi/reprint/285/4/421).
B-REF	Tanner, Michael (1995). What's Wrong With the Present System. In: Arnett, Grace-Marie. Empowering
I-REF	Health Care Consumers Through Tax Reform, Chapter 2. University of Michigan Press/Galen-Institute,
I-REF	Flint/Alexandria (http://www.galen.org/bookcontent.asp?p=6#10).
B-REF	Tanner, Michael (1995). Medical Savings Accounts: Answering the Critics. Cato Policy Analysis No. 228,
I-REF	Cato Institute, Washington DC (http://www.cato.org/pubs/pas/pa228.html).
B-REF	Tarn, Derjung; Heritage, John; Paterniti, Debora; Hays, Ron; Kravitz, Richard; Wenger, Neil (2006a). Phy-
I-REF	sician Communication When Prescribing New Medications. Arch Intern Med 166 (17), S. 1855-1862
I-REF	(http://pubs.ama-assn.org/media/controlled/archinte/pdf/1855.pdf).
B-REF	Tarn, Derjung; Paterniti, Debora; Heritage, John; Hays, Ron; Kravitz, Richard; Wenger, Neil (2006b). Phy-
I-REF	sician Communication About the Cost and Acquisition of Newly Prescribed Medications. Am J Man Care
I-REF	12 (11), S. 657-664 (http://www.ajmc.com/files/articlefiles/AJMC_06novTarn657to664.pdf).
B-REF	Tatar, Mehtap; Özgen, Hacer; Sahin, Bayram; Belli, Paolo; Berman, Peter (2007). Informal Payments In The
I-REF	Health Sector: A Case Study From Turkey. H Aff 26 (4), S. 1029-1039
I-REF	(http://content.healthaffairs.org/cgi/reprint/26/4/1029).
B-REF	Taylor, Humphrey; Leitman, Robert (Eds.) (2001). Out-of-Pocket Costs are a Substantial Barrier to Prescrip-
I-REF	tion Drug Compliance. HarrisInteractive, Health Care News 1 (32)
I-REF	(http://www.harrisinteractive.com/news/newsletters/healthnews/HI_HealthCareNews2001Vol1_iss32.pdf).
B-REF	Taylor, Humphrey; Leitman, Robert (Eds.) (2002). Higher out-of-pocket costs cause massive non-
I-REF	compliance in the use of prescription drugs, and this is likely to grow. Harris Interactive, Health Care News
I-REF	2 (22) (December 6, 2002)
I-REF	(http://www.harrisinteractive.com/news/newsletters/healthnews/HI_HealthCareNews2002Vol2_Iss22.pdf).
B-REF	Tervonen-Gonçalves, Leena; Jehto, Juhani (2004). Transfer of Health for All policy – What, how and in
I-REF	which direction? A two-case study. H Res Pol Syst 2 (8) (http://www.health-policy-
I-REF	systems.com/content/pdf/1478-4505-2-8.pdf).
B-REF	The Coalition for Health and Education Rights (CHER) (2002). User fees: the right to education and health
I-REF	denied. A policy brief for the UN Special Session on Children, CHER, New York
I-REF	(http://www.campaignforeducation.org/resources/May2002/CHER_Fees0502.pdf).
B-REF	The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications
I-REF	(DCCT/EDIC) Study Research Group (2005). Intensive Diabetes Treatment and Cardiovascular Disease in
I-REF	Patients with Type 1 Diabetes. N Engl J Med 353 (25), S. 2643-2653
I-REF	(http://content.nejm.org/cgi/reprint/353/25/2643.pdf).
B-REF	The Economist (1995). An Insurers Worst Nightmare. The Economist 336, S. 66.
B-REF	Thiebaud, Patrick; Patel, Bimal; Nichol, Michael (2007). The demand for statin: the effect of copay on utili-
I-REF	zation and compliance. H Econ 17 (1), S. 83.97 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/114282002/PDFSTART).
B-REF	Thomas, Cindy; Wallack, Stanley; Lee, Sue; Ritter, Grant (2002). Impact Of Health Plan Design And Man-
I-REF	agement On Retirees' Prescription Drug Use And Spending, 2001. H Aff, Web Excl, S. w2 408-419
I-REF	(http://content.healthaffairs.org/cgi/reprint/hlthaff.w2.408v1).
B-REF	Thorpe, Kenneth (2006). Cost sharing, caps on benefits, and the chronically ill – a policy mismatch. N Engl
I-REF	J Med 354 (22), S. 2385-2386 (http://content.nejm.org/cgi/reprint/354/22/2385.pdf).
B-REF	Thomas, Merlin; Mann, Jim (1998). Increased thrombotic vascular events after change of statin. Lancet 52
I-REF	(9143), S. 1830-1831.
B-REF	Topol, Eric (2004). Intensive Statin Therapy — A Sea Change in Cardiovascular Prevention. N Engl J Med
I-REF	350 (15), S. 1562-1564 (http://content.nejm.org/cgi/reprint/350/15/1562.pdf).
B-REF	Torrey, Barbara; Jacobs, Eva (1993). More Than Loose Change: Household Health Spending In The United
I-REF	States And Canada. H Aff 12 (1), S. 126-131 (http://content.healthaffairs.org/cgi/reprint/12/1/126).
B-REF	Towse, Adrian (1999). Could charging patients fill the cash gap in Europe’s health care systems? Eurohealth
I-REF	5 (3). Geneva: World Health Organization, S. 27-28
I-REF	(http://www.euro.who.int/document/obs/EuroHealth5_3.pdf).
B-REF	Traynor, Kate (2002). Drug costs for 2003 may rise 20%. American Society of Health-System Pharmacists,
I-REF	Bethesda (www.safemedication.com/meds/ShowArticle.cfm?id=3188).
B-REF	Tretter, Felix; Erbas, Beate; Sonntag, Gert (2003). Ökonomie der Sucht und Suchttherapie. Pabst Science
I-REF	Publishers, Lengerich. ISBN 3-89967-100-7.
B-REF	Tretter, Felix (2005). Krankes Gesundheitswesen und die Reformen. Dt. Ärztebl 102 (9), S. 446-447
I-REF	(http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=heft&id=45666).
B-REF	Trude, Sally; Christianson, Jon; Lesser, Cara; Watts, Carolyn; Benoit, Andrea (2002). Employer-Sponsored
I-REF	Health Insurance: Pressing Problems, Incremental Changes. H Aff 21 (1), S. 66-75
I-REF	(http://content.healthaffairs.org/cgi/reprint/21/1/66f).
B-REF	Trude, Sally (2003). Patient Cost Sharing: How Much is Too Much? Issue Brief No. 72, Center for Studying
I-REF	Health System Change, Washington DC (http://hschange.org/CONTENT/630/).
B-REF	Trude, Sally, Grossman, Joy (2004). Patient cost-sharing innovations: promises and pitfalls. Issue Brief Re-
I-REF	port No. 75, Center for Studying Health System Change, Washington DC
I-REF	(http://www.hschange.com/CONTENT/643/643.pdf).
B-REF	Tscheulin, Dieter; Helmig, Bernd (2001). On the acceptability of excess modells in the German statuatory
I-REF	health insurance (GKV). Freiburger Betriebswirtschaftliche Diskussionsbeiträge Nr. 39/01, Freiburg im
I-REF	Breisgau. ISBN 3-931416-32-1.
B-REF	Tseng, Chien-Wen; Brook, Robert; Keeler, Emmett; Mangione, Carol (2003). Impact of an Annual Dollar
I-REF	Limit or „Cap“ on Prescription Drug Benefits for Medicine Patients. JAMA 290 (8), S. 222-227
I-REF	(http://jama.ama-assn.org/cgi/reprint/290/2/222.pdf).
B-REF	Tseng, Chien-Wen; Brook, Robert; Keeler, Emmett; Steers, Neil; Mangione, Carol (2004). Cost-Lowering
I-REF	Strategies Used by Medicare Beneficiaries Who Exceed Drug Benefit Caps and Have a Gap in Drug Cover-
I-REF	age. JAMA 292 (8), S. 952-960. (http://jama.ama-assn.org/cgi/reprint/292/8/952.pdf).
B-REF	Tu, Ha; May, Jessica (2007). Self-Pay Markets In Health Care: Consumer Nirvana Or Caveat Emptor? Mar-
I-REF	ket Watch, H Aff, Web Excl, S. w2 217-226
I-REF	(http://content.healthaffairs.org/cgi/reprint/hlthaff.26.2.w217v1).
B-REF	Tu, Feng; Anan, Makato; Kiyohara, Yukata; Okada, Yasushi; Nobutomo, Koichi (2003). Analysis of hospi-
I-REF	tal charges for ischemic stroke in Fukuoka, Japan. H Pol 66 (3), S. 239-246.
B-REF	Tu, Jack; Gong, Yanyan (2003). Trends in Treatment and Outcomes for Acute Stroke Patients in Ontario,
I-REF	1992-1998. Arch Int Med 163 (3), S. 293-297 (http://archinte.ama-assn.org/cgi/reprint/163/3/293).
B-REF	Tu, Shin-Ping; Taplin, Stephen; Barlow, William; Boyko, Edward (1999). Breast cancer screening by Asian-
I-REF	American women in a managed care environment. Am J Prev Med 17 (1), S. 55-61.
B-REF	Tuffs, Annette (2007). German doctors accused of boosting pay by offering patients “unnecessary extras”.
I-REF	BMJ 335 (7611), S. 116 (http://www.bmj.com/cgi/reprint/335/7611/114-a).
B-REF	Tye, Sherilyn; Phillips, Kathryn; Liang, Su-Ying; Haas, Jennifer (2004). Moving beyond the Typologies of
I-REF	Managed Care: The Example of Health Plan Predictors of Screening Mammography. H Serv Res 39 (1), S.
I-REF	179-206 (http://www.blackwell-synergy.com/doi/full/10.1111/j.1475-6773.2004.00221.x).
B-REF	USA Today/Kaiser Family Foundation/Harvard School of Public Health (2006). National Survey of House-
I-REF	holds Affected by Cancer. Kaiser Family Foundation, Washington DC
I-REF	(http://www.kff.org/kaiserpolls/pomr112006pkg.cfm; Summary:
I-REF	http://www.kff.org/kaiserpolls/upload/7591.pdf).
B-REF	Valdez, Burciaga; Brook, Robert; Rogers, William; Ware, John Jr; Keeler, Emmett; Sherbourne, Cathy;
I-REF	Lohr, Kathleen; Goldberg, George; Camp, Patricia; Newhouse, Joseph (1985). Consequences of Cost-
I-REF	Sharing for Children's Health. Pediatrics 75 (5), S. 952-961
I-REF	(http://pediatrics.aappublications.org/cgi/reprint/75/5/952).
B-REF	van Beusekom, Ineke; Tönshoff, Silke; de Vries, Han; Spreng, Connor; Keeler, Emmett (2004). Possibility
I-REF	or Utopia? Consumer Choice in Health Care: A Literature Review. Technical Report, RAND Euro-
I-REF	pe/Bertelsmann-Stiftung, Santa Monica/Gütersloh
I-REF	(http://www.rand.org/pubs/technical_reports/2005/RAND_TR105.pdf).
B-REF	van de Voorde, Carine; van Doorslaer, Eddy; Schokkaert, Erik (2001). Effects of cost sharing on physician
I-REF	utilization under favourable conditions for supplier-induced demand. H Econ 10, S. 457–471
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/85005211/PDFSTART).
B-REF	van Doorslaer, Eddy; Wagstaff Adam (1992). Equity in the Delivery of Health Care: Some International
I-REF	Comparisons. J H Econ 11 (4), S. 389-411.
B-REF	van Doorslaer, Eddy; Wagstaff, Adam; van der Burg, Hattem; Christiansen, Terkel; Citoni, Guido; Biase,
I-REF	Rita di, Gerdtham, Ulf; Gerfin, Mike; Gross, Lorna; Häkinnen, Unto; John, Jürgen; Johnson, Paul; Klavus,
I-REF	Jan; Lachaud, Claire; Lauritsen, Jørgen; Leu, Robert; Nolan, Brian; Pereira, João, Propper, Carol; Puffer,
I-REF	Frank, Rochaix, Lise; Schellhorn, Martin; Sundberg, Gun; Winkelhake, Olaf (1999). The redistributive ef-
I-REF	fect of health care finance in twelve OECD countries. J H Econ 18 (3), S. 291-313.
B-REF	van Doorslaer, Eddy; Wagstaff, Adam; van der Burg, Hattem; Terkel; Christiansen; de Graeve, Diana;
I-REF	Duchesne, Inge; Gerdtham Ulf; Gerfin, Michael; Geurts, Jose; Gross, Lorna (2000). Equity in the delivery
I-REF	of health care in Europe and the US. J H Econ 19 (5), S. 553-84.
B-REF	van Doorslaer, Eddy; Koolman, Xander; Puffer, Frank (2002). Equity in the Use of PhysiciansVisits in
I-REF	OECD Countries: Has Equal Treatment for Equal Need Been Achieved. In: OECD (Hrsg.) (2002). Measur-
I-REF	ing Up: Improving health systems performance in OECD countries, Chapter 11, S. 225-248. OECD, Paris,
I-REF	(http://www.econ.ubc.ca/evans/384physic.pdf).
B-REF	van Doorslaer, Eddy; O'Donnell, Owen; Rannan-Eliya, Ravi; Somanathan, Aparnaa, et al. (2005). Paying
I-REF	out-of-pocket for health care in Asia: Catastrophic and poverty impact. Working Paper No. 2, EQUITAP
I-REF	Project, Colombo/Rotterdam/Dhaka (http://www.equitap.org/publications/wps/EquitapWP2.pdf).
B-REF	van Vliet, Jan (2004). Deductibles and Health Care Expenditures: Empirical Estimates of Price Sensitivity
I-REF	Based on Administrative Data. Int J H Care Fin Econ 4 (4), S. 283–305
I-REF	(http://www.springerlink.com/content/n22ux27j932168r3/fulltext.pdf).
B-REF	Vardy, Daniel; Freud, Tami; Shvartzman, Pesach; Sherf, Michael; Spilberg, Ofer; Goldfarb, Dan; Mor-
I-REF	Yosef, Shlomo (2006). Introducing Co-payment for Consultant Specialist Services. Isr Med Ass J 8 (8), S.
I-REF	558-562 (http://www.ima.org.il/imaj/ar06aug-9.pdf).
B-REF	Vogel, Rüdiger; Häßner, Konrad (Hrsg.) (1999). Selbstbeteiligung im deutschen Gesundheitswesen.
I-REF	Sachstand, Ausblick und internationaler Vergleich. Georg Thieme Verlag, Stuttgart-New York.
B-REF	Vogt, Albrecht; Bonzel, Tassilo; Harmjanz, Dietrich; von Leitner, Enz-Rüdiger; Pfafferott, Conrad; Engel,
I-REF	Hans-Jürgen; Niederer, Walter; Schuster, Peter; Glunz, Hans-Georg; Neuhaus, Karl-Ludwig für die Arbeits-
I-REF	gemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) study group (1997). PTCA registry of
I-REF	German community hospitals. Eur Heart J 18 (7), S. 1110-1114
I-REF	(http://eurheartj.oxfordjournals.org/cgi/reprint/18/7/1110).
B-REF	Voss, Jens-Uwe; Hassauer, Martin (2004). Vorbeugender Gesundheitsschutz durch Mobilisierung der Min-
I-REF	derungspotentiale bei Straßenverkehrslärm und Luftschadstoffen. Teilprojekt „Risikoberechnung zum Ein-
I-REF	fluss verkehrsbedingter Luftschadstoffe und Straßenverkehrslärm auf die Gesundheit exponierter Personen“.
I-REF	Endbericht: Aktionsprogramm Umwelt und Gesundheit Nordrehin-Westfalen, Düsseldorf
I-REF	(http://www.apug.nrw.de/pdf/minderungspotential2_verkehr.pdf).
B-REF	Wagstaff, Adam; Doorslaer, Eddy van (1992). Equity in the Finance of Health Care: Some International
I-REF	Comparisons. J H Econ 11 (4), S. 361-387.
B-REF	Wagstaff, Adam; Doorslaer, Eddy van; Burg, Hattem van den; Calonge, Samuel; Christiansen, Terkel; Ci-
I-REF	toni, Guido; Gerdtham, Ulf; Gerfin, Michael; Gross, Lorna; Häkkinnen, Unto; Johnson, Paul; John, Jürgen;
I-REF	Klavus, Jan; Lachaud, Claire; Lauritsen, Jørgen; Leu, Robert; Nolan, Brian; Perán, Encarna; Pereira, João;
I-REF	Propper, Carol; Puffer, Frank; Rochaix, Lise; Rodríguez, Marisol; Schellhorn, Martin; Sundberg, Gun;
I-REF	Winkelhake, Olaf (1999). Equity in the Finance of health Care: some further International Comparisons. J H
I-REF	Econ 18 (3), pp. 263-290.
B-REF	Wagstaff, Adam; Doorslaer, Eddy van (2001). Paying for Health Care: Quantifying Fairness, Catastrophe,
I-REF	and Impoverishment, with Applications to Vietnam, 1993-98. Policy Research Working Paper Series 2715,
I-REF	World Bank, Washington (http://econ.worldbank.org/files/2601_wps2715.pdf).
B-REF	Wagstaff, Adam; Pradhan, Menno (2005). Health Insurance Impacts on Health and Nonmedical Consump-
I-REF	tion in a Developing Country. WPS 3565, World Bank, Washington DC (http://www-
I-REF	wds.worldbank.org/servlet/WDSContentServer/WDSP/IB/2005/04/19/000012009_20050419132636/Render
I-REF	ed/PDF/wps3563.pdf).
B-REF	Wallen, John; Roddy, Paul; Fahs, Michael (1982). Cost Sharing, Mental Health Benefits, and Physical
I-REF	Complaints in Retired Miners and Their Families. American Public Health Association, Washington DC.
B-REF	Wallen, Jacqueline; Roddy, Pamela; Meyers, Samuel (1986). Male-female differences in mental health visits
I-REF	under cost-sharing. H Serv Res 21 (2, Part 2), S. 341-350
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1068955&blobtype=pdf).
B-REF	Walley, Tom (1998). Prescription charges: change overdue? Britain can learn from systems of copayments
I-REF	based on drugs' effectiveness. BMJ 317 (7157), S. 487-488
I-REF	(http://www.bmj.com/cgi/content/full/317/7157/487).
B-REF	Walley, Tom; Mrazek, Monique; Mossialos, Elias (2005). Regulating pharmaceutical markets: improving
I-REF	efficiency and controlling costs in the UK. Int J H Plan Mgmt 20 (4), S. 375-398
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/112140377/PDFSTART).
B-REF	Wanless, Derek (2001). Securing our Future Health: Taking a Long-Term View. HM Treasury, London
I-REF	(http://www.hm-treasury.gov.uk).
B-REF	Wanless, Derek (2002). Securing our Health Future: Taking a Long Term View. HM Treasury, London
I-REF	(http://www.hm-treasury.gov.uk/wanless).
B-REF	Ward, Paul; Noyce, Peter; St. Leger, Antony (2007). How equitable are GP practice prescribing rates for
I-REF	statins?: an ecological study in four primary care trusts in North West England. Int J Equ H 6 (2),
I-REF	doi:10.1186/1475-9276-6-2 (http://www.equityhealthj.com/content/pdf/1475-9276-6-2.pdf).
B-REF	Wasem, Jürgen (1999). Das Gesundheitswesen in Deutschland: Einstellungen und Erwartungen in der Be-
I-REF	völkerung. Janssen-Cilag GmbH, Neuss.
B-REF	Waters, Hugh; Morlock, Laura; Hatt, Laurel (2004). Quality-based purchasing in health care. Int J H Plan
I-REF	Mgmt 19 (4), S. 365-381 (http://www3.interscience.wiley.com/cgi-bin/fulltext/109855894/PDFSTART).
B-REF	Wedig, Gerald (1988). Health status and the demand for Health: results on price elasticities. J H Econ 7 (2),
I-REF	S. 151-163.
B-REF	Wedig, Gerard; Mitchell, Janet; Cromwell, Jerry (1989). Can Price Controls Induce Optimal Physician Be-
I-REF	havior? J H Polit Pol Law 14 (3), S. 601- 620 (http://jhppl.dukejournals.org/cgi/reprint/14/3/601).
B-REF	Wehkamp, Karl-Heinz (2004). Ethik der Heilberufe: Brücke zwischen Qualität und Ökonomie. Dt Ärztebl
I-REF	101 (36), S. A-2374 / B-1995 / C-1923
I-REF	(http://www.aerzteblatt.de/v4/archiv/artikel.asp?src=suche&id=43184).
B-REF	Wei, Li; Wang, Jixian; Thompson, Philip; Wong, Suzanne; Struthers, Allan; MacDonald, Thomas (2002).
I-REF	Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up
I-REF	study. Heart 88 (3), S. 229-233 (http://heart.bmjjournals.com/cgi/reprint/88/3/229).
B-REF	Weinick, Robin; Beauregard, Karen (1997). Women's Use of Preventive Screening Services: A Comparison
I-REF	of HMO versus Fee-for-Service Enrollees. Med Care Res Rev 6 (54), S. 176-199
I-REF	(http://mcr.sagepub.com/cgi/reprint/54/2/176).
B-REF	Weinick, Robin; Byron, Sepheen; Bierman, Arlene (2005). Who can't pay for health care? J Gen Int Med 20
I-REF	(6), S. 504-509 (http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1490134&blobtype=pdf;
I-REF	http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1525-1497.2005.0087.x).
B-REF	Weissman, Joel (2005). The Trouble with Uncompensated Hospital Care. N Engl J Med 352 (12), S. 1171-
I-REF	1173 (http://content.nejm.org/cgi/content/full/341/16/1227).
B-REF	Wells, Rebecca; Banaszak-Holl, Jane (2000). A critical reciew of recent US market level health care strat-
I-REF	egy literature. Soc Sc Med 51 (5), S. 639-656.
B-REF	Wells, Kenneth; Manning, Willard; Duan, Naihua; Newhouse, Joseph; Ware, John (1987). Cost-Sharing and
I-REF	the Use of General Medical Physicians for Outpatient Mental Health Care. H Serv Res 22 (1), S. 1-17
I-REF	(http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1065420&blobtype=pdf).
B-REF	Werblow, Andreas (2002). Alles nur Selektion? Der Einfluss von Selbstbehalten in der Gesetzlichen Kran-
I-REF	kenversicherung. Vierteljahreshefte zur Wirtschaftsforschung 71 (4), S. 427-436.
B-REF	Werblow, Andreas; Felder, Stefan (2003). Der Einfluss von freiwilligen Selbstbehalten in der Gesetzlichen
I-REF	Krankenversicherung: Evidenz aus der Schweiz. Schmoller’s Jahrbuch 123, S. 235-264. Duncker & Hum-
I-REF	blot, Berlin.
B-REF	West, Donna; Johnson, Jill; Hong, Song-Hee (2006). A 30-month evaluation of the effects on the cost and
I-REF	utilization of proton pump inhibitors from adding omeprazole OTC to drug benefit coverage in a state em-
I-REF	ployee health plan. J Manag Care Pharm 12 (1), S. 25-32
I-REF	(http://www.amcp.org/data/jmcp/JanFebjournal06.pdf.pdf).
B-REF	Wharam, Frank; Landon, Bruce; Galbraith, Alison; Kleinman, Ken; Soumerai, Stephen; Ross-Degnan, Den-
I-REF	nis (2007). Emergency Department Use and Subsequent Hospitalizations Among Members of a High-
I-REF	Deductible Health Plan. JAMA 297 (10), S. 1093-1102 (http://jama.ama-assn.org/cgi/reprint/297/10/1093).
B-REF	Wheeler, Benedict; Ben-Shlomo, Yoav (2005). Environmental equity, air quality, socioeconomic status, and
I-REF	respiratory health: a linkage analysis of routine data from the Health Survey for England. J Epid Comm H 59
I-REF	(11), S. 948-954 (http://jech.bmj.com/cgi/reprint/59/11/948).
B-REF	White, Jeffrey; Chang, Eunice; Leslie, Scott; Gilderman, Alex; Berenbeim, David; Dezii, Christopher; Me-
I-REF	likian, Caron (2002). Patient adherence with HMG reductase inhibitor therapy among users of two types of
I-REF	prescription services. J Manag Care Pharm 8 (3), S.186-191 (http://www.amcp.org/data/jmcp/Research-186-
I-REF	191.pdf).
B-REF	Whitehead, Margaret; Evandrou, Maria; Haglund, Bengt; Diederrichsen, Finn (1997). As the health divide
I-REF	widens in Sweden and Britain, what’s happening to access to care? BMJ 315 (7114), S. 1006-1009
I-REF	(http://bmj.bmjjournals.com/cgi/content/full/315/7114/1006).
B-REF	Whitehead, Margaret; Dahlgren, Göran; Evans, Timothy (2001). Equity and health sector reforms: can low-
I-REF	income countries escape the medical poverty trap? Lancet 358 (9284), S. 833-836
I-REF	(http://www.thelancet.com/journals/lancet/article/PIIS014067360105975X/fulltext;
I-REF	http://www.deza.ch/ressources/product_22_es_1242.pdf;
I-REF	http://www.healthp.org/article.php?sid=64&mode=thread&order=0&thold=0).
B-REF	Wickizer, Thomas; Schulman, Beryl; Schwartz, Sheryl; Drylie, Diana (1998). Occupational health Services
I-REF	Project. Final Report. Department of Health Services, University of Washington
I-REF	(www.lni.wa.gov/ClaimsIns/Files/ Providers/ohs/Historical/OhsProjectFinalRpt.pdf).
B-REF	Wilkinson, Richard; Marmot, Michael (2003a). Social Determinants of Health: The Facts. 2. Edition, WHO
I-REF	Regional Office for Europe, Kopenhagen. ISBN 92 890 3370 3
I-REF	(http://www.euro.who.int/document/e81384.pdf).
B-REF	Wilkinson, Richard; Marmot, Michael (2004b). Soziale Determinanten von Gesundheit: Die Fakten. 2. Aus-
I-REF	gabe, WHO Regional Office for Europe, Kopenhagen. ISBN 92 890 3370 3
I-REF	(http://www.euro.who.int/document/e81384g.pdf).
B-REF	Williams, Flora; Hagler, Amy; Martin, Marshall; Pritchard, Mary; Bailey, William (1991). Predictors of
I-REF	Out-of-Pocket Medical Expenditures in Low-Income Households. J Fam Econ 12 (1), S. 43-62
I-REF	(http://www.springerlink.de/content/m367n7851h727062/fulltext.pdf).
B-REF	Williams, Robert (1996). The Costs of Visits to Emergency Departments. N Engl J Med 334 (10), S. 642-
I-REF	646 (http://content.nejm.org/cgi/reprint/334/10/642.pdf).
B-REF	Willison, Donald; Miktorowicz, Mary; Grootendorst, Paul; O’Brien, Bernie; Levien, Mitchell; Deber, Raisa;
I-REF	Hurley, Jeremiah (2001). International Experience with Pharmaceutical Policy: Common Challenges and
I-REF	Lessons for Canada. Research Working Paper 01-08, Centre for Health Economics and Policy Analysis
I-REF	(CHEPA), McMaster University, Hamilton (http://www.chepa.org/research/01-08.pdf).
B-REF	Wilson, Marcia; Levi, Jeffrey; Owen, Aimee (2002). Mitigating Financial Risk with HIV/AIDS Patients.
I-REF	Center for Health Services Research and Policy. Washington DC
I-REF	(http://www.gwumc.edu/sphhs/healthpolicy/chsrp/downloads/MitigatingHIV.pdf).
B-REF	Wilson, Ira; Rogers, William; Chang, Hong; Safran, Dana (2005). Cost-related skipping of medications and
I-REF	other treatments among Medicare beneficiaries between 1998 and 2000. J Gen Int Med 20 (8), S. 715-720
I-REF	(http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1525-1497.2005.0128.x;
I-REF	http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1490185&blobtype=pdf).
B-REF	Wilson, Ira; Schoen, Cathy; Neuman, Patricia; Kitchman Strollo, Michelle; Rogers, William; Chang, Hong;
I-REF	Safran, Dana (2007). Physician–Patient Communication About Prescription Medication. Nonadherence: A
I-REF	50-State Study of America’s Seniors. J Gen Int Med 22 (1), S 6–12
I-REF	(http://www.springerlink.com/content/f88n482w643p1477/fulltext.pdf;
I-REF	http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1824770&blobtype=pdf).
B-REF	Windeler, Jürgen (2006). Individuelle Gesundheitsleistungen – Spagat zwischen Markt und Medizin. G+G
I-REF	Wissenschaft 2/2006, S. 17-27. Wissenschaftliches Institut der AOK, Bonn
I-REF	(http://wido.de/fileadmin/wido/downloads/pdf_ggw/wido_ggw_aufs2_0406.pdf).
B-REF	Winkelmann, Rainer (2004). Co-payments for prescription drugs and the demand for doctor visits – evi-
I-REF	dence from a natural experiment. H Econ 13 (11), S. 1081-1089 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/107628897/PDFSTART).
B-REF	Winkelmann, Rainer (2004). Health Care Reform and the Number of Doctor Visits – An Econometric
I-REF	Analysis. J Appl Econ 19 (4), S. 455–472 (http://www3.interscience.wiley.com/cgi-
I-REF	bin/fulltext/109581132/PDFSTART).
B-REF	Wolf, Peter de; Brouwer, Werner; Rutten, Frans; (2005). Regulating the Dutch pharmaceutical market: im-
I-REF	proving efficiency or controlling costs? Int J H Plan Mgmt 20 (4), S. 351-374
I-REF	(http://www3.interscience.wiley.com/cgi-bin/fulltext/112140376/PDFSTART).
B-REF	Wong, Mitchell; Andersen, Ronald; Sherbourne, Cathy; Hays, Ron; Shapiro, Martin (2001). Effects of Cost
I-REF	Sharing on Care Seeking and Health Status: Results From the Medical Outcomes Study. Am J Pub H 91
I-REF	(11), S. 1889-1894 (http://www.ajph.org/cgi/reprint/91/11/1889).
B-REF	Woolhandler, Steffie; Himmelstein, David; Lewontin, James (1993). Administrative Costs in U.S. Hospitals.
I-REF	N Engl J Med 329 (5), S. 400-403 (http://content.nejm.org/cgi/content/full/329/6/400).
B-REF	Woolhandler, Steffie; Himmelstein, David (1997). Costs of Care and Administration at For-Profit and Other
I-REF	Hospitals in the United States. N Engl J Med 336 (11), S. 769-774
I-REF	(http://content.nejm.org/cgi/reprint/336/11/769.pdf).
B-REF	Woolhandler, Steffie; Campbell, Terry; Himmelstein, David (2003). Costs of Health Care Administration in
I-REF	the United States and Canada. N Engl J Med 349 (8), S. 768-775
I-REF	(http://content.nejm.org/cgi/reprint/349/8/768.pdf).
B-REF	World Health Organisation (1996). European Health Care Reforms. Analysis of Current Strategies. Region-
I-REF	albüro für Europa, Kopenhagen.
B-REF	World Health Organisation (2004). Ottawa-Charta zur Gesundheitsförderung. WHO-autorisierte Überset-
I-REF	zung: Hildebrandt/Kickbusch auf der Basis von Entwürfen aus der DDR und von Badura sowie Milz. Regi-
I-REF	onalbüro für Europa, Kopenhagen (http://www.cvl-a.tum.de/Download/WHO_Ottawa.pdf).
B-REF	Wortley, Pascale; Levy, Paul; Quick, Linda; Shoemaker, Trevor; Dahlke, Melissa; Evans, Brian; Burke,
I-REF	Brian; Schwartz, Benjamin (2007). Predictors of Smallpox Vaccination Among Healthcare Workers and
I-REF	Other First Responders. Am J Prev Med 32 (6), S. 538-541.
B-REF	Wurzer, Alfred; Robinig, Roswitha; Rodler, Josef (2004). Selbstbehalte. Eine Bestandsaufnahmezur Orien-
I-REF	tierungshilfe. Kärntner Gebietskrankenkasse, Klagenfurt.
B-REF	Xu, Ke; Evans, David; Kawabata, Kei; Zeramdini, Riadh; Klavus, Jan; Murray, Christopher (2003). House-
I-REF	hold catastrophic health expenditure: a multicountry analysis. Lancet 362 (9378), S. 111–117
I-REF	(http://www.thelancet.com/journals/lancet/article/PIIS0140673603138615/fulltext;
I-REF	http://www.who.int/health_financing/Lancet%20paper-catastrophic%20expenditure.pdf).
B-REF	Xu, Ke; Evans, David; Kadama, Patrick; Nabyonga, Juliet; Ogwang Ogwal, Peter; Aguilar, Ana M. (2005).
I-REF	The elimination of user fees in Uganda: impact on utilization and catastrophic health expenditures. WHO,
I-REF	Genf
I-REF	(http://www.who.int/health_financing/The%20elimination%20of%20user%20fees%20in%20Uganda%20%
I-REF	20DP.05.4.pdf;
I-REF	http://www.who.int/health_financing/Understanding%20the%20impact%20of%20eliminating%20user%20f
I-REF	ees.pdf).
B-REF	Yang, Zhou, Gilleskie, Donna; Norton, Edward (2004). Prescription Drugs, Medical Care, And Health Out-
I-REF	comes: A Model of Elderly Health Dynamics. NBER Working Paper 10964, National Bureau for Economic
I-REF	Research, Washington DC (http://www.nber.org/papers/w10964).
B-REF	Yang, Zhou; Olomu, Ade; Corser, William; Rovner, David; Holmes-Rovner, Margaret (2006). Outpatient
I-REF	Medication Use and Health Outcomes in Post-Acute Coronary Syndrome Patients. Am J Manag Care 12
I-REF	(10), S. 581-587 (http://www.ajmc.com/files/articlefiles/AJMC06_Yang581to587.pdf).
B-REF	Yegian, Mathews (2006). Coordinated Care In A ‘Consumer-Driven' Health System. H Aff 25 (6), S. w531-
I-REF	w536 (http://content.healthaffairs.org/cgi/content/full/hlthaff.25.w531v1/DC1).
B-REF	Zahnforum (2004). Gesundheitsreform bringt Einsparungen bei Patienten ärgern sich über Zuzahlungen.
I-REF	Kassenzahnärztliche Vereinigung Baden-Württemberg, Freiburg (http://www.zahn-
I-REF	fo-
I-REF	rum.de/zf/zf.nsf/ContentByKey/6B0D49708F17F722C1256E4D002EADBB?open&WDT=Print_Standard_
I-REF	PA&DL=Print).
B-REF	Zeber, John; Grazier, Kyle; Valenstein, Marcia; Blow, Frederic; Lantz, Paula (2007). Effect of a Medication
I-REF	Copayment Increase in Veterans With Schizophrenia. Am J Man Care 13 (6, Part 2), S. 335-346
I-REF	(http://www.ajmc.com/files/articlefiles/AJMC_07junPrt2_Zeber_335to46.pdf).
B-REF	Zeckhauser, Richard (1970). Medical Insurance: A Case Study of the Tradeoff Between Risk Spreading and
I-REF	Appropriate Incentives. J Econ Theory 2 (1), S. 10-26.
B-REF	Zentner, Annette; Busse, Reinhard (2004). Das Ausland in aller Munde: Eine systematische Analyse zum
I-REF	Einfluss anderer Gesundheitssysteme auf die deutsche Reformdebatte. Gesundheits- und Sozialpolitik 9-
I-REF	10/2004, S. 24-34 (http://www.wm.tu-berlin.de/~mig/papers/index.html).
B-REF	Zimmermann, Gerd (2004). Praxisgebühr seit dem 1.1.2004. Verwaltungstechnischer Schwachsinn!. Der
I-REF	Hausarzt 1/04, S. 1 (http://www.hausarzt-online.de/sys/pdf.php?rubrik=ha&url=0104/01.pdf;
I-REF	http://www.medizin-online.de/cda/DisplayContent.do?cid=103475&fid=107664&type=pdf).
B-REF	Zimmermann, Gerd (2005). Budgetkontrollen verhindern? Kassen regeln pauschale Zuzahlung selbst. Der
I-REF	Hausarzt 3/05, S. 1 (http://www.hausarzt-online.de/sys/pdf.php?rubrik=ha&url=0104/01.pdf;
I-REF	http://www.medizin-online.de/cda/DisplayContent.do?cid=149616&fid=107664&type=pdf).
B-REF	Ziniel, Georg (2004). Finanzielle Selbstbeteiligung im Gesundheitswesen. In: Wurzer et al. 2004, S. 31-47.
B-REF	Zok, Klaus (2005a). Das Inanspruchnahmeverhalten der Versicherten nach Einführung der Praxisgebühr.
I-REF	Ergebnisse aus zwei Repräsentativumfragen unter 3.000 GKV-Versicherten. WidO-Monitor 2 (2), S. 1-7,
I-REF	(http://wido.de/uploads/media/wido_mon_praxisgeb_3108.pdf).
B-REF	Zok, Klaus; Schuldzinski, Wolfgang (2005b). Private Zusatzleistungen in der Arztpraxis – Ergebnisse aus
I-REF	Patientenbefragungen. Wissenschaftliches Institut der AOK, Bonn
B-REF	Zok, Klaus (2006). Arzneimittelmarkt: Selbstmedikation im Fokus. WiDO-Monitor 3 (1), S. 1-7
I-REF	(http://wido.de/uploads/media/wido_mon_selbstmed_0506.pdf).
B-REF	Zuckerman, Stephen; McFeeters, Joshua; Cunningham, Peter; Nichols, Len (2004). Trends: Changes In
I-REF	Medicaid Physician Fees, 1998-2003: Implications For Physician Participation. H Aff Web Excl 23 (3), S.
I-REF	w4 372-384 (http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.374v1).
B-REF	Zurn, Pascal; Dal Poz, Mario; Stilwell, Barbara; Adams, Orvill (2002). Imbalances in the health workforce.
I-REF	Briefing paper. WHO, Genf (http://www.who.int/hrh/documents/en/imbalances_briefing.pdf).
B-REF	Zuvekas, Samuel; Cohen, Joel (2007). Prescription Drugs And The Changing Concentration Of Health Care
I-REF	Expenditures. H Aff 26 (1), S. 249-257 (http://content.healthaffairs.org/cgi/reprint/26/1/249).
B-REF	Zweifel, Peter (1987). Bonus systems in health insurance: a microeconomic analysis. H Pol 7 (2), S. 273-
I-REF	288.
